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ABSTRACT 
Over the past three decades, concerns have been raised regarding the potential adverse effects of 
certain natural and synthetic chemicals that can disrupt the endocrine systems of humans and 
wildlife. These endocrine disrupting chemicals (EDCs) have been reported to cause developmental 
and reproductive effects at low concentrations (ng/L) in many vertebrate species, particularly in 
aquatic organisms such as fish. One of the most prevalent sources of EDCs in aquatic environments 
is municipal wastewater effluents (MWWEs). This is because conventional wastewater treatment 
systems are inefficient at removing many of the diverse contaminants present in raw sewage, 
including EDCs. Although multiple initiatives have been initiated to establish standardized testing 
and monitoring criteria for EDCs in the environment worldwide, our understanding of the 
contribution of MWWEs to endocrine disruption in Canadian surface waters is incomplete. 
Therefore, the main aims of this project were to 1) further our understanding of the contribution 
of MWWEs to the contamination of freshwater bodies in Canada with EDCs, and to 2) characterize 
the removal efficiency of EDCs by six wastewater treatment plants (WWTPs) across Canada.  
Specifically, this study explored the presence of EDCs and their potencies in influents and effluents 
as a function of wastewater treatment level/system, climate/seasonality and population size served 
by the WWTP using a combination of three in vitro bioassays and targeted chemical analysis. The 
MVLN, MDAkb2, and H295R Steroidogenesis assays were applied to assess (anti-)estrogenic, 
(anti-)androgenic and steroidogenesis disrupting potentials, respectively, of extracts of influents 
and effluents collected throughout the year from the WWTPs of the cities of Saskatoon (SK), 
Regina (SK), Guelph (ON), Kitchener (ON), Quebec City (QB) and Montreal (QB).  In parallel, 
targeted chemical analysis was performed to determine the presence of selected chemicals with 
proven or suspected endocrine activities, and results were correlated with bioactivities determined 
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in vitro. Overall, influents showed great androgenic activities regardless of treatment plant while 
significant estrogenic potentials were only observed in a few cases such as Regina effluent and 
Montreal influent. With the exception of Montreal, high to moderate treatment efficiencies of 
WWTPs occurred for the removal of androgens, while low or no removal of substances with 
estrogenic properties was observed. Significant anti-estrogenic and anti-androgenic potentials 
were detected in most of the influent and effluent samples, regardless of the treatment level. In 
general, WWTPs representing less advanced treatment technologies were less efficient at 
removing certain endocrine active substances. In particular, effluents from the two lagoon-based 
facilities, Regina and Montreal, had significant remaining estrogenic and androgenic activities, 
respectively. Furthermore, population size seemed to play an important role regarding EDC 
removal, with WWTPs serving greater than 500,000 habitants showing decreased removal of 
compounds with endocrine activities in general. However, given the limited sample size (only two 
of the cities investigated had populations greater than 500,000 inhabitants) it cannot be determined 
with certainty whether this decreased removal efficiency was a result of population size or simply 
insufficient capacities of the WWTPs. Thus, additional studies including more treatment facilities 
with different treatment levels and larger population sizes should be conducted to determine 
whether population does significantly affect the removal of EDCs. Furthermore, our original 
hypothesis that extremely cold temperatures would result in decreased efficiency of EDC removal 
due to reduced biological activity and light exposure was not always supported by the results. 
Samples collected during the spring season had the highest endocrine activities overall, which 
could potentially be a result of colder months. However, neither early nor late winter samples 
showed a comparable effect on removal efficiency. The observation that spring samples had the 
greatest endocrine activities may be of significant ecological concern as this season coincides with 
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the spawning season of many fishes. This concern was further corroborated by two parallel studies 
that investigated the impacts of MWWEs collected from the Regina and Saskatoon WWTPs on 
fish.  These studies observed general inhibition of reproductive functions such as delayed 
maturation, degeneration of gonadal tissues, reduction in the expression of secondary sex 
characteristics, and significant reduction of fecundity in fathead minnows exposed to both diluted 
effluents or that were collected downstream of the WWTP outflow of Regina. The observation 
that antagonistic effects at both the ER and AR represented the most prevalent endocrine potentials 
was also supported by chemical analysis that revealed greater concentrations of compounds with 
the ability to act as ER and AR antagonists, while there were low concentrations or no presence of 
chemicals previously shown to agonistically interact with these receptors. The results obtained by 
the combination of in vitro and the two parallel in vivo and chemical analysis demonstrated that in 
vitro assays can be used as a cost-effective tool for prioritizing potential endocrine disrupting 
impacts of MWWEs in aquatic environments. The significant endocrine activity, in particular, 
antagonism of sex steroid receptors, warrants further investigations to characterize the actual risks 
they may pose to aquatic wildlife. This is particularly true in cases where WWTPs utilize primary 
and/or outdated lagoon-based treatment technologies, such as Regina and Montreal. Furthermore, 
in cases where effluent flow is proportionally higher than that of the receiving water body, which 
can be encountered in many urban municipalities in semi-arid regions such as Regina in southern 
Saskatchewan, or in situations where the population is greater than WWTPs’ treatment capacity, 
bypassing untreated sewage, downstream ecosystems may be of particular risk. 
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PREFACE 
This thesis is written in manuscript style format. Chapter 1 is a general introduction and literature 
review of endocrine disrupting chemicals, their occurrence, and sources, known effects on aquatic 
life, as well as methods of detection, and also provides a brief review of the concept of effect-
directed analysis. Chapters 2 and 3 are organized as manuscripts for publication in peer-reviewed 
scientific journals. Chapter 4 is a general discussion and synthesizes the findings of Chapters 2 
and 3 and relates them to the overall objectives this thesis set out to address. As a consequence, 
there may be some repetition between the introduction, materials and methods, results and 
discussion sections in each chapter. 
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CHAPTER 1: GENERAL INTRODUCTION 
Municipal wastewater effluents (MWWEs) contain complex mixtures of chemicals that are diverse 
in their structures and biological activities (Reemtsma et al. 1999). There has been increasing 
concern that some of these chemicals have the potential to disrupt the endocrine system of 
organisms, which can impact growth, development, and reproduction (Jobling et al. 1998; Hecker 
et al. 2006; Kidd et al. 2007). These endocrine disrupting chemicals (EDCs) differ from traditional 
contaminants such as metals and dioxin-like chemicals in that they can be biologically active at 
very low concentrations, creating unique challenges for traditional risk assessment approaches 
(Hecker and Hollert 2009). In addition to several well-described EDCs such as natural or synthetic 
steroid hormones, plasticizers, etc., MWWEs also contain a large number of unknown chemicals 
that are likely to contribute to environmental endocrine disruption. Therefore, specific screening 
programs such as the United States Environmental Protection Agency’s (US-EPA) Endocrine 
Disruptor Screening Program (EDSP) have been established to assess the potential hazards that 
these chemicals may pose to humans and wildlife. Specifically, programs like the EDSP aim to 
identify chemicals with specific endocrine properties including those that have the potential to 
interact with the estrogen receptor (ER), androgen receptor (AR) and sex-hormone 
steroidogenesis.     
Traditionally, analytical chemistry has been utilized to identify EDCs in complex mixtures such 
as MWWEs (Burgess et al. 2013). However, this approach is limited as it does not provide a 
complete analysis of all biologically active contaminants in a sample, and also does not account 
for potential interactions of the different compounds present in these mixtures (Samolloff et al. 
1983; Ankley, Gerald T. and Mount 1996). Therefore, alternative approaches are needed to better 
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characterize the overall endocrine disrupting potential of these effluents. One such approach 
involves the use of targeted in vitro bioassays that enable characterization of the specific endocrine 
activity of complex mixtures since they respond to all chemicals with the same mode of action in 
a mixture, including unknowns and those for which no analytical detection methods are available 
(Wilson et al. 2002, 2004; Hecker et al. 2006; Hecker and Giesy 2011). Specifically, this study 
aimed to apply an in vitro bioassay-directed approach using a combination of receptor- and non-
receptor-mediated cell-based bioassays as well as targeted chemical analysis to characterize 
endocrine potentials in influents and effluents of six WWTPs across Canada.   
1.1 Endocrine disruption  
Endocrine disrupting chemicals are a heterogeneous group of natural and synthetic compounds 
that can mimic the action of endogenous hormones and/or affect their production, elimination or 
transport (Sonnenschein and Soto 1998), thus disrupting the homeostatic systems of organisms 
(Kavlock et al. 1996). Much of the past research on endocrine disruption has focused on the 
agonistic or antagonistic interaction of chemicals with nuclear hormone receptors, specifically the 
ER and AR. Disruption of ER- and AR-signaling pathways can result in alterations of several 
physiological processes in fish, birds, and mammals, including impacts on early embryonic 
development, growth, and reproductive success or fecundity (Colborn et al. 1993; Janošek et al. 
2006). For example, elevated concentrations of estrogens from municipal effluents led to 
feminization and infertility of male fish in UK rivers resulting in intersex in male fish, 
characterized by the presence of both male and female gonadal characteristics in the same 
organism (Jobling et al. 1998). Furthermore, there is increasing evidence to suggest that chemicals 
that antagonistically bind to steroid hormone receptors, such as anti-estrogenic (e.g. ibuprofen and 
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naproxen) and anti-androgenic (e.g. carbamazepine, gemfibrozil, DEET) compounds, have the 
potential to affect the nervous systems of wildlife and humans, as well as the potential to alter 
behavior and diminish immune system responses (Colborn et al. 1993; Heberer 2002; Stackelberg 
et al. 2004; Sumpter 2008; Kloas et al. 2009; Zenobio et al. 2014; Ezechiáš et al. 2016; Fraz et al. 
2018). Additionally, it has been established that certain chemicals have the ability to inhibit 
enzymes involved in steroid biosynthesis, resulting in significant reproductive abnormalities in 
aquatic animals including, but not limited to, decreased testosterone (T) or 17β-estradiol (E2) 
production (Villeneuve et al. 2007; Ezechiáš et al. 2016; Fraz et al. 2018). 
1.2 Types of endocrine disruption 
Many EDCs are found at elevated concentrations in MWWEs due to anthropogenic activities 
(Boxall et al., 2012), and from which they are then released into the aquatic environments with the 
potential to cause adverse effects in organisms living in downstream environments. Several of 
these EDCs are relatively new and have very little information available regarding their 
toxicological properties (Vandenberg et al. 2012). Hence, there is an increasing need for the 
characterization of the fate and effects of these chemicals to organisms that are at risk of exposure. 
Most of the research that has been performed to date has focused on exogenous chemicals causing 
endocrine disrupting effects through binding to the ER, and to a lesser extent to the AR. Disruption 
of normal estrogen signaling can occur when a compound either agonistically or anatgonistically 
binds to the ER (Björnström and Sjöberg 2005; Leung et al. 2006). Common chemicals that have 
been reported to act as estrogens include the natural or synthetic steroid hormones estrone (E1), 
estradiol (E2), and ethinylestradiol (EE2), as well as several plasticizers and surfactants including 
bisphenol-A (BPA), octylphenol (OP) and nonylphenol (NP) (Metcalfe et al. 2001; Rodgers-Gray 
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et al. 2001; Ankley et al. 2003; Kidd et al. 2007; Wright-walters et al. 2007; Sousa et al. 2010a; 
Jarošová et al. 2014b). 
Although there has been a great focus on EDCs that target estrogen-dependent pathways (Sumpter, 
2008), equal importance should be placed on chemicals that interact with other pathways of the 
endocrine system.  In particular, chemicals with (anti-)androgenic properties such as DEET and 
triclosan are of concern, as they are thought to be abundant within aquatic environments and there 
is increasing research linking the presence of (anti-)androgenic chemicals to some forms of 
reproductive abnormalities or deficiencies (Johnson et al. 2007; Jobling et al. 2009a; Hill et al. 
2010). Therefore, additional research is required to determine the biological significance of (anti-
) androgenic compounds, as there is still little information about the distribution and identity of 
these substances.   
Although the ability of a chemical to agonistically or antagonistically bind to sex steroid receptors 
represents a biological relevant mechanism of endocrine disruption, there are a number of non-
receptor mediated process such as the synthesis or elimination of hormones that present an equal 
concern with regard to endocrine disruption (Sanderson, 2000; Sanderson et al., 2002). 
Specifically, several studies have found substances in the environment that have the potential to 
disrupt the production of the natural sex steroid hormones E2 or testosterone (T) (Bláha et al. 2006; 
Hecker and Hollert 2011). For example, polybrominated diphenyl ethers (PBDEs) used as additive 
flame retardants were found to disrupt steroidogenesis in vitro by decreasing E2 production (He et 
al. 2008). Furthermore, ibuprofen was found to decrease E2 production in vitro and in vivo 
resulting in impaired sperm motility and reproduction of aquatic organisms (Han et al. 2010). 
Therefore, the combination of receptor-mediated and non-receptor-mediated assays is pertinent 
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for a comprehensive assessment of the potential endocrine activity of chemicals of concern or 
complex environmental samples (Grund et al. 2011; Hecker and Hollert 2011; Maletz et al. 2013).  
1.2.1 ER receptor-mediated endocrine disruption 
Estrogens are responsible for mediating several female reproductive functions including 
development of feminine sexual characteristics and ovarian maturation, and are primarily 
synthesized by the gonads; and in most cases, higher amounts are present in females than in males 
(Wallace 1985; Bondesson et al. 2015). However, according to several studies, human estrogens 
such as E2, E1, and the synthetic estrogen EE2, which are released through MWWEs into the 
environment, are responsible for a significant portion of the endocrine disrupting effects seen in 
aquatic systems (Desbrow et al. 1998; Snyder et al. 2001). Estrogens control the expression of 
specific genes through the interaction of the ligand-bound ER dimer complex with specific DNA 
sequences called estrogen-responsive elements (ERE). As a result of this interaction, the 
expression of specific proteins is regulated by cells that regulate physiological functions (Colborn 
and Clement, 1992; Colborn et al., 1995). There are two types of ERs; membrane-bound ERs and 
nuclear ERs, but the majority of related research has focused on nuclear ERs. Once an estrogenic 
compound (e.g. EE2) binds to the nuclear ER, the ER homodimerizes and interacts with the ERE, 
which then can trigger the transcription of genes involved in estrogenic response pathways (Figure 
1.1) (Gogos et al. 2015). Alternately, membrane ERs, although less researched, also have the 
ability to elicit an estrogenic response when bound by an estrogenic compound. Pang and Thomas 
(2010) established that zebrafish oocytes exposed to E2 displayed estrogenic responses through 
the biding of the membrane ERs. In addition to its natural ligands, the ER is known for binding 
compounds that have structural similarity to estrogen hormones, which can result in an unwanted 
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estrogenic response. For example, EE2 is a synthetic estrogen that is present in the vast majority 
of birth control medication and is excreted by women in an inactive form.  However, it can be 
reactivated during the wastewater treatment process by deconjugation (Peter Guengerich 1990; 
Larsen et al. 2008). EE2 is considered an EDC as it induces estrogenic responses, and as such can 
disrupt normal endocrine functions of non-target organisms affecting their reproduction, 
development, behaviour, and general homeostasis (Nasuhoglu et al. 2012). EE2 is more persistent 
compared to naturally occurring estrogens (e.g. E2) (Larsen et al. 2008) and has been detected in 
Canadian wastewater effluents as high as 42 ng/L (Ternes et al. 1999). Adverse effects, such as 
(de)feminization, (de)masculinization, or intersex in aquatic organisms induced by EE2 at 
environmentally relevant concentrations have been observed in several studies (Seki et al. 2002; 
Chikae et al. 2003; Örn et al. 2003, 2006). In addition, exposure to EE2 induces synthesis of 
vitellogenin (Vtg), a yolk protein precursor that is under strict estrogen control, delay in time to 
spawn, altered mating behaviour, and a decrease in growth, egg number and fertilization success 
at environmentally relevant concentrations as low as 0.1 to 10 ng/L (Purdom et al. 1994; Rose et 
al. 2002; Segner et al. 2003; Nash et al. 2004; Kidd et al. 2007; Larsen et al. 2008; Lange et al. 
2009). In addition to EE2 and other estrogenic steroids such as E1, E2, and E3, it has been 
established that other chemicals such as genistein and BPA can induce estrogenic responses 
through agonistic binding to the ER (Chikae et al. 2003; Schiller et al. 2013).  
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Figure 1.1 – Schematic representation of the cellular response to an ER ligand), such as 17α-
ethynylestradiol (EE2). Figure adapted from Gogos et al. (2015). For a detailed description, please 
see text.   
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1.2.2 AR receptor-mediated endocrine disruption 
The AR is a soluble nuclear receptor protein that predominantly occurs in the cytoplasm. The AR 
binds androgens such as T, 11-ketotestosterone (11-keto, the active androgen in most fishes) and 
dihydrotestosterone (DHT, the active androgen in mammals) as well as synthetics androgens (e.g. 
trenbolone, a cattle growth promotor) to induce a receptor-mediated response mediating male 
reproduction and anabolic growth promotion. By binding to the AR and inducing a cascade of 
hormone responses, androgens stimulate and control the development and maintenance of 
masculine characteristics (Weiss et al. 2009). Androgens play decisive roles in sexual 
differentiation of the male reproductive tract, accessory reproductive organs, and other tissues 
during fetal developments (Clark et al. 1998). Binding of androgens such as T and methyl-
testosterone to the AR prompts activation of the receptor (AR agonism) resulting in transcription 
of genes responsible for androgenic effects, similar to the ER receptor (Figure 1.1). Although the 
AR is regulated mainly by androgens, other hormones or chemicals can affect the process as well 
by acting as androgen agonists or antagonists. For example, female fish exposed to the anabolic 
androgen 17β-trenbolone showed a significant increase in masculinization and decrease in Vtg 
production, as well as increased testicular area and sperm percentage after exposure to 50 ng/L in 
zebrafish and Japanese medaka (Örn et al. 2006). Additionally, the metabolite of the pesticide 
dichloro-diphenyl-trichloroethane (DDT), 1,1-Dichloro-2,2-bis(p-chlorophenyl) ethylene (DDE), 
was found to act as an androgen, as female amphibians exposed to DDE exhibited occurrence of 
intersex, thus hindering the sexual delineation and maturation of these organisms (Clark et al. 
1998; Boelsterli 2003). Furthermore, environmental pollutants such as pesticides and industrial 
chemicals, have been found to interfere with the androgen system in both wildlife and humans, 
mainly by antagonistically binding to the AR (Weiss et al. 2009; Jálová et al. 2013). For example, 
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anti-androgens such as flutamide, linuron or atrazine have the ability to bind to the AR, but cannot 
activate the receptor, resulting in AR antagonism (Orton et al. 2009; Weiss et al. 2009; Jálová et 
al. 2013). To date, only a few studies have focused on compounds with the ability to act as 
androgen agonists altering endocrine systems, and even less research focusing on the antagonist 
effects, rendering aquatic environments to potential endocrine risks. 
1.2.3 Non-receptor mediated endocrine disruption 
There are multiple mechanisms within an organism that regulate the concentrations of circulating 
sex steroid hormones, and which help to ensure its normal growth, development, and reproduction. 
Steroidogenesis, or the synthesis of sex steroid hormones, as well as the production of 
glucocorticoids (cortisol) and mineralocorticoids (aldosterone), is one of these key processes that 
increases the concentration of steroid hormones when needed (Hecker et al. 2006). Another 
important factor regulating the availability of hormones are steroid-binding proteins that act as 
transporter proteins that carry sex steroids throughout the body (Burton and Westphal, 1972). 
While bound to the protein the sex steroid is inactive, rendering it unable to interact with a target 
receptor. In a normal functioning state, steroid binding proteins are responsible for ensuring the 
protection of sex steroids from excretion and metabolism. Finally, eliminatory metabolic processes 
represent an important regulatory mechanism to maintain endocrine homeostasis as they ensure 
removal of hormones after they exerted their specific function. When the process is performing 
properly, the interplay among synthesis, transport as well as metabolism and excretion of steroid 
hormones are balanced to ensure proper hormone concentrations at target tissues. However, some 
chemicals have been shown to affect steroidogenesis, the biosynthesis of steroid hormones (Figure 
1.2). For example, exposure to two common pharmaceutical drugs, gemfibrozil, and 
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carbamazepine have been found to decrease the production of 11-keto in zebrafish, which resulted 
in the decreased whole body, plasma, and testicular hormone levels, as well as reduced 
reproductive output (Fraz et al. 2018). Therefore, in addition to chemicals that can agonistically or 
antagonistically bind to the ER and AR, non-receptor mediated processes can significantly alter 
endocrine functions, specifically if disruption of the synthesis or metabolism/excretion of steroid 
hormones occurs.              
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Figure 1.2 – Schematic of hormone production response of H295R cells exposed to chemicals 
such as gemfibrozil and carbamazepine (adapted from Wang et al. 2015).  
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1.3 Sources of endocrine disrupting chemicals in aquatic environments 
EDCs are introduced into water bodies through a number of different pathways such as runoff 
from agricultural areas, industrial effluents, and MWWEs discharged into streams, rivers, lakes, 
and reservoirs (Clara et al. 2005; Benotti et al. 2009). Among the sources of EDCs, MMWEs are 
considered to be the main contributor to the contamination of aquatic environments with these 
compounds (Johnson et al. 2007). EDCs found in wastewater include complex mixtures of natural 
and synthetic hormones (e.g. E2, E1 and EE2) (Ternes et al. 1999; Carballa et al. 2004), plasticizers 
such as BPA and phthalates, a large number of pharmaceuticals and personal care products 
(PPCPs), and organic detergents (e.g. nonylphenol) (Metcalf et al. 1973; Jobling et al. 1995; Giesy 
et al. 2002; Lahnsteiner et al. 2005). MWWEs have been reported to contain compounds with the 
ability to cause (anti-)estrogenic and (anti-)androgenic effects in aquatic organisms (Purdom et al. 
1994).   
Traditionally, WWTPs were designed for the removal of organic nutrients, nitrate, and 
phosphorus; however, removal or breakdown of other contaminants such as PPCPs, industrial 
chemicals, and detergents is typically incomplete. Studies have demonstrated that some EDCs can 
be partially removed from wastewater by WWTPs with efficiencies ranging between 60% and 
90%, while others pass through without any reduction in concentration (Carballa et al. 2004; Clara 
et al. 2005; Fent et al. 2006; Díaz-Cruz et al. 2009), rendering receiving aquatic environments at 
risk from the exposure to EDCs (Halling-Sørensen et al. 1998; Daughton and Ternes 1999; 
Kümmerer 2001; Zorita et al. 2009). Pharmaceuticals that pass through the human body can be 
excreted in their native form or as metabolites, and a significant un-metabolized fraction is 
discarded into municipal wastewater (Ternes 1998a; Falconer et al. 2006; Fent et al. 2006). 
Because pharmaceuticals are designed with a specific mode of action, they typically have high 
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potency at low concentrations, stable molecular structure, and are relatively persistent in order to 
reach their target site in the body before degrading. It is these properties that render PPCPs of 
particular toxicological concern for aquatic organisms (Fent et al. 2006). Although some PPCPs 
may be partially broken down during wastewater treatment processes, their continuous release can 
result in pseudo-persistence in the environment (Daughton and Ternes 1999; Loos et al. 2009). In 
addition to PPCPs, naturally produced hormones and steroids have been frequently found in 
surface and groundwater in trace amounts (Barnes et al. 2008). Pharmaceuticals are typically found 
at greater concentrations in surface waters than groundwater, suggesting that discharge of 
MWWEs may be the most prominent source of EDCs into the aquatic environment (Barnes et al. 
2008).  
1.4 Municipal wastewater treatment systems 
Traditional wastewater treatment facilities were mainly designed to remove bacteria and organic 
materials from raw sewage, and thus, many other contaminants including EDCs are not or only 
partially broken down during the treatment process. As EDCs can be biologically active at very 
low concentrations, the inability to remove these chemicals raises a significant concern for 
receiving environments. Several studies have demonstrated that more advanced treatment facilities 
have the ability to better remove some EDCs of concern from wastewater using activated sludge, 
ultraviolet (UV) irradiation, ozonation and other advanced treatments (Kirk et al. 2002; Leusch et 
al. 2005; Rostkowski et al. 2011). According to ERRIS (2013), levels of wastewater treatments 
vary greatly in Canada, ranging from primary treatments to advanced quaternary treatments 
(Figures 1.3 to 1.6).  In brief, primary treatment systems mainly remove solids, using screening 
and chemical flocculation to help the breakdown of materials and some chemicals (Figures 1.3 and 
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1.4).  Secondary treatment involves extended aeration, and can also involve an activated sludge 
treatment step, which replaces some of the chemical flocculation with biological treatment steps 
comprising digesters with bacteria (Figures 1.3 and 1.5).  Tertiary treatments are characterized by 
even more advanced technologies including biofiltration of nutrients, ammonia, nitrogen, and 
phosphorus, decreasing the need for the use of chemicals and their discharge into aquatic 
environments (Figures 1.3 and 1.6). Some facilities also include disinfection systems using 
chlorine, hypochlorite or UV radiation. Quaternary treatment facilities further enhance the quality 
of effluent, including potential removal of chemicals such as EDCs, by using ozonation, reverse 
osmosis, membrane filtration and activated carbon technologies (Figure 1.3) (CCME, 2006). 
However, due to their high cost, most WWTPs in Canada do not have tertiary or quaternary 
processes established.  
Although there has been a growing number of approaches for the assessment of individual EDCs 
in context with chemical risk assessment, there is only limited information regarding the 
effectiveness of current WWTPs technologies to remove EDCs from wastewater. Research that 
focuses on determining the efficiencies of existing systems will help guide governments and other 
decision-making bodies in implementing cost-effective solutions for EDC removal.     
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Figure 1.3 – Overview of the different types of treatments used in WWTPs employing primary, 
secondary, tertiary and quaternary treatments (adapted from (Salama et al. 2017).  
 
 
 
 
 
 
 
16 
 
1.5 Assessment approaches for endocrine disrupting chemicals 
Due to the complex nature of wastewater, one of the major challenges in context with the 
assessment of the potential toxicological risks of MWWEs is to identify specific compounds that 
are responsible for biological effects in exposed organisms. Traditionally, analytical chemistry has 
been utilized to identify chemicals with endocrine disrupting potentials in complex matrices such 
as effluents (Hecker and Hollert 2009; Hecker and Giesy 2011). However, due to a large number 
of different types of chemicals present in wastewater, targeted chemical analysis alone is not able 
to provide a complete and objective exposure assessment. Characterization of exposure using 
chemical analytical approaches requires prior knowledge of the compounds to be analyzed, and if 
chemicals were not initially targeted, they will not be identified (Samolloff et al. 1983; Ankley et 
al. 1996). Therefore, toxicologically relevant compounds could be overlooked by relying solely 
on the quantification of individual residues using instrumental analyses, underestimating the 
potential biological risks posed by the effluent.  Furthermore, analyzing the vast amount of 
chemicals in complex environmental mixtures such as MWWEs by chemical analytical 
methodologies would be extremely time-consuming and prohibitively expensive (Hecker and 
Giesy 2011). Additionally, when results are obtained through analytical chemistry they are often 
difficult to evaluate with regard to their potential hazard, as toxicological data of the compounds 
identified are often not readily available or has not been established yet (Reemtsma et al. 1999). 
Furthermore, instrumental analyses provide little data on the biological availability and activity of 
chemicals in mixtures and do not consider the possible interactions among different compounds 
(e.g. synergism or antagonism) or provide information on their effects. Therefore, over the past 
decades, a number of alternative approaches to supplement analytical chemistry for the 
characterization of complex environmental samples have been developed. One of these approaches 
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is termed Effect Directed Analysis (EDA) and utilizes a combination of biological assays 
(bioassays), fractionation techniques, and chemical analysis (Brack 2003; Hecker and Hollert 
2009).  
The bioassay-directed analysis portion of EDA represents the first step to aid in the identification 
of the biologically active substances in a complex mixture. It is comprised of in vitro or in vivo 
mechanistic assays that enable identification of the potential of a sample to interact with specific 
biological pathways or targets (Hecker and Hollert 2009; Hecker and Giesy 2011). The advantages 
of in vitro bioassays include biological relevance, integrated measures of the combined potency of 
all chemicals in a complex mixture, and the ability to identify unknown compounds for which 
analytical methods have not been developed. These assays can also account for interactions 
between chemicals, which means the effect of two or more chemicals is equal to the sum of the 
effect of the same chemicals taken separately, which is usually due to the different chemicals acting 
on the body via the same or a similar mechanism. Many in vitro assays can aid in the 
characterization of the specific mechanism of toxicity a chemical, and in some cases are more 
sensitive than instrumental analyses.  Another advantage of the use of in vitro bioassays for initial 
screening of complex samples such as effluents is that they allow for prioritizing samples based 
on their biological activity for further analysis, thus avoiding unnecessary and expensive chemical 
analysis of inactive samples (Jeffcoate 1996; Meager 2006). Most in vitro research on EDCs has 
focused on the ER or the AR, specifically the effects of xenobiotic-mediated binding or the cross-
talk of the ER and AR receptors (Villeneuve et al. 1997). However, a number of studies have 
demonstrated that the disruption of production of steroid hormones or altered expression and 
activity of steroidogenic enzymes can also occur and that not all effects are the result of direct 
hormone mimics (Hecker et al. 2006; Grund et al. 2011). Therefore, the use of analytical tools that 
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only target a few selected modes of action (i.e. ER and AR agonism) is insufficient when dealing 
with complex matrices such as MWWEs, suggesting that a combination of in vitro assays capturing 
different endpoints and bio-analytical methods may be required (Burgess et al. 2013; Maletz et al. 
2013). With regard to the assessment of EDCs, it has been demonstrated that the combination of 
receptor-mediated and non-receptor mediated assays can be a cost-effective method of evaluating 
the potential endocrine activity within a complex environmental sample in support to instrumental 
analysis (Grund et al. 2011).  
1.6 In vitro vs in vivo bioassays 
A major issue with the globally increasing need for chemical safety assessment is the reliance of 
current testing strategies on the use of live animals. Increasing testing demands and requirements 
result in the need for large numbers of live organisms such as rats, mice, fish, and frogs, creating 
ethical and economic problems (Jeffcoate 1996; Meager 2006; Hecker et al. 2011). In order to 
reduce the number of test animals, programs such as US-EPA’s EDSP and international 
organizations such as the Organization for Economic Co-operation and Development (OECD) are 
increasingly recommending replacement of certain in vivo tests with in vitro assays that are based 
on stable cells lines or sub-cellular compartments in their testing schemes (Hecker et al. 2011). In 
vitro tests have a number of advantages over in vivo approaches because of their often greater 
specificity in their response, their amenability to high throughput testing, lower cost, and the fact 
that they are less time consuming than in vivo tests.  Most importantly, they address current animal 
welfare concerns associated with toxicity testing approaches that use a large number of live 
animals (Gray et al. 1997). Moreover, in vitro bioassays include biological relevance and 
integrated measures of the combined potency of all chemicals in a complex mixture.  
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Although in vitro assays have been shown to be a good tool to support chemical or environmental 
risk assessment, one has to be aware of their limitations. For example, pharmacokinetics, tissue 
distribution, and biotransformation of chemicals that occur in vivo are often not or only partially 
accounted for by in vitro bioassays. Many cell lines possess only limited metabolic activities, and 
therefore, substances that undergo metabolic elimination or activation may not be appropriately 
assessed by these in vitro systems. Furthermore, cell-based in vitro tests comprise of isolated cells 
from individual tissues that do not include interactions among different cell types or tissues such 
as paracrine interactions or endocrine feedback loops, respectively, and which occur in tissue 
explant or in vivo assays (Villeneuve et al. 1997). In addition, in vitro bioassays alone do not 
provide information on the individual compounds causing the measured effects; they only identify 
candidate groups of causative agents (e.g. those with estrogen or androgen action) in the samples 
as a first step, and further chemical analysis must be conducted to confirm candidate chemicals.      
1.6.1 Bioassay endpoints   
The potential of chemicals or environmental samples to interact with the reproductive endocrine 
system is typically assessed by means of three endpoints: binding to the ER, binding to the AR, 
and alteration of sex steroid production through interaction with steroidogenic pathways (US-EPA 
EDSP 2016; OECD 2018). There are a number of in vitro assays available for examining different 
levels of biological complexity, particularly ER binding or transactivation assays (Pons et al. 1990; 
Legler et al. 1999; Rogers and Denison 2000). Some of the commonly used bioassays engineered 
to identify and quantify chemicals that can bind to the ER in environmental samples and their 
ability to complement chemical analysis include the yeast estrogen screen (YES) (Routledge and 
Sumpter 1996), the ER-CALUX or T47-D (Legler et al. 1999), the MCF-7 (Pons et al. 1990), as 
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well as the MVLN (Demirpence et al. 1993), and E-SCREEN (Soto et al. 1995) assays. For 
example, the MVLN assay has been effectively used to determine total (anti-) estrogenicity of 
complex samples as well as specific potencies of individual estrogens (e.g. E1, E2, estriol (E3) and 
EE2)(Gutendorf and Westendorf 2001; Snyder et al. 2001). This assay originated from the human 
MCF-7 breast cancer cell line (Pons et al. 1990), and consists of cells stably transfected with the 
mouse mammary tumor virus promoter with the firefly luciferase gene under the control of the ER 
(Demirpence et al. 1993; Gutendorf and Westendorf 2001; Snyder et al. 2001; Coors et al. 2003; 
Kusk et al. 2011; Demirpence et al. 1993).  
Some of the available in vitro assays to detect and quantify (anti-)androgenic activities include the 
yeast androgen screen (YAS) (Sohoni and Sumpter 1998), the AR-CALUX (Van der Burg et al. 
2010), and the MDA-kb2 assay (Wilson et al. 2002). The MDA-kb2 assay is one of the most 
commonly used tests for studying the agonistic or antagonistic interaction of chemicals with the 
AR. It is a robust and rapid assay, as the cells are generally easy to culture, maintain and results 
can be consistently replicated (Wilson et al. 2002). This assay has shown to be highly sensitive for 
the detection and characterization of (anti-) androgenic potentials of chemicals in water samples, 
such as MWWEs (Wilson et al. 2002). Similar to the MVLN assay, the androgen transactivation 
assay MDA-kb2 is based on stable transfection of a cell line with two plasmids encoding for the 
human AR and GR. Specifically, binding of the testosterone- or other AR agonists-AR complex 
to the androgen response element (ARE) triggers the expression of the reporter gene luciferase, 
where the bioluminescent response can be measured either in the cellular homogenate or in intact 
living cells (Wilson et al. 2002). 
As previously mentioned, in addition to receptor-mediated mechanisms of endocrine disruption, 
there are a number of non-receptor mediated processes, such as the modulation of enzymes 
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involved in the production, transformation, or elimination of steroids, that can also affect the 
concentrations, availability or actions of hormones, thus also presenting significant concerns 
regarding endocrine disruption (Sanderson 2000; Ohno et al. 2002; Sanderson et al. 2002; 
Hilscherova et al. 2004). One assay that has been shown to be useful for the characterization of 
chemicals or complex environmental mixtures for their potential to disrupt the production of the 
sex steroids T and E2 is the H295R Steroidogenesis Assay. The H295R assay is based on 
immortalized human adrenal cancer cells able to produce mineralocorticoids, glucocorticoids, and 
sex hormones, and integrates effects on all relevant steroid synthesis pathways leading to the 
production of those hormones (Hilscherova et al. 2004; Zhang et al. 2005; Gracia et al. 2006; 
Hecker et al. 2007; Gazdar et al. 1990).  Endpoints that can be assessed by this assay include the 
disruption of the production of T, E2 and other steroid hormones either by measuring actual 
hormone concentrations in cell medium or by assessing changes in activity or expression of 
steroidogenic enzymes in cells (Sanderson 2000; Zhang et al. 2005; Hecker et al. 2006, 2007, 
2011). H295R test methods and measurements have been optimized by several laboratories and 
standardized by the US-EPA EDSP and OECD (OECD Test No. 456, 2011). Currently, it 
represents the only validated in vitro test for the determination of chemicals or complex mixtures 
with steroidogenesis disrupting potential (Gazdar et al. 1990; Gracia et al. 2006; Hecker et al. 
2006, 2007, 2011).  
1.7 Objectives 
Little is known regarding the contribution that MWWEs have on the presence of complex mixtures 
of EDCs in receiving aquatic environments across Canada. To date, few studies have been 
conducted, predominantly focusing on the Eastern provinces (Metcalfe et al. 2001, 2003; Lishman 
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et al. 2006; Hicks et al. 2017b, a). In addition, most of the past research has focused on agonists 
or antagonists of the ER (Jobling et al. 1998; Snyder et al. 2001; Leusch 2008; Leusch et al. 2010; 
Pessoa et al. 2014). However, chemicals with androgenic and anti-androgenic properties present 
an equal concern (Ankley et al. 2003; Weiss et al. 2009), as well as chemicals that disrupt other 
pathways, such as the production of sex steroid hormones, as they also have shown to affect the 
endocrine systems of organisms (Hecker and Giesy 2011). Furthermore, little is known about the 
effects of seasonality, particularly under extreme climatic conditions, such as occur in the 
Canadian prairies, on the efficiency of WWTPs to remove EDCs. Similarly, more information is 
needed regarding the potential impacts different treatment levels and population demographics can 
have on the removal of EDCs by WWTPs.  Therefore, the overall objective of the research 
conducted in this thesis was to determine whether MWWEs represent a significant source of EDCs 
with (anti-)estrogenic, (anti-)androgenic, and steroidogenesis disrupting potencies in Canada.  
Specifically, endocrine potentials were assessed in influents and effluents collected from six 
WWTPs in Saskatchewan, Ontario and Quebec, Canada using a battery of in vitro assays. Results 
on in vitro bioactivity were then compared with targeted chemical analysis and in vivo effects in 
fish endocrine system (data obtained during two parallel studies) to evaluate the utility of these in 
vitro assays as a predictive tool to prioritize environments at greater risks with the exposure to 
EDCs. This study was part of a larger project (Aquatic Impact Assessment of Municipal Effluents 
[AIME]) that aimed to characterize the presence of chemicals with endocrine activities in MWWEs 
across central and eastern Canada, to assess the potential impacts of these effluents on sensitive 
wildlife (fish) in receiving environments, and to develop a “toolbox” to efficiently, economically 
and reliably prioritize MWWEs of concern.  
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1. In vitro characterization of endocrine disrupting potentials of municipal effluents in 
the Canadian prairies, Saskatchewan.  
The first study evaluated two WWTPs in Saskatchewan, Canada, with different treatment levels 
(Regina, primary lagoon system vs Saskatoon, advanced tertiary system) regarding their efficiency 
to remove endocrine active compounds from wastewater, and to characterize the potential effects 
the extreme climatic conditions (hot summers and extreme cold winters with temperatures ranging 
between -40 to +35°C) may have on this removal efficiency. The specific research objectives were 
to: 
a. Characterize the presence of chemicals in influents and effluents of the Regina and Saskatoon 
WWTPs that:  
i. agonistically or antagonistically bind to the ER and AR using MVLN cells and MDA-
kb2, respectively;  
ii. disrupt the production of the sex steroid hormone E2 using the H295R Steroidogenesis 
Assay; and 
iii. compare bioassay-derived endocrine potentials to the presence of selected contaminants 
using targeted chemical analysis 
b. Determine whether treatment level and seasonality influence removal efficiency of EDCs by 
WWTPs; 
c. Correlate in vitro results with in vivo toxicity data for fish endocrine physiology exposed to 
the same MWWEs either in situ or under controlled laboratory conditions as part of two 
parallel studies to evaluate the predictivity of in vitro assays for whole organism responses. 
  
2. Bioassay-directed analysis of endocrine disrupting potencies of municipal effluents in 
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central and eastern Canada. 
The second study was designed to expand on the research under Objective 1 by investigating the 
endocrine modulating potential in Ontario and Quebec with different treatment levels, population 
size and climate to generate a more comprehensive understanding of MWWEs as a source of EDCs 
to aquatic environments across Central and Eastern Canada. Specifically, the objectives of this 
study were to:  
1. Characterize the presence of chemicals in influents and effluents from four WWTPs in Ontario 
and Quebec that:  
a. agonistically or antagonistically bind to the ER and AR using MVLN cells and MDA-
kb2, respectively;  
b. disrupt the production of the sex steroid hormone E2 using the H295R Steroidogenesis 
Assay; and 
c. compare bioassay-derived endocrine potentials to the presence of selected contaminants 
using targeted chemical analysis. 
2. Determine whether the level of treatment, population size and climate influence removal 
efficiency of EDCs by WWTPs; and 
3. Compare responses to those reported for Saskatchewan WWTPs under Objective 1. 
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CHAPTER 2: IN VITRO CHARACTERIZATION OF 
ENDOCRINE DISRUPTING POTENTIALS OF MUNICIPAL 
EFFLUENTS IN THE CANADIAN PRAIRIES, 
SASKATCHEWAN 
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PREFACE 
Little information regarding the potential effects of municipal wastewater effluents, particularly 
EDCs, discharged into prairie water bodies is available to date. Therefore, Chapter’s 1 aim was to 
investigate the efficiency of two WWTPs in the prairies, Saskatchewan, Canada to remove EDCs 
with (anti-)estrogenic, (anti-)androgenicity and steroidogenesis disrupting potentials using a 
battery of in vitro assays, as well as to determine whether treatment level and seasonality influence 
removal efficiency of EDCs by WWTPs. This chapter was organized as a manuscript for 
publication in a peer-reviewed scientific journal. 
  
Author contributions: 
Tabata Bagatim (University of Saskatchewan) designed and managed the experiment, generated 
and analyzed all data, and drafted the manuscript. 
Sara Hanson (University of Saskatchewan) conducted a parallel study on the endocrine system of 
fish exposed to municipal effluent downstream of the WWTPs studied, providing information on 
in vivo studies to correlate with in vitro results. 
Kean Steeves (University of Saskatchewan) conducted a parallel study on the endocrine system of 
laboratory fish exposed to municipal effluent from the WWTPs studied, providing information on 
in vivo studies to correlate with in vitro results.  
Hongda Yuan (University of Saskatchewan) helped with the design and performance of 
experiments to measure selected PPCPs in wastewater using LC-MS. 
27 
 
Steve Wiseman (University of Lethbridge) provided guidance throughout experiments and offered 
comments and edits to the manuscript. 
Natacha Hogan (University of Saskatchewan) provided guidance throughout in vivo experiments 
and offered comments and edits to the manuscript. 
Alice Hontela (University of Lethbridge) provided guidance throughout in vivo experiments, 
particularly regarding in vivo findings and offered comments and edits to the manuscript. 
Paul Jones (University of Saskatchewan) provided guidance throughout chemical analysis 
experiments, as well as offered comments and edits to the manuscript. 
Giesy John (University of Saskatchewan) provided the cell laboratory for the in vitro study to be 
conducted and offered comments and edits to the manuscript. 
Markus Hecker (University of Saskatchewan) provided guidance and inspiration for the 
conception and design of the experiment, offered comments and edits to the manuscript, and 
provided research funding.   
28 
 
2.1 Abstract 
Over the past decades increasing concerns regarding the presence of contaminants in the 
environment that have the potential to affect the endocrine system of humans and wildlife have 
been raised. Municipal wastewater effluents (MWWEs) are considered one of the major sources 
of endocrine disrupting chemicals (EDCs) in surface waters, as conventional wastewater treatment 
technologies are frequently inefficient at removing these compounds from raw sewage. The aim 
of this project was to investigate the efficiency of two WWTPs in Saskatchewan, Canada to remove 
EDCs with (anti-)estrogenic, (anti-)androgenicity and steroidogenesis disrupting potentials using 
the MVLN, MDAkb2, and H295R Steroidogenesis assays, respectively. The plants investigated 
were in Regina, a lagoon-based primary treatment system, and in Saskatoon, an advanced tertiary 
treatment system. The results of this study confirmed generally high efficiencies of WWTPs to 
remove chemicals with androgenic properties, and low to moderate removal efficiencies of anti-
androgens and anti-estrogens. Thus, ER and AR receptor-antagonists remain a significant concern 
in MWWEs. Furthermore, Regina WWTP with its lagoon-based treatment system was not as 
efficient at removing contaminants, particularly estrogens, as compared to the more advanced 
treatment system of the city of Saskatoon. Significant but weak effects on E2 production were 
observed for a few samples collected from both treatment plants; however, these effects did not 
follow any clear patterns. Furthermore, seasonality and treatment level seemed to play an 
important role in the efficiency of EDC removal. Regina effluent is discharged into Wascana 
Creek, a small surface system with low dilution (<1% during the dry season), and thus, this creek 
may be particularly at risk with the exposure to EDCs and other emerging contaminants. Results 
obtained by this in vitro study were supported by two parallel studies investigating the effects of 
the same effluents on fish endocrine physiology, as well as by chemical analysis, demonstrating 
29 
 
in vitro assays can be used as a cost-effective tool for prioritizing endocrine disrupting potential 
of MWWEs in aquatic environments.  
Keywords: emerging contaminants, wastewater, in vitro, monitoring 
2.2 Introduction  
Endocrine disrupting chemicals (EDCs) are a heterogeneous group of natural and synthetic 
compounds that can impair reproduction, growth, and development of organisms, in some cases at 
very low concentrations (Kavlock et al. 1996; Jobling et al. 1998; Hecker et al. 2006; Kidd et al. 
2007; Hecker and Hollert 2009).  EDCs are introduced into water bodies through several different 
pathways such as runoff from agricultural areas, industrial effluents and municipal wastewater 
effluents (MWWEs).  Among these, MMWEs are considered to be the main contributor to the 
contamination of surface waters  (Clara et al. 2005; Johnson et al. 2007; Benotti et al. 2009).  
MWWEs contain complex mixtures of a wide variety of known and unknown chemicals including 
natural and synthetic hormones (e.g. 17β-estradiol [E2], estrone [E1] and ethynylestradiol [EE2]), 
plasticizers such as bisphenol A (BPA) and phthalates, a large number of pharmaceuticals and 
personal care products (PPCPs), and organic detergents (e.g. nonylphenol) (Ternes et al. 1999; 
Carballa et al. 2004; Metcalf et al. 1973; Jobling et al. 1995; Giesy et al. 2002; Lahnsteiner et al. 
2005). In addition, they can contain significant quantities of unknown chemicals with the ability 
to cause (anti-)estrogenic and (anti-)androgenic effects in aquatic organisms (Purdom et al. 1994; 
Reemtsma et al. 1999).  
Traditionally, wastewater treatment plants (WWTPs) were designed to predominantly remove 
organic materials, nitrate, and phosphorus, and the removal or breakdown of PPCPs, industrial 
chemicals, and detergents is often incomplete (Hecker and Hollert 2009).  Studies have 
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demonstrated that some EDCs, such as E2 and EE2 can be partially removed from wastewater by 
WWTPs with efficiencies ranging between 60% and 90%, whiles others bypass without any 
reduction (Kümmerer 2001; Carballa et al. 2004; Clara et al. 2005; Díaz-Cruz et al. 2009; Zorita 
et al. 2009). According to Environment and Climate Change Canada (ECCC), levels of wastewater 
treatments vary greatly across Canada, ranging from less advanced primary treatments to 
sophisticated quaternary treatments  (ERRIS, 2013). While lower level treatment systems tend to 
be limited in removing xenobiotics from wastewater, quaternary treatment facilities are aimed at 
enhancing the quality of effluent, including removal of chemicals such as EDCs, by using 
ozonation, reverse osmosis, membrane filtration and activated carbon technologies (CCME, 2006). 
However, due to their high cost, most WWTPs in Canada do not have tertiary or quaternary 
processes (ERRIS, 2013). 
The Canadian prairies represent a region of particular concern with regard to release and potential 
effects of EDCs from WWTPs into surface waters. This geographic region is characterized by an 
extreme temperature regime and semi-arid climatic conditions. The extreme fluctuations in 
temperature and precipitation during the various seasons, ranging from positive 35°C to negative 
40°C, can significantly impact the efficiency of the biological treatment processes used in WWTPs 
(Fernandez et al. 2008; Jálová et al. 2013).  This, in turn, is likely to result in higher concentrations 
of nutrients and contaminants, including EDCs, being released into downstream water bodies.  
Furthermore, dilution of effluents in receiving water bodies can dramatically change among 
seasons.  For example, a study conducted by Waiser et al. (2011b) showed that Wascana Creek, a 
small water body in the southern Canadian prairies downstream of the city of Regina, SK, can 
have flows of effluent of up to 99% during the dry season, or during emergency overflow events. 
However, little information with regard to the potential effects of municipal effluents, and 
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specifically EDCs, discharged into prairie water bodies is available to date (Waiser et al. 2011a, 
b).  Moreover, the prairie region of Canada has a similar climate compared to parts of Eastern 
Europe and Asia, with extreme fluctuations in temperatures and semi-arid conditions (Wang and 
Overland 2004). Thus, improved understanding of effects of such climatic conditions on the 
removal efficiency of EDCs from municipal wastewater during treatment processes can potentially 
be used to infer analogous challenges across similar regions in Europe and Asia for which little 
information on the potential presence and impacts of EDCs is available.  
Traditionally, analytical chemistry has been utilized as the primary tool to identify EDCs in 
complex mixtures such as MWWEs. However, this approach alone is limited as it does not provide 
a complete analysis of all biologically active contaminants in a sample, including unknown 
chemicals (Hecker and Giesy 2011). Therefore, in vitro bioassays are increasingly used to 
characterize the specific endocrine activity of complex mixtures as they respond to all chemicals 
with the same mode of action, including unknowns and those for which analytical detection 
methods are unavailable (Wilson et al. 2002, 2004, Hecker et al. 2006, 2011).  Furthermore, in 
vitro assays can account for interactions among chemicals such as antagonism or synergism 
(Hecker and Giesy 2011). Although bioassays alone do not provide information on the individual 
compounds causing the measured effects, they can identify and prioritize candidate groups of 
causative agents in the samples. Further targeted chemical analysis can then be conducted to 
pinpoint chemicals or mixture responsible for the effects observed (Villeneuve et al. 1997).  
Another significant advantage of in vitro bioassays is that they enable detection of disruption of 
specific biological processes without the need for live animal testing. Therefore, programs such as 
US Environmental Protection Agency Endocrine Disruptor Screening Program (US-EPA’s EDSP) 
and international organizations such as the Organization for Economic Co-operation and 
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Development (OECD) are increasingly recommending replacement of certain in vivo tests with in 
vitro assays in their testing schemes that are based on stable cells lines or sub-cellular 
compartments (Hecker and Hollert 2011; Hecker et al. 2011; Maletz et al. 2013).   
Most studies on EDCs conducted over the past three decades focused on receptor-mediated effects 
of compounds that bind to the estrogen (ER) or androgen receptor (AR) (Villeneuve et al. 1997; 
Wilson et al. 2002, 2004).  However, recent studies demonstrated that the combination of receptor-
mediated and non-receptor-mediated assays was pertinent for a comprehensive assessment of the 
potential endocrine activity of complex environmental samples such as MWWEs (Grund et al. 
2011; Hecker and Hollert 2011; Maletz et al. 2013). In fact, in addition to nuclear receptor-
mediated effects, the synthesis of steroid hormones is one of the key processes in endocrine 
regulation, and which has been shown to be affected by different EDCs including, for example, 
polychlorinated biphenyls (PCBs) (Li et al. 2004), pesticides (Sanderson et al. 2002) or phthalate 
esters (Nakajin et al. 2001). In addition, to better understand effects of EDCs, it is important to 
conduct a combined assessment of agonistic and antagonistic receptor-mediated potential, as the 
presence of antagonists can decrease agonist responses or have deleterious effects on organisms 
by inhibiting critical biological processes such as growth or reproduction (Ihara et al. 2014). 
Therefore, this study aimed to apply an in vitro bioassay-directed analysis approach to determine 
whether MWWEs represent a significant source of EDCs to aquatic environments in the Canadian 
prairies.  Specifically, the objectives of this study were to 1) characterize the presence of chemicals 
in influents and effluents of two WWTPs that a) agonistically or antagonistically bind to the ER 
and AR using MVLN and MDA-kb2 cells, respectively, and/or b) disrupt production of the sex 
steroid hormone E2 using the H295R Steroidogenesis Assay;  2) determine whether treatment level 
and seasonality influence removal efficiency of EDCs by WWTPs; 3) correlate in vitro results 
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with fish toxicity data generated by two parallel studies to evaluate the predictivity of in vitro 
assays for organismal responses; and 4) compare bioassay-derived endocrine potentials to the 
presence of selected contaminants using targeted chemical analysis. 
2.3 Methods 
2.3.1 Sampling and extraction 
Samples of influents and effluents were collected during spring, summer, and early and late winter 
in 2014 and 2015 from the Regina and Saskatoon WWTPs in Saskatchewan, Canada, representing 
different effluent types, varying methods of treatment (lagoon-based primary and advanced 
tertiary, respectively), and a range of climatic conditions over the year (Figure 2.1 and Table S2.1). 
During each sampling event, two to three 24-hour composite samples were collected at different 
days spaced over one week per season. Four liters of influent and four liters of effluent were 
collected in pre-cleaned sterile amber glass bottles from each site per sampling event. Two to three 
drops of chloroform were added immediately after sampling to each bottle to avoid biological 
breakdown of compounds and samples were stored in the dark at 4°C to avoid possible biological 
breakdown prior to further processing.  All samples were processed within two weeks of sampling.  
Particulates were removed from samples by using glass microfiber filters (0.6µm) recommended 
for filtration of wastewater (Canadian Life Science, Quebec City, Canada) to prevent obstruction 
of the extraction cartridges, remove the chloroform previously added, and to permit maximum 
volumes to be extracted. The used filters were stored at -20°C for further analysis as part of a 
separate project. Samples were extracted by solid phase extraction (SPE) using Waters Oasis® 
Hydrophilic-Lipophilic Balance (HLB; 6cc, 150 mg; Mississauga, Ontario, Canada), and Mixed 
Cation-exchange (MCX; 6cc, 500 mg) cartridges. Each cartridge was conditioned with 5 mL of 
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methanol followed by 5 mL of ultrapure water. Two liters of the sample or a blank control 
consisting of 2 L of laboratory ultrapure water were run through each cartridge, at a flow rate of 
approximately 1 drop/second for extraction. Cartridges were then left to dry, subsequently eluted 
with 5 mL of ultrapure water followed by 0.1% acetic acid. Dried cartridges were extracted with 
5 mL of methanol followed by 5 mL of 1:1 hexane: dichloromethane (DCM). The extracts were 
then blown down to dryness using a gentle stream of nitrogen, reconstituted in 400 µL of isooctane, 
and HLB and MCX extracts were combined, resulting in 5000x concentrated samples. Samples 
were stored at -20oC in 2 mL amber crimp top vials with clear inserts.  
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Figure 2.1 – Geographical location of Regina and Saskatoon WWTPs (in green), in Saskatchewan, 
Canada. Data on population (pop) served are according to Statistics Canada, Census Profile, 2016.  
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2.3.2 Bioassays 
Three cell assays were used to evaluate endocrine disrupting potentials of influents and effluents. 
MVLN and MDA-kb2 assays were used to determine (anti-)estrogenic and (anti-)androgenic 
activities, respectively (Demirpence et al. 1993; Wilson et al. 2002). The H295R cell assay was 
used to measure steroidogenesis disruption (Hecker et al. 2006, 2007, 2011). All cell lines were 
obtained from the American Type Culture Collection (ATCC, Manassas, USA). 
2.3.2.1 Cytotoxicity   
Prior to conducting endpoint-specific in vitro assays (receptor transactivation and steroidogenesis), 
cytotoxicity of samples to each cell line was assessed using the MTT assay (Mosmann 1983).  
Cells were seeded at a density in accordance with each cell line assay protocol (see below sections) 
in 96-well cell culture plates (Corning Inc., NY, USA) with 100 µL of appropriate media for 24 h, 
as optimized by earlier studies (Ferrari et al. 1990; Ohno and Abe 1991; van de Loosdrecht et al. 
1994). Next, the cells were exposed to graded concentrations of extracted samples in isooctane 
(0.1 % v/v isooctane) in triplicate wells ranging from 0.1x to 10x concentrations of the original 
samples for 24 h (MVLN, MDA) or 48h (H295R). Samples from two or three collection days per 
sampling season were analyzed independently. Cell viability was then determined using a 
spectrophotometer (SpectraMAX 190, Molecular Devices Corporation, California, USA) at an 
absorbance of 470 nm and 630 nm as described by Mosmann (1983). 
2.3.2.2 MVLN cell assay 
The MVLN human breast cancer cell line stably transfected with an ER (Demirpence et al. 1993) 
was used to determine total (anti-)estrogenic activities of the sample extracts.  Cells were grown 
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in maintenance medium Dulbecco's Modified Eagle Medium-F-12 (DMEM-F12) without phenol 
red (Sigma Aldrich, USA) with 10% fetal bovine serum (FBS; Gibco-Life Technologies Inc., 
Burlington, Canada) under a 5% CO2 atmosphere at 37 °C with final pH adjusted to 7.3. Once 
cells reached approximately 80% confluency, they were trypsinized and seeded into sterile 96-well 
luminometer plate (Perkin-Elmer, Woodbridge, Canada) at a density of 300,000 cells/mL using 
100 µL/well in assay media containing 10% of dextran-charcoal FBS (DCC-FBS; HyClone 
Laboratories, South Logan, Utah, USA) to reduce concentrations of natural steroids in the bovine 
serum. Cells were not added to outer perimeter wells, where only PBS was added to be used as 
background luminescence blanks. After 24 h, cells were exposed to graded concentrations 
(representing 10x, 3x, 1x, 0.3x and 0.1x concentration of the original samples) of the extracted 
samples for another 24 h at 37°C as optimized by earlier studies in quadruplicates (wells) (Van 
Den Belt et al. 2004; Freyberger and Schmuck 2005; Jarošová et al. 2014a). Samples from two or 
three collection days per sampling season were analyzed independently. An E2 standard curve (1:3 
serial dilutions between 0.4-817.1 ng/L E2 in 0.1 % [v/v] Ethanol) and solvent control (SC) (0.1 
%v/v Isooctane) were also included on each plate. The medium was then removed, and luciferase 
activity was measured after adding 75 ml of phosphate buffered saline (PBS) and 75 ml of 
SteadyLite (Perkin Elmer, USA) with luminescence measured by a microplate luminescence 
reader (Polarstar Optima, BGM Labtech, Guelph, Canada). Fold-changes relative to the SC were 
calculated as described by Demirpence et al. (1993), and coefficients of variation (CV) were less 
than or equal to 20%. Significant activities of samples were confirmed in an independent second 
experiment. Estrogen equivalents (EEQs) were calculated from the E2 standard curve (four 
parameters logistic function). EEQs were expressed as ng E2-equivalent/L of influent and effluent 
samples (1x concentrated). To determine anti-estrogenic activities, the natural ligand E2 was added 
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to the medium at a concentration that produced a sub-maximal response (1nM E2), and the ability 
of chemicals to inhibit the luminescence was then determined compared to the anti-estrogen 
hydroxytamoxifen (HT) added at the same time as described in Demirpence et al. (1993). All other 
procedures prior to exposure were identical to those described above for the estrogenicity test.  
2.3.2.3 MDA-KB2 cell assay 
MDA-KB2 human breast cancer cells stably transfected with the AR (Wilson et al., 2002) were 
used to determine (anti-)androgenic activity. In brief, cells were grown in supplemented medium 
containing Lebovitz’s (L-15) culture media (Gibco) with 10% FBS (Gibco) in a 5% CO2 
atmosphere at 37°C with final pH adjusted to 7.6. Once cells reached approximately 80% 
confluence, they were trypsinized and seeded into a sterile 96-well luminometer plate (Perkin-
Elmer) at a density of 200,000 cells/mL using 100 µL/well. Cells were not added to outer perimeter 
wells, where only PBS was added to be used as background luminescence blanks. After 24 h, cells 
were exposed to graded concentrations (10x, 3x, 1x, 0.3x and 0.1x concentration of the original 
samples) of the extracted samples for 24 h at 37 °C following the protocol by Wilson et al. (2002) 
for optimal response. A dihydrotestosterone (DHT) standard curve (1:2 serial dilutions between 
2.3-145.2 ng/L DHT in 0.1 % v/v isooctane) and solvent control (0.1 % v/v isooctane) were also 
included on each plate (Figure A2.1). Media was then replaced by 75 ml of PBS and 75 ml of 
SteadyLite (Perkin Elmer, USA) and luciferase activity was measured using a Polarstar Optima 
microplate reader (BGM Labtech, Guelph, Canada). Samples were tested in quadruplicates, and 
CVs were ≤20%. Samples from two or three collection days per sampling season were analyzed 
independently. Significant activities of samples were confirmed in an independent second 
experiment. Fold-change relative to the solvent control was calculated as described by Wilson et 
39 
 
al. (2002). Androgen equivalents (AEQs) were calculated from the DHT standard curve (four 
parameters logistic function). AEQs were expressed as ng DHT-equivalent/L of influent and 
effluent samples (1x concentrated). To determine anti-androgenic activities, the natural AR ligand 
DHT was added to the medium at a concentration that produced a sub-maximal response (125 pM 
DHT) and the ability of chemicals to inhibit the luminescence was then determined compared to 
the anti-androgen hydroxyflutamide (HF) added at the same time as described in Wilson et al. 
(2002). All other procedures prior to exposure were identical to those described above for the 
androgenicity test.   
2.3.2.4 H295R cell assay 
The H295R human adrenal cancer cell line (Hecker et al. 2006, 2011) was used to determine 
disruption of steroidogenesis through the modulation of synthesis of E2 in accordance with OECD 
Test No. 456 (2011). Cells were grown in supplemented medium containing DMEM-F12 Hams 
(Sigma), 2.5% of BD-serum and 1% of ITS+ premium mix (both from BD Biosciences, 
Mississauga, Canada) under a 5% CO2 atmosphere at 37o C with final pH adjusted to 7.4 for a 
minimum of 4-5 passages to ensure sufficient basal E2 production, and for a maximum of 10 
passages as described by Hecker et al. (2006). Once cells reached 80% confluency, they were 
trypsinized and seeded into 24-well tissue culture plates (Corning Inc., NY, USA) at a density of 
300,000 cells/mL using 1000 µL/well. After 24 h, cells were exposed to graded concentrations of 
the extracted samples (10x, 3x, 1x, 0.3x and 0.1x) for another 48 h, as described by Hecker et al. 
(2006) for optimal response in triplicate wells at 37 °C. Samples from two or three collection days 
per sampling season were analyzed independently. Furthermore, forskolin (FOR) (10µM) and 
prochloraz (PRO) (3 µM) that served as positive controls for induction and inhibition of E2 
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production, respectively, as well as a SC (0.1 %v/v isooctane/DMSO) and blanks (medium only) 
were included in each plate. After the exposure, the medium was harvested and concentrations of 
E2 were determined by enzyme-linked immunosorbent assay (ELISA) (Cayman Chemicals, Anne 
Arbor, MI, USA) following the manufacturer’s instructions. Significant activities of samples were 
confirmed in an independent second experiment. CVs were ≤20% in all cases.  
2.3.3 Chemical analysis 
2.3.3.1 Orbitrap chemical analysis - liquid chromatography-mass spectrometry (LC-MS) 
Extracts were analyzed using a Q Exactive™ mass spectrometer (Thermo Fisher Scientific, 
Toronto, ON) interfaced to a Dionex™ UltiMate™ 3000 ultra-high-performance liquid 
chromatography (UHPLC) system (Thermo Fisher Scientific, Toronto, ON). Separation of 
chemicals was achieved with a Betasil C18 column (5 µm; 2.1 mm × 100 mm; Thermo Fisher 
Scientific, Toronto, ON) with an injection volume of 5 µl.  Ultrapure water (A) and methanol (B) 
were used as mobile phases.  Initially, 10% B was increased to 50% in 5 min, then increased to 
100% at 20 min and held static for 6 min, followed by a decrease to initial conditions of 10% B 
and held for 3 min to allow for column re-equilibration.  The flow rate was 0.20 mL/min. The 
column and sample chamber temperatures were maintained at 40°C and 10°C, respectively.  Data 
were acquired using full scan mode and selected ion monitoring (SIM). Briefly, MS scans (100 - 
1000 m/z) were recorded at resolution R = 70000 (at m/z 200) with a maximum of 3×106 ions 
collected within 200 ms, based on the predictive automated gain control. SIM scans (m/z = 
227.1072, 271.1698, 269.1542, 295.1698) were recorded at a resolution R = 35000 (at m/z 200) 
with a maximum of 5×104 ions collected within 80 ms, based on the predictive automated gain 
control, with the precursor isolation width set at 2.0 m/z.  The general mass spectrometry settings 
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applied for negative ion mode were as follows: spray voltage, 2.7 kV; capillary temperature, 
375°C; sheath gas, 46 L/h; auxiliary gas, 11 L/h; probe heater temperature, 375oC.  Similarly, the 
settings applied for positive ion mode were: spray voltage, 3.0 kV; capillary temperature, 400oC; 
sheath gas, 46 L/h; auxiliary gas, 15 L/h; probe heater temperature, 350oC. 
 2.3.3.2 Spike recovery experiments 
Prior to chemical analysis, samples were diluted to a 100X concentration in acetonitrile (ACN) 
and 10 ng/mL of internal standards (Table S2.6) were added for recovery analysis for each sample 
injection. Extraction efficiencies were determined from a spike recovery experiment. Samples of 
influent and effluent were extracted following the same SPE method utilized for in vitro assays. 
Non-spiked extracts were first analyzed using the same standards. Pre-existing chemical 
concentrations in each type of sample were calculated to serve as background. Compound mixtures 
were then spiked in each sample in triplicates, with concentrations for each standard approximately 
ten times greater than pre-existing concentrations or maximum allowed concentrations. Recovery 
was calculated by comparing the detected concentration of each chemical to the expected 
concentration (Table S2.5). For SIM analysis, estrogenic hormone standards (E1, E2, EE2, and 
BPA) along with deuterated internal standards (E1, E2, and BPA) were injected at controlled 
concentrations every six samples. Peak areas of internal standards in samples were compared to 
peak areas of internal standards alone for recovery calculation. Concentrations of estrogenic 
hormones were calculated from the peak area ratio of each chemical in a sample and in standards 
while making reference to the recovery of each individual sample. For full-scan analysis, a 
standard mixture containing 21 chemicals was injected at 500, 100, 50, 20, 10, 5, 1, 0.1, and 0.01 
ng/mL to construct calibration curves. Internal standards containing D3 naproxen, D3 caffeine, 
and D3 DEET at 10 ng/mL were present in each standard mixture for recovery analysis. The 50 
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ng/mL standard was also injected after every six samples for concentration calculation. Chemical 
concentrations in each sample were calculated using the 50 ng/mL standard closest in time as the 
reference. 
2.3.4 Data analysis 
Statistical analyses were performed using SPSS version 20.0 (SPSS, Chicago, IL, USA). Data 
were expressed as mean ± standard error of the mean (± 1SEM) and analyzed by one-sample 
Kolmogorov-Smirnov test for normality, and by Levene’s test for homogeneity of variance.  
Differences among samples (influent vs effluent, WWTPs, sampling day) for normally distributed 
data were analyzed by analysis of variance (ANOVA), followed by a 2-way Dunnett’s test or 
Tukey’s test.  Non-parametric data were analyzed by Kruskal Wallis test followed by the Mann 
Whitney-U test. A probability of p ≤ 0.05 was considered statistically significant.  Dose-response 
relationships between sample dilutions and magnitude of biological responses were calculated 
using Microsoft Excel 2016 by fitting data to a four-parameter logistic model. Effective 
concentrations at which 50% (EC50) and 20% (EC20) of the maximum response for each sample 
were reported where possible. Androgenic and estrogenic potencies were expressed as the relative 
change to the SCs, as well as AEQs and EEQs in ng/L based on dilution of a sample as determined 
by the DHT and E2 standard curves tested simultaneously in each assay plate, respectively. 
Steroidogenesis disruption was determined by changes in E2 production expressed as relative 
changes compared to SC.  
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2.4 Results 
2.4.1 Cytotoxicity 
Most of the extracted samples, particularly influent, at the greatest concentrations, 10x and 3x, 
caused significant cell death in all bioassays (MVLN, MDA, and H295R), suggesting one or more 
compounds in the extracts were acutely cytotoxic (Figures S2.2, S2.3, S2.4). Cytotoxic doses were 
excluded from further analyses of specific endocrine potentials and 1x concentrations of extracts 
were used as the highest non-cytotoxic concentration for comparison reasons. 
2.4.2 Estrogenicity and anti-estrogenicity 
Significant estrogenic potentials relative to the solvent controls were only detected in effluent 
samples collected from the Regina WWTP during spring and summer with a 2.3-fold (0.9±0.2 ng 
EEQ/L) and 2.0-fold (0.7±0.1 ng EEQ/L) increase, respectively (Figure 2.2A). No significant 
increase in estrogenic potentials relative to SCs was observed either in influents or effluents from 
the Saskatoon WWTP (Figure 2.2C). A significant reduction in estrogenic responses occurred in 
influent samples during spring; however, such a response was not detected in any other case 
(Figure 2.2C).  
Significant anti-estrogenic potentials relative to the controls were detected in influent and effluent 
samples from both Regina and Saskatoon during spring and summer (Figure 2.2B and D). During 
spring, a 0.7- and 0.5-fold change was observed in influent and effluent samples collected from 
the Regina WWTP samples, and a 0.6- and 0.7-fold change occurred during summer, respectively.  
In Saskatoon, a 0.4- and 0.5-fold change was shown for influent and effluent samples, respectively, 
collected during spring, while a 0.6- and 0.7-fold change was measured during summer for 
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influents and effluents, respectively.  No significant anti-estrogenic potentials were detected during 
early and late winter from either WWTP (Figure 2.2 B and D). 
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Figure 2.2 - Estrogenic (A and C) and anti-estrogenic (B and D) activity of extracts of influents 
and effluents (1x concentrated) collected from Regina (A and B) and Saskatoon (C and D) WWTPs 
during four seasons in 2014/2015 determined using the MVLN in vitro assay. Estrogenicity is 
expressed as relative changes compared to the solvent control (SC). Anti-estrogenic activity is 
expressed as fold-change relative to the positive control (PC; 81.7 ng/L E2). Data are represented 
as the mean ± SEM (n=4, wells). Dashed line represents baseline (controls). The asterisk (*) 
denotes a significant difference from the SC/PC (p<0.05). 
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2.4.3 Androgenicity and anti-androgenicity 
Influents collected during all four seasons from both WWTPs showed a significant increase in 
androgenicity compared to SCs (Figure 2.3A and C).  AEQs of influents from Regina were found 
to be 45.0±6.6, 15.2±0.8, 24.4±6.8 and 18.7±5.6 ng AEQ/L, and Saskatoon influents were 6.8±0.6, 
52.2±12.0, 63.3±12.0 and 8.9±1.6 ng AEQ/L during spring, summer, early and late winter, 
respectively.  In contrast, no androgenic potentials were observed in effluents, except for the 
sample collected from the Regina WWTP during early winter, which had a 1.2-fold increase in 
androgenicity relative to SCs (2.6 ± 0.3 ng AEQ /L) (Figure 2.3A).    
Significant anti-androgenic potentials relative to the controls were only observed in influent and 
effluent samples collected during spring from Regina and Saskatoon (Figures 2.3B and D).  A 0.8- 
and 0.6-fold change was detected for effluents collected from Regina and Saskatoon, respectively, 
while a 0.1-fold change occurred for the Saskatoon influent sample at the same sampling time.  
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Figure 2.3 - Androgenic (A and C) and anti-androgenic (B and D) activity of extracts of influents 
and effluents (1x concentrated) collected from Regina (A and B) and Saskatoon (C and D) WWTPs 
during four seasons in 2014/2015 determined using the MDA-kb2 in vitro assay. Androgenicity is 
expressed as relative changes compared to the solvent control (SC). Anti-androgenic activity is 
expressed as fold-change relative to the positive control (PC; 36.3 ng/L DHT). Data are 
represented as the mean ± SEM (n=4, wells). Dashed line represents baseline (controls). The 
asterisk (*) denotes a significant difference from the SC/PC (p<0.05). 
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2.4.4 Steroidogenesis disruption 
Analyses of samples with the H295R Steroidogenesis Assay revealed some effects on the 
production of E2 during select seasons; however, the effects observed did not follow a consistent 
pattern (Figure 2.4).  Specifically, effluent samples from Regina showed a significant increase in 
the production of E2 during spring and late winter, with a 1.4- and 1.2-fold change compared to 
the SCs, respectively (Figure 2.4A). Exposure to influent samples from the Saskatoon WWTP 
caused a 2.3- and 1.5-fold increase in E2-production during spring and summer, respectively, while 
effluent samples collected during late winter showed a 1.2-fold increase compared to SCs (Figure 
2.4B). In contrast, a significant decrease in E2 production was observed in the Regina effluent 
sample collected during summer and in the Saskatoon effluent sample collected during spring.  
None of the samples collected during early winter caused any significant effects on E2 production 
(Figure 2.4).  
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Figure 2.4 - Changes in 17β-estradiol production caused by extracts of influents and effluents (1x 
concentrated) from Regina (A) and Saskatoon (B) WWTPs sampled during four seasons in 
2014/2015 determined by H295R Steroidogenesis Assay. Data are relative changes compared to 
the solvent control (SC). Results are represented as the mean ± SEM (n=3, wells). Dashed line 
represents baseline (controls). The asterisk (*) denotes a significant difference from the SC 
(p<0.05). FOR forskolin [10 µM]. PRO prochloraz [3 µM]. *p<0.05. 
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2.4.5 Chemical analysis  
LC-Q Exactive UHPLC analysis revealed the presence of a wide variety of prescription and non-
prescription drugs, insecticides, herbicides, and other emergent contaminants in untreated and 
treated wastewaters (Table S2.2).  Most chemicals were detected at greater concentrations in 
influents compared to effluents, excepted for clofibrate. Among those, contaminants detected at 
greatest concentrations in influents and effluents during both seasons were carbamazepine 
(anticonvulsant) at 0.7-17.6 ng/L, clofibrate (antihyperlipidemic) at 30.9-52.7 ng/L, N,N-Diethyl-
meta-toluamide (DEET) (insecticide) at 10.3-7,815 ng/L and triclosan (antimicrobial disinfectant) 
at 0.2-140.7 ng/L. Furthermore, gemfibrozil (antihyperlipidemic) was measured at 268 ng/L only 
in influent samples from Regina during summer.  Also, progesterone (reproductive hormone) 
occurred at concentrations between 1.8 and 2.3 ng/L but was only detected in influent samples 
collected from both WWTPs. Other compounds such as reproductive hormones, E2, EE2, E1, 
Estriol (E3) and Testosterone (T) were below the detection limit in both influent and effluent 
samples regardless of season (Table S2.2).   
2.5 Discussion  
In vitro bioassay-based analyses revealed significant endocrine potentials in influents and effluents 
collected from two WWTPs in Saskatchewan. Endocrine potentials varied among seasons and 
between treatment systems, confirming that MWWEs represent significant sources of EDCs to 
receiving environments in Canada. 
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2.5.1 Estrogenicity and anti-estrogenicity 
Estrogenic potentials observed in influents (<MDL-0.7 ng EEQ/L) were less than those detected 
by other studies conducted in Australia, New Zealand, Czech Republic, Israel and Germany with 
EEQs ranging between <4.0-185 ng/L (Leusch et al. 2006; Jálová et al. 2013; Shore and Shemesh 
2016). However, EEQs detected in effluent samples (<MDL-0.9 ng/L) were similar to those 
reported by some of these other authors, ranging between <1.0-5.1 ng/L (Leusch et al. 2006; Jálová 
et al. 2013). In addition, fold-change increases observed for effluents in the present study (<0.5-
2.3-fold change), were similar to those observed by Maletz et al. (2013), 1.5-2.9 and 2.0-3.8-fold 
change in effluent samples using the LYES and ER CALUX® assay, respectively.   
The lack of significant estrogenic potentials in influent samples is likely the result of high 
concentrations of complex mixtures of contaminants, including compounds with anti-estrogenic 
or general toxic potentials, masking the estrogenic responses of the cell system used. A similar 
observation was also made by Jálová et al. (2013).  Orton et al. (2009) and Jálová et al. (2013) 
suggested that the presence of chemicals with anti-estrogenic potencies, including pesticides such 
as linuron or atrazine, could be the cause of reduced or lack of estrogenic responses. Furthermore, 
effluent samples collected from the lagoon-based Regina WWTP showed significant estrogenic 
potentials during spring and summer. This is in accordance with earlier reports of lagoon-based 
WWTPs having low removal efficiencies for estrogenic hormones, ranging between 54 and 80% 
(Pessoa et al. 2014). In addition, the greater estrogenic response of effluents compared to influents 
could indicate that during the treatment process some of the anti-estrogen substances that were 
competing for the same receptor were removed.  
Our original hypothesis was that the extreme cold temperatures during winter, particularly in the 
open lagoon-based Regina WWTP, would result in reduced biological activity, and thus, reduced 
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elimination of biologically active substances in effluent samples. However, the opposite was the 
case for estrogenic responses, where estrogenic activity was the highest during summer when 
significantly greater temperature occurred.  Pessoa et al. (2014) hypothesized that the higher 
estrogenic response in effluents was a result of high evaporation in open lagoon-based systems 
due to the high temperatures in Brazil, resulting in a greater concentration of compounds with 
estrogenic properties.  This is also in accordance with findings by Fernandez et al. (2008) and 
Jálová et al. (2013) who reported lower EEQ concentrations in effluents during fall and winter 
compared to summer in Canada and the Czech Republic, indicating lower temperatures during 
winter did not negatively influence the removal of estrogenic potency by the WWTPs. Fernandez 
et al. (2008) attributed this to the fact that the mean daily air temperature varied by as much as 
43°C during the sampling period (September/2006 to January/2007), while the effluent wastewater 
temperature varied only by 7°C, and that the effluent temperature is a more relevant condition 
influencing estrogens concentrations. Similar variation in temperature was also noticed in the 
current study, where the mean daily air temperature differences across seasons were 38.8°C in 
Regina and 36.8°C in Saskatoon (April/2014 to April/2015), while the effluent temperature 
differences were 19.3°C and 8.2°C in Regina and Saskatoon, respectively. It could be argued that, 
as Regina showed a higher fluctuation of temperature compared to Saskatoon, the high 
estrogenicity found in the effluent samples during the spring could potentially be explained by the 
low temperature of the effluent (2°C) with reduced biological activity; however, this cannot 
explain the high estrogenicity detected during summer. Similarly, other studies such as Tixier et 
al. (2003) also could not determine a distinct seasonal pattern in contaminant removal by WWTPs.  
In conclusion, the original hypothesis that extremely low temperatures will reduce the efficiency 
of biological degradation activities in WWTPs was not supported by the data obtained during this 
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study; however, the potential effect evaporation in open lagoon-based systems may have on the 
concentration of contaminants in effluent warrants further study.   
Significant anti-estrogenic potentials were also observed during spring and summer in both 
influent and effluent samples collected from both WWTPs.  This would suggest that the estrogenic 
signal in effluents from the Regina WWTP may have been suppressed by the co-occurrence of 
anti-estrogenic compounds.  This hypothesis is supported by the remaining significant 
estrogenicity even in the presence of anti-estrogenic potentials.  Jálová et al. (2013) also reported 
anti-estrogenic potency in extracts from eight sites studied in the Czech Republic, including 
influents and effluents, as well as rivers downstream of WWTPs, with greatest anti-estrogenicity 
occurring in samples exposed to WWTP effluent.  
As discussed above, Regina wastewater effluent is released into a small stream, Wascana Creek, 
providing a low dilution during low flow regimes of sometimes less than 1% (Waiser et al. 2011b).  
This raises significant concerns regarding the possible impacts of contaminants from wastewater 
to aquatic wildlife downstream of the WWTP.  This is particularly true during the spring and 
summer seasons when greatest EEQs were observed, and which coincide with gonadal maturation 
and reproductive season of resident fishes such as FHM. EEQs detected in Regina effluent during 
spring and summer, 0.9 and 0.7 ng/L, were similar to concentrations found by Zha et al. (2008) 
and Parrott and Blunt (2005) to cause significant adverse effects. Zha et al. (2008) reported that 
concentrations as low as 0.2 ng/L were able to completely inhibit the reproduction of the F1 
generation of Chinese rare minnows (Gobiocypris rarus) in a multigeneration study, and Parrott 
and Blunt (2005) observed significant decreases in egg fertilization and sex ratio alteration (with 
higher incidence towards females) in FHM at concentrations of EE2 as low as  0.32 ng/L. 
Nevertheless, the estimates performed in the current studies were more conservative, as they were 
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based on E2, which are known to be slightly less potent in fish than EE2 compared to these 
previous studies. In a parallel study that investigated the potential impacts of effluents from the 
Regina WWTP on the endocrine system of resident fish populations of FHMs, in situ and under 
controlled laboratory conditions Steeves et al. (in preparation) and Hanson et al. (in preparation 
a,b), no significant effects that could be linked to exposure with estrogens were observed (i.e. 
induction of vitellogenin production in males, feminization of males or incidence of intersex), and 
which is in accordance with the low EEQs reported by this study that were below biological effects 
levels reported by some earlier studies (Segner et al. 2003; Kidd et al. 2007). However, the fish 
studies found significant impacts on gonadal maturation, decrease in egg production and increase 
in oocyte atresia in the ovaries in females, which appears to be in accordance with the predominant 
anti-estrogenic potentials observed.  
2.5.2 Androgenicity and anti-androgenicity 
Concentrations of androgens reported as AEQs and removal efficiencies of androgenic potentials 
observed in the present study were similar to those reported by a number of previous studies with 
concentrations ranging between <MDL and 320 ng AEQ/L in influents, and between <MDL and 
163 ng AEQ/L in effluents (Svenson and Allard 2004; Jálová et al. 2013; Shore and Shemesh 
2016) compared to 6.8-63.3 ng AEQ/L and <MDL-2.6 ng AEQ/L in influents and effluents, 
respectively, collected from the Regina and Saskatoon WWTPs. However, Leusch et al. (2005) 
detected much greater androgenic potencies ranging from 1,920 to 9,330 ng AEQ/L in influents 
and <6.5 to 736 ng AEQ/L in final effluents.  In contrast, other studies reported androgenic 
potentials in effluents that were consistently below the detection limit (Kirk et al. 2002; Blankvoort 
et al. 2005; Leusch et al. 2006; Sousa et al. 2010b; Jálová et al. 2013). Androgenic activities in 
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influent samples observed in the current study were on average 10- to 65-fold greater than 
estrogenic activities, similar to what was observed by (Leusch et al. 2005) with average differences 
ranging between 50- to 100-fold. According to Kirk et al. (2002), androgen levels in humans are 
generally higher than estrogen levels, and most of the androgenic activity in municipal effluents 
with a high domestic to industrial input ratio is likely caused by androgens excreted by humans. 
Testosterone levels in plasma of adult human’s can be between 3,000 and 10,000 ng/L and between 
200 and 750 ng/L in men and women, respectively, while E2 concentrations are normally detected 
at concentrations between 10 and 60 ng/L in men and between 30 and 400 ng/L in women (Tietz 
1976). Therefore, concentrations of androgens in wastewater would be expected to be higher than 
those of estrogens. Interestingly, neither Testosterone nor other androgenic steroids were measured 
in influents by LC/MS analyses.  However, we did not analyze metabolites, and which may have 
been contributors to the observed androgenic activities of influent samples.  
The relatively low androgenic potentials observed in Regina and Saskatoon effluents indicated 
high removal efficiencies of androgenic compounds of >83% and >72% by the respective 
WWTPs, which were in accordance with (albeit slightly lower) removal efficiencies (between 93 
and 99%) observed previously (Kirk et al. 2002; Leusch et al. 2005; Jálová et al. 2013).  Most of 
the treatment facilities investigated in the above studies had secondary or greater treatment 
systems, with the highest removal efficiencies by systems using activated sludge. While the 
treatment facilities that used primary systems without activated sludge had the lowest removal 
efficiency (7% during spring in the UK; Kirk et al. 2002). Additionally, most treatment facilities 
were located within areas with moderate to warm climates (UK, Australia, and the Czech 
Republic), with air temperature rarely falling below 0°C. Although high removal efficiencies were 
seen for both Regina and Saskatoon treatments regardless of season, Regina effluent samples 
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during early winter showed a slight but significant increase in androgenicity (1.2-fold change) 
compared to controls, which could potentially be due to both temperature and treatment level. In 
addition to the less advanced technology provided by the Regina WWTP, which does not include 
an activated sludge treatment. Exposure to average winter air temperatures of -12.4°C for extended 
periods of time due to longer retention time in the open lagoon systems, can result in significant 
decrease in biological treatment efficiency as a result of reduced microbial activity (ECCC 2018). 
As presented in the current study, advanced tertiary treatments, such as used by the Saskatoon 
plant, have the ability to keep the effluent temperatures more consistent throughout the year, 
ranging between 9.3 and 12.5oC during early winter to spring, and higher in the summer, while in 
Regina the effluent temperatures, except for summer, ranged between 2.7 and 4.3C (Appendix 
Table A2.3). Kirk et al. (2002) also observed lower androgenic and estrogenic activities in 
effluents of WWTPs with more advanced treatments and reported that the major reduction in 
activity, due to biological degradation, occurred during secondary treatment, particularly activated 
sludge. As Regina WWTP is considered a lagoon-based primary treatment, it was able to remove 
some androgenicity, but in colder months, such as early winter, this removal was incomplete. 
Surprisingly, the same pattern was not observed during late winter and spring when comparable 
temperatures were observed, and thus, other factors were likely to have contributed to the 
fluctuations of androgenicity patterns throughout the year. Similarly, Tixier et al. (2003) were also 
unable to find a clear pattern of seasonality in Switzerland, where some contaminants increased 
during snow-melt seasons, while others decreased, illustrating that seasonality can strongly affect 
removal efficiency. Overall, limited information is available regarding seasonal variability of 
removal efficiency of compounds with androgenic properties from wastewater, and it remains 
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difficult to establish clear correlations between climatic/weather conditions and removal 
efficiencies of androgenic compounds.  
While both the Regina and Saskatoon treatment plants showed high removal efficiencies of 
androgenicity, there were significant anti-androgenic potentials in effluents from both WWTPs in 
spring.  Interestingly, this trend was only observed during the spring season.  Increased anti-
androgenic potencies exhibited by Regina effluents were likely due to a less advanced treatment 
level compared to Saskatoon. A similar pattern was observed by Rostkowski et al. (2011), where 
effluents from WWTPs subjected to less advanced treatments showed a higher number of anti-
androgens fractions compared with effluents from more advanced treatments including sand 
filtration or denitrification stages.  In contrast, influent samples collected during spring from the 
Saskatoon WWTP that had low androgenic agonistic activity revealed highly significant 
antagonistic activity, suggesting that androgenic effects could have been masked by anti-
androgenic compounds within the influent samples tested.  Also, the treatment plant was not able 
to completely remove some of the inhibitors with effluents still showing significant inhibition. 
This could indicate that both androgenic and anti-androgenic compounds were present in influent 
samples, competing for the same receptors, and that treatment may have predominantly removed 
androgenic compounds, resulting in remaining anti-androgenic substances in the effluents. The 
Saskatoon WWTP showed higher removal efficiency of antagonists (56%) compared to Regina 
with negative or no removal, suggesting that the advanced Saskatoon treatment system was more 
efficient at removing AR antagonists from raw wastewater. Similar anti-androgenic potencies to 
those in both the Regina and Saskatoon WWTPs influent and effluents were observed by Jálová 
et al. (2013), where most extracts of influents and effluents showed anti-androgenic activities. 
However, in contrast to what was found in the current study, Jálová et al. (2013) verified that anti-
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androgenic potencies were approximately 60% greater in influents than that in effluents, which 
could be due to different composition of the influent with mixed industrial and domestic (50:50) 
wastewaters resulting in greater inhibition, compared to prevalent domestic influents in Regina 
and Saskatoon. In addition, the lesser inhibition detected in effluents investigated in the Jálová et 
al. (2013) study was likely due to the advanced secondary/tertiary treatment system with four times 
greater flow capacity than Regina and Saskatoon. 
Overall, significant anti-androgenic properties were prevalent in effluents, and thus, may pose a 
risk to aquatic wildlife. This may be of particular concern for Wascana Creek downstream of the 
Regina WWTP, due to the low dilution of effluents.  In fact, up to 99% of Wascana Creek flows 
can be composed of effluents during dry seasons (Waiser et al. 2011b, a). To date, androgenic and 
anti-androgenic effects in wildlife have not been reported as frequently as estrogenic effects; 
however, some studies verified that chemicals with anti-androgenic properties, such as triclosan 
and methyl-triclosan that are ubiquitous within the aquatic environment (Johnson et al. 2007; 
Urbatzka et al. 2007; Hill et al. 2010), may be significant contributors to reproductive dysfunction 
in aquatic wildlife (Jobling et al. 2009a). The potential biological relevance of anti-androgenic 
properties of effluents is further supported by two parallel studies that investigated androgenic and 
estrogenic effects of the Regina and Saskatoon WWTPs in vivo using fathead minnows (FHM; 
Pimephales promelas), a resident fish species (Steeves et al. in preparation;  Hanson et a. in 
preparation a,b).  Fish exposed to the same effluents in the laboratory or wild fish collected 
downstream of the Regina WWTP showed no signs of androgenicity such as masculinization of 
female fish. However, these studies revealed significant anti-androgenic responses, such as 
delayed gonadal maturation and demasculinization of males, indicating AR antagonists present in 
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effluents could potentially have contributed to the impacts on normal reproductive functioning of 
male fish downstream of the Regina WWTP.  
2.5.3 Steroidogenesis disruption 
Only very few of the samples from either treatment plant caused a significant increase or decrease 
in E2 production. The magnitude of the effects observed in the present study (<2.0-fold induction 
of E2) were comparable to those reported by Maletz et al. (2013) after exposure to MWWEs in 
Germany, who emphasized that fold-changes lesser than 2.0 should not be considered highly 
relevant effects. However, influent samples from Saskatoon during spring showed a 2.3-fold 
increase in E2 production, suggesting these samples contained compounds with the ability to 
stimulate E2 production. In contrast, a significant decrease of E2 production was observed in 
effluent samples collected from the Regina WWTP during summer and Saskatoon during spring 
with 0.6- and 0.5-fold changes, respectively.  Thus, there was no clear pattern in the presence of 
compounds that disrupt steroidogenesis either as a function of season or treatment level. Contrary 
to results observed in the current study, Gracia et al. (2008) detected inhibition of E2 production 
primarily in influent samples from WWTPs in Hong Kong, SAR, China, while most of the effluent 
samples did not affect E2 production, except for the outdated sewage WWTP in San Wai.  
Exposure of H295R cells to MWWE of the latter plant resulted in a 4-fold increase in E2 
production, and the authors suggested that this was due to the treatment process not being able to 
effectively remove EDCs with steroidogenesis disrupting properties. Together with the results 
from this study, these data emphasize that MWWEs are containing complex mixtures of EDCs 
that are in continuous flux, resulting in varying effects on endocrine endpoints, likely due to a 
number of factors, such as variation of chemical concentration and composition in raw sewage, 
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and removal efficiency. Moreover, a study conducted by Hadrup et al. (2013) that investigated the 
effects of environmentally relevant mixtures of five pesticides with steroidogenesis stimulating 
and inhibiting properties, found that mixtures of combinations of inhibitors and inducers did not 
always respond as predicted based on their individual properties, and that one chemical alone is 
unlikely to drive the effects of the mixture (Heindel et al. 1995; Olmstead and LeBlanc 2005).  As 
effluents and influents of WWTPs contain highly complex mixtures including stimulators and 
inhibitors of steroidogenic functions as well as cytotoxic components, this may explain the lack of 
clear response patterns observed in our study, where in some cases influent samples showed 
significant increase in E2, and effluent extracts showed a significant decrease, while in other 
situations no significant response was observed, regardless of the treatment level. To date few 
studies have been conducted that investigated the potential impacts MWWEs can have on 
steroidogenic functions, and those that report on effects on E2 production showed significant 
variation both within and among studies, making it challenging to conduct a more detailed 
assessment of the steroidogenesis disrupting potentials of MWWEs. Despite the variation due to 
the reasons listed above, clear signs of steroidogenesis effects were observed, showing that the 
steroidogenesis disruption assay utilized is an important component for EDC screening.  In 
addition, there is a need for future studies that more thoroughly describe the effects of seasonality 
as well as compare different treatment levels of WWTPs on steroidogenic pathways including 
experiments that analyze direct effects on steroidogenic enzymes or their gene expression as well 
as other endpoints within the steroidogenic pathway such as androgen or corticosteroid production.  
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2.5.4 Chemical analysis 
The current study did not detect the presence of reproductive hormones or other chemicals that 
have been previously reported to act as hormone receptor agonists. The lack of detection of 
hormones such as EE2 and E2 was not anticipated, in particular for the effluent of the lagoon-
based Regina WWTP.  However, this observation was comparable to results from other studies 
(Ternes et al. 1999; Baronti et al. 2000; Huang and Sedlak 2001; Kolpin et al. 2002), which rarely 
detected EE2 and E2 in WWTP effluents, and if detections occurred they were at low 
concentrations. Although endogenous and synthetic hormones were not detected, a number of 
other compounds were found at elevated concentrations.  The four most prevalent compounds 
included carbamazepine, clofibrate, DEET and triclosan in influents and effluents from the Regina 
and Saskatoon WWTPs.  
Carbamazepine, an anticonvulsant has been found in wastewaters at highly variable 
concentrations, ranging from <MDL to 1,850 ng/L in influents and 33 to 6,300ng/L in effluents 
(Table S2.4). In the present study, the concentrations of carbamazepine were found to be lower 
than measured in many previous studies, ranging from 1.7 to 17.6 and 0.7 to 8.8 ng/L in influent 
and effluent samples, respectively. Fraz et al. (2018) observed that chronic exposure of fish to 
carbamazepine at 10,000 ng/L showed decreased androgen levels and fish reproduction in 
laboratory studies. However, given the low concentrations of carbamazepine detected, it is unlikely 
that this compound has contributed to any of the biological activities observed. Clofibrate is an 
effective antihyperlipidemic agent (Schulman et al. 2002), detected worldwide at concentrations 
ranging from <MDL to 360 and 37 to 990 ng/L in influents and effluents, respectively (Table 
S2.4). In the present study, clofibrate was detected between 35.9 and 52.7 ng/L in influent and 
between 30.9 and 37.8 ng/L in effluent samples, which is consistent with the 37 ng/L observed by 
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Brun et al. (2006) in effluent samples in Canada. Previous studies have demonstrated that 
clofibrate can act as an inhibitor of the estrogen receptor at 41,462 µg/L using YES assay (Ezechiáš 
et al. 2016), and has the ability to inhibit enzymatic activities involved in the synthesis of active 
androgens at 242,690 µg/L (Fernandes et al. 2011). However, the concentrations detected in the 
current study were 1,000 to 10,000-fold less than what was described by Fernandes et al. (2011) 
and Ezechiáš et al. (2016), and therefore, it is unlikely that the presence of clofibrate has 
contributed to the anti-androgenicity and anti-estrogenicity observed in this study.  DEET, an all-
purpose individual insect repellent, and has been observed in the environment at highly variable 
concentrations ranging from 10 to 10,000 ng/L in influent and 140 to 2,238 ng/L in effluent 
samples (Table S2.4). In the present study, comparable concentration ranges of DEET were 
observed, between 152 to 7,815 and 10.3 to 3,169 ng/L in influent and effluent samples, 
respectively. Few studies are available that investigated the endocrine disrupting potential of 
DEET in aquatic vertebrates such as fish, but one study by Zenobio et al. (2014) observed androgen 
receptor gene downregulation (0.4-fold change) in female FHM after DEET exposure at 600 ng/L.  
Concentrations of DEET observed in this study were greater than effect levels previously reported, 
suggesting the anti-androgenic activity measured in vitro, as well as the inhibition of reproductive 
functions in the parallel fish experiments, could be explained by the presence of this chemical 
alone or in mixture with other compounds. This warrants further studies to better understand 
DEET’s mode of action and possible endocrine effects. Triclosan is an antimicrobial known to be 
structurally similar to estrogenic and androgenic EDCs, containing molecules with two aromatic 
rings (Veldhoen et al. 2006; Allmyr et al. 2008). Although, high removal efficiency by WWTPs 
has been reported with >95% (Table S2.4), its high and continuous consumption results in pseudo-
persistence and continuing detection in MWWEs (Waiser et al. 2011b, a). Concentrations of 
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triclosan worldwide range between 10 and 26,800 ng/L in influent and between 10 and 3,100 ng/L 
in effluent samples (Table S2.4). In the current study, triclosan was measured in influent samples 
at the lower range of concentrations previously measured, 6.1-140.7 ng/L, and at lesser 
concentrations, 0.2-29 ng/L, in effluent samples. Recent studies have shown that triclosan has the 
potential to interact with the endocrine system of vertebrates via disruption of thyroid hormone 
homeostasis and possibly the reproductive axis, but effects occurred at much greater 
concentrations between 20,000 and 100,000 ng/L (Foran et al. 2000; Ishibashi et al. 2004; Raut 
and Angus 2010). Thus, it is unlikely that the presence of triclosan alone could have contributed 
to the results observed.  
Furthermore, in this study, some chemicals were only found in influent samples, such as 
gemfibrozil (antihyperlipidemic) at 268 ng/L during summer in Regina and progesterone 
(reproductive hormone) between 1.8 and 2.3 ng/L in both WWTPs.  This indicates that the two 
studied WWTPs were efficient at removing these compounds and that improvements regarding 
volume capacity to avoid bypass of untreated raw influent during specific times of the year with 
potentially higher concentrations of these contaminants is important. Most of the chemicals 
detected in the present study, except for DEET, were found at concentrations previously reported 
as “nontoxic”; however, these chemicals are occurring in complex mixtures with each other as 
well as a myriad of other compounds, and little to nothing is known regarding the potential 
combinatory effects of these mixtures.  Many of these chemicals including hormonally active 
chemicals, personal care products, and pharmaceuticals are developed to stimulate certain 
therapeutical or other physiological responses in humans, plants, and animals at low 
concentrations, and as such may pose a greater risk than traditional contaminants (Daughton and 
Ternes 1999; Jorgensen and Halling-Sorensen 2000). Moreover, the strong variations of chemicals 
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concentrations among WWTPs and seasons may be explained by a number of factors also observed 
by other studies, including daily concentration fluctuations due to consumption, environmental 
regulations, effectiveness of the WWTPs and seasonal conditions affecting WWTP removal 
efficiency (Petrovic et al. 2009; Jelić et al. 2012; Luo et al. 2014a).  
2.6 Conclusion 
The results of this study confirmed generally high treatment efficiency of WWTPs for the removal 
of androgens throughout the year, while low to moderate removal efficiencies occurred for anti-
androgens and (anti-)estrogens. Thus, receptor-antagonists for both the ER and AR remain a 
significant concern in the effluents of the Regina and Saskatoon WWTPs. Furthermore, the Regina 
WWTP with its lagoon-based treatment was not as efficient at removing other contaminants, 
particularly estrogens, as Saskatoon with a more advanced treatment system. This is particularly 
concerning as Regina effluent is discharged into Wascana Creek, a small surface system with low 
dilution, which can be composed of 99% effluent before it connects with the Qu’Appelle River 
downstream (Waiser et al. 2011b), which renders this creek and other low-flow systems in semi-
arid environments at higher risk to the exposure with EDCs, especially during the dry seasons. 
Spring appeared to be the most concerning season, showing the greatest effects with regard to 
EDCs with MWWEs when receptor and non-receptor mediated assays were compared. The results 
obtained by the in vitro study were supported by two parallel in vivo studies, as well as by the 
chemical analysis, demonstrating in vitro assays can be a relevant cost-effective tool for 
prioritizing potential EDC impacts of MWWEs in aquatic environments.  
To conclude, both the seasonality and treatment level seemed to play an important role regarding 
EDC removal (Table 2.1). Future studies should include WWTPs with different population 
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demographics, treatment levels, and temperature regimes in order to better understand how these 
endpoints can affect EDC removal. Furthermore, to better pinpoint the potential main drivers of 
toxicities of MWWEs, other endpoints such as genotoxicity, metabolic toxicity, corticoids, etc. 
should be included to identify other relevant stressors in addition to EDCs that could explain the 
alterations observed in the fish studies. Finally, future studies should be conducted at the Regina 
WWTP, which has recently undergone a major upgrade, to evaluate removal improvements of 
EDCs.  
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Table 2.1: Summary of in vitro results describing the endpoints and outcomes of potential risks 
of MWWEs from Regina and Saskatoon, detected by MVLN (anti-)estrogenicity, MDA (anti-
)androgenicity, and H295R (steroidogenesis disruption). YES, effluent from both WWTPs showed 
at least one season of significant activity. SOME, effluent from one of the WWTPs showed 
significant activity at least during one season. NO, no significant activity >2-fold change from 
either WWTP. 
 
 
 
 
 
 
 
Endpoint Outcome MWWEs
ER SOME Regina
Anti-ER YES Regina/Saskatoon
AR NO None
Anti-AR YES Regina/Saskatoon
Steroidogenesis disputors
SOME
Regina/Saskatoon WWTPs affected production of 
E2, with effluents causing decrease of E2 overall. 
However, no consistent pattern was observed
Does treament level affect EDC removal? SOME Regina showed greater endocrine activity overal
Does seasonality affect EDC removal? SOME Spring showed greater endocrine activity overal
Can in vitro assays be used as a cost-
effective tool for prioritizing potential 
endocrine disrupting impacts of MWWEs
YES
Results from parallel in vivo and chemical 
analysis  studies, were in agreement with in vitro 
findings
Are MWWEs a significante source of EDCs?
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CHAPTER 3: BIOASSAY-DIRECTED ANALYSIS OF 
ENDOCRINE DISRUPTING POTENCIES OF MUNICIPAL 
EFFLUENTS IN CENTRAL AND EASTERN CANADA 
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PREFACE 
This chapter was developed based on the results from chapter 2 where the efficiency of two 
WWTPs in Saskatchewan, Canada were investigated for their ability to remove EDCs with (anti-
)estrogenic, (anti-)androgenicity and steroidogenesis disrupting potentials, as well as to determine 
whether treatment level and seasonality influenced removal efficiency. According to chapter 2, 
both seasonality and treatment level seemed to play an important role regarding EDC removal; 
however, a clear pattern, particularly as a function of temperature, was not determined. Therefore, 
Chapter 3 further evaluated four additional WWTPs across Canada with different treatment levels, 
temperature regimes, and population demographics in order to better understand how these 
endpoints could affect EDC removal. This chapter was organized as a manuscript for publication 
in peer-reviewed scientific journals 
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3.1 Abstract 
There has been increasing concern with regard to the release of chemicals that can affect the 
endocrine system of aquatic organisms by municipal wastewater effluents (MWWEs).  In 
particular, there is significant uncertainty regarding the ability and efficiency of wastewater 
treatment plants (WWTPs) to remove these compounds from raw sewage. This project aimed to 
investigate the efficiency of four WWTPs in Ontario and Quebec to remove EDCs, and to compare 
results with those obtained during an earlier study that characterized the endocrine disrupting 
properties of influents and effluents from two WWTPs in Saskatchewan. The studies used a 
combination of three in vitro bioassays: the MVLN ((anti-)estrogenicity), MDAkb2 ((anti-
)androgenicity), and H295R Steroidogenesis (steroidogenesis disruption) assays. Treatment levels 
of the investigated WWTPs ranged from lagoon-based primary to tertiary with activated sludge 
and UV filtration.  The results of this study confirmed medium to high treatment efficiencies of 
WWTPs for the removal of androgens and low to moderate removal efficiencies of anti-androgens 
and (anti)-estrogens. Thus, ER and AR receptor-antagonists remain a significant concern in 
MWWEs in Canada that requires further research and analysis. Furthermore, population, 
seasonality and treatment level seemed to play an important role in driving the efficiency of 
WWTPs to remove EDCs. The Montreal and Quebec City WWTPs, which serve the largest 
populations among the cities studied, had the greatest androgenic potentials in both influents and 
effluents. Both Montreal and Regina, which utilized primary open lagoon systems that are exposed 
to fluctuations in temperature and have longer retention times, showed the least removal efficiency 
of contaminants, specifically estrogens, as compared to the more advanced treatment systems 
utilized by the other WWTPs. Chemical analysis confirmed the results of the in vitro assays and 
verified that in vitro assays can be a cost-efficient first step when analyzing the potential presences 
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of EDCs in MWWEs being discharged into surface waters.  
Keywords: emerging contaminants, wastewater, in vitro, monitoring 
3.2 Introduction 
Concerns regarding the potential health effects associated with exposure of humans and wildlife 
to endocrine disrupting chemicals (EDCs) have been increasing over the past decades. EDCs can 
be found in the form of both natural and synthetic compounds that can alter the development, 
reproduction and growth of humans and other animals (Kavlock et al. 1996; Jobling et al. 1998; 
Kidd et al. 2007). Specifically, EDCs can significantly affect key physiological processes of 
organisms and have been shown to cause intersex (occurrence of both male and female tissues 
simultaneous in an organism), reduced egg production, abnormal growth of testes and other 
reproductive issues (Kidd et al. 2007). One of the primary sources of EDCs to surface waters is 
municipal wastewater effluents (MMWEs), particularly those discharged into water bodies with 
low flow rates or that originate from wastewater treatment plants (WWTPs) with inefficient or 
outdated treatment systems. MWWEs represents complex mixtures with a wide variety of known 
and unknown chemicals with the ability to affect endocrine systems (Purdom et al. 1994; 
Reemtsma et al. 1999), including natural and synthetic hormones (e.g. 17β-estradiol [E2], estrone 
[E1] and ethynylestradiol [EE2]), plasticizers such as bisphenol A and phthalates, a large number 
of pharmaceuticals and personal care products (PPCPs), and organic detergents (e.g. nonylphenol) 
(Jobling et al. 1995; Ternes et al. 1999; Giesy et al. 2002; Carballa et al. 2004; Lahnsteiner et al. 
2005). Traditionally, WWTPs were designed to primarily filter or settle particulates, organic 
materials, nitrate and phosphorus from the wastewater; however, degradation or removal of 
contaminants such as EDCs is often incomplete (Hecker and Hollert 2009). Advanced treatment 
facilities aim to improve effluent quality by further removing some contaminants, such as EDCs, 
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using ozonation, membrane filtration and activated carbon (ERRIS, 2013). Previous studies have 
demonstrated that tertiary and quaternary, and sometimes advanced secondary technologies can 
improve the efficiencies of WWTPs to remove EDCs (Ternes 1998b; Jálová et al. 2013; Pessoa et 
al. 2014). In Canada, levels of treatment facilities vary greatly, with some small cities having 
heavily invested in advanced quaternary treatment technologies, such as Swift Current, SK, while 
some larger cities, such as Montreal, QC, with a population close to 2 million habitants are still 
relying on systems built in the 1950s and 1960s with simple primary filtration steps, consisting of 
lagoons (Lishman et al. 2006). However, due to the high cost associated with advanced treatment 
systems, only a few municipalities are actively incorporating these types of technologies, meaning 
the gap among treatment levels used by WWTPs across Canada is significant.  
In addition to the high variability of treatment technologies across Canada, extreme climates and 
highly diverse geographic distribution of the population can make it challenging to understand the 
occurrence of EDCs and its removal by WWTPs. Canada can be characterized into eleven distinct 
climate areas with a vast difference in temperature and precipitation, varying from +40°C to -40°C 
throughout the year. For example, the minimum temperature among the six WWTPs evaluated in 
the current study can vary by 12.1°C degrees in January, while only by 1.2°C degrees in July 
(Statistics Canada, 2011). Furthermore, the yearly precipitation shows even greater disparity, with 
Saskatoon and Regina, which are part of the prairie region, having nearly three times lesser 
precipitation (350-385 mm yearly), compared to the other cities (900-1100 mm yearly) (Statistics 
Canada, 2011). Additionally, population density across Canada also varies greatly, with Guelph 
WWTP serving 131,794 habitants; Saskatoon, Regina, and Kitchener serving 215,000 to 246,000, 
while Quebec City and Montreal serve the largest number of people, at 531,000 and 1.7 million, 
respectively (Statistics Canada, 2016). 
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Despite a general understanding that advanced treatment systems may improve removal of 
contaminants, little is known about the in situ efficiency of WWTPs to remove EDCs, and in 
particular, how changes in temperature and precipitation can affect their degradation or 
concentration due to evaporation and dilution (Kirk et al. 2002; Pessoa et al. 2014). Furthermore, 
little is known regarding the effects population density has on the presence of EDCs in MWWEs, 
particularly when analyzing less advanced treatment facilities that are at capacity of treatment, and 
that have different sewage retention and processing times (Kirk et al. 2002; Jálová et al. 2013). It 
is also important to consider dilution and accumulation of contaminants from WWTPs that have 
combined domestic sewage and stormwater systems, such as Montreal, during heavy rain events 
and seasonal snowmelt, where untreated sewage can be bypassed and discharged into the receiving 
waters (Kirk et al. 2002). Therefore, it is important to establish an understanding of the potential 
impact treatment level, temperature regime and climate, as well as population size,  have on the 
presence and removal efficiency of EDCs by WWTPs. Moreover, the results obtained from the six 
cities examined within this study can potentially provide information to cities with similar climates 
and precipitation, specifically in Europe and Asia (Wang and Overland 2004). 
To date, traditional chemical analysis has been the most utilized method for identifying the 
presence of EDCs in complex environmental samples such as municipal effluents (Hecker and 
Giesy 2011). However, wastewater influents and effluents are complex mixtures of thousands of 
chemicals, making individual chemical analysis difficult and cost prohibitive at times. In fact, 
many of the compounds present in these mixtures are unknown and/or do not yet have analytical 
procedures established that would enable their reliable quantification, and as such chemical 
analysis cannot completely assess all the biologically active contaminants within a sample (Brack 
2003; Hecker and Giesy 2011). Additionally, many of the chemicals present in MWWEs have no 
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or only limited toxicity data associated with them, making it difficult to predict any potential 
biological risks (Brack 2003; Hecker and Giesy 2011). Therefore, bioassays, in particular, 
mechanism-specific in vitro assays, are increasingly used in conjunction with targeted chemical 
analysis of complex environmental samples such as effluents as they can characterize the specific 
biological activity within a sample. Specifically, bioassays respond to all the chemicals with the 
same mode of action (e.g. (anti-)estrogenic and (anti-)androgenic compounds) including 
unidentified ones for which analytical detection is unavailable, even at low concentrations (Wilson 
et al. 2002, 2004, Hecker et al. 2006, 2011). However, while bioassays can help identify and 
prioritize candidate groups of causative agents in complex samples, they cannot pinpoint 
individual chemicals. Subsequently, it is recommended to combine bioassays with targeted 
chemical analysis to identify the causative chemicals or mixtures responsible for the effects 
observed (Villeneuve et al. 1997). 
Traditionally, studies conducted to characterize the presence of EDCs in MWWEs have focused 
on compounds binding to the estrogen receptor (ER) or the androgen receptor (AR) (Wilson et al. 
2002). However, several studies have demonstrated that chemicals with different endocrine 
mechanisms of action such as inhibitors or inducers of steroidogenesis can be of equal importance, 
and thus, efforts are increasingly made to include both receptor and non-receptor mediated assays 
for the comprehensive assessment of endocrine activity in complex mixtures (Grund et al. 2011; 
Hecker and Hollert 2011; Maletz et al. 2013). In particular, the H295R Steroidogenesis Assay has 
been shown to be a useful tool for the detection of compounds that can disrupt production of steroid 
hormones (Nakajin et al. 2001; Li et al. 2004).   
Given this background, this study aimed to use an in vitro bioassay-directed analysis approach to 
determine endocrine disrupting potentials of MWWEs from different WWTPs across central and 
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eastern Canada, and whether they might pose a potential risk to the receiving aquatic environment. 
Specifically, the objectives of this study were to: 1) characterize the presence of chemicals in 
influents and effluents of six WWTPs that a) agonistically or antagonistically bind to the AR and 
ER using MDA-kb2 and MVLN cells, respectively, and/or b) disrupt the production of the sex 
steroid hormone E2 using the H295R Steroidogenesis Assay; 2) determine whether level of 
treatment and climate influence removal efficiency of EDCs by WWTPs; and 3) compare 
bioassay-derived endocrine potentials to the presence of selected contaminants using targeted 
chemical analysis 
3.3 Methods 
3.3.1 Sampling and extraction 
Municipal wastewater influent and effluent samples were collected from four WWTPs across 
Canada in 2014 during the spring and summer months: Guelph and Kitchener, ON, and Quebec 
City and Montreal, QC. Furthermore, data from chapter 2, investigating two WWTPs in 
Saskatchewan (Regina and Saskatoon), were included for comparison. The samples were 
characterized according to their treatment technologies (lagoon-based, primary and advanced 
tertiary technologies), population size, and climatic conditions throughout the year (Table S3.1 
and Figure 3.1). WWTPs were divided into two main categories, low concern (Saskatoon, Guelph, 
and Quebec City) and high concern (Regina, Kitchener, and Montreal), according to their 
treatment level (Table S3.1).  
Sampling, as well as preservation and extraction of wastewaters, was in accordance with the 
procedures described in chapter 2. Briefly, each sampling event consisted of 24-hour composite 
samples collected during two to three days over one week per season, where four liters of influent, 
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and four liters of effluent were collected and stored separately in pre-cleaned sterile amber glass 
bottles from each location. Two to three drops of chloroform were added immediately after 
collection to avoid breakdown of compounds, which were removed by subsequent filtration, and 
samples were stored in the dark at 4°C prior to analysis, which occurred within two weeks of 
sampling. Organic chemicals were extracted from 2L of samples or a blank control consisting of 
2L laboratory ultrapure water filtered through 0.6µm glass microfiber filters (Canadian Life 
Science, Quebec City, Canada) by solid phase extraction (SPE) using Waters Oasis® Hydrophilic-
Lipophilic Balance (HLB) 6cc, 150 mg, and Mixed Cation-exchange (MCX) 6cc, 500 mg 
(Mississauga, Ontario, Canada) as described in chapter 2. The hexane/dichloromethane extracts 
from HLB and MCX cartridges were then blown to near dryness under a gentle stream of nitrogen, 
and subsequently combined and reconstituted in 400 µL of isooctane. The final concentration of 
each sample was consequently 5,000X more concentrated than the unprocessed samples. Extracted 
samples were stored at -20oC in 2 mL amber crimp top vials with clear inserts.  
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Figure 3.1 – Geographical location (in green), treatment level of the six WWTPs studied across 
Canada.  Data on population (pop) served are according to Statistics Canada, Census Profile, 2016.  
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3.3.2 Bioassays 
MVLN and MDA assays were used to determine (anti-)estrogenic and (anti-)androgenic activities, 
respectively (Demirpence et al. 1993; Wilson et al. 2002), while the H295R cell assay was used to 
measure disruption of E2 production (Hecker et al. 2006, 2007, 2011). All cell lines were obtained 
from the American Type Culture Collection (ATCC, Manassas, USA). 
3.3.2.1 Cytotoxicity   
Each cell line underwent cytotoxicity tests prior to conducting endpoint-specific in vitro assays 
using the MTT assay (Mosmann 1983) (Figures S3.2 to S3.7). Cells were seeded in 96-well cell 
culture plates (Corning Inc., NY, USA) at a density in accordance with each cell line assay protocol 
(see below sections) with 100µL of appropriate media for 24 hours as optimized and described by 
earlier studies (Ferrari et al. 1990; Ohno and Abe 1991; van de Loosdrecht et al. 1994). 
Subsequently, cells were exposed to graded concentrations of extracted samples in 0.1% isooctane 
in triplicate wells for 24 h (MVLN, MDA) or 48 h (H295R). Samples from two or three collection 
days per sampling season were analyzed independently. Concentrations ranged from 0.1x to 10x 
of the original samples. After exposure, 10 µL of MTT assay dye solution (Biotium, Fremont, 
USA) was added to each well and incubated for 2-4 hours at room temperature. Last, 200µL of 
dimethyl sulfoxide (DMSO) was added to each well, and cell viability was measured at an 
absorbance of 470nm and 630nm using a spectrophotometer.  
3.3.2.2 MVLN cell assay 
To determine total (anti-)estrogenic activities of the sample extracts from influent and effluent, the 
MVLN human breast cancer cell line stably transfected with the ER (Demirpence et al. 1993) was 
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used. Specific procedures followed were in accordance with those previously described in chapter 
2 for wastewater extracts. Cells were cultured in maintenance medium Dulbecco's Modified Eagle 
Medium-F-12 (DMEM-F12) without phenol red (Sigma Aldrich, USA) with 10% FBS (Gibco) 
under a 5% CO2 atmosphere at 37 °C with final pH adjusted to 7.3. Cells were seeded at a density 
of 300,000 cells/mL using 100 µl/well into a sterile 96-well luminometer plate (Perkin-Elmer) in 
assay media containing 10% of dextran-charcoal FBS (DCC-FBS; HyClone Laboratories, South 
Logan, Utah, USA) to decrease concentrations of natural steroids in FBS. Cells were not added to 
outer perimeter wells, where only PBS was added as a background for luminescence blanks. After 
24h, cells were exposed to graded concentrations of the extracted samples (10x, 3x, 1x, 0.3x and 
0.1x) or a serial dilution of an E2 standard in quadruplicate wells for another 24h as optimized by 
earlier studies (Van Den Belt et al. 2004; Freyberger and Schmuck 2005; Jarošová et al. 2014a) at 
37 °C. Samples from two or three collection days per sampling season were analyzed 
independently. Final dosing concentrations of E2 standards (1:3 serial dilution) ranging between 
0.4-817.1 ng/L in 0.1% ethanol vehicle, as well as SC were included in each plate. The media was 
then replaced by SteadyLite (Perkin Elmer, USA), and estrogenicity was measured by a microplate 
luminescence reader (Polarstar Optima). Fold change relative to the SC was calculated as 
described by (Demirpence et al. 1993) and coefficients of variation (CV) were less than or equal 
to 20%. Significant activities of samples were confirmed in an independent second experiment. 
Estrogen equivalents (EEQs) were calculated from the E2 standard curve (four parameter logistic 
function). EEQs were expressed as ng E2-equivalents/L of influent and effluent samples from the 
six WWTPs at 1x concentration during spring and summer of 2014. In a separate exposure, to 
determine anti-estrogenicity, the natural ER ligand E2 was added to the medium at a concentration 
that produced a sub-maximal response (81.7 ng/L; 1nM E2), while the remaining test procedures 
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were identical to those described above. The ability of chemicals to inhibit luminescence was then 
determined compared to the anti-estrogen hydroxytamoxifen (HT) added at the same time as 
described in Demirpence et al. (1993).  
3.3.2.3 MDA-KB2 cell assay 
The human breast cancer cell assay stably transfected with an androgen receptor (AR), namely 
MDA-KB2 (Wilson et al. 2002), was used to determine (anti-)androgenic activities of wastewater 
extracts as previously described in chapter 2. First, cells were cultivated in supplemented medium 
containing Lebovitz’s (L-15, Gibco-Life Technologies Inc. Burlington, Canada) with 10% Fetal 
Bovine Serum (FBS) (Gibco) in a 5% CO2 atmosphere at 37°C with final pH adjusted to 7.6. Cells 
were seeded at a density of 200,000 cells/mL using 100 µL/well into a sterile 96-well luminometer 
plate (Perkin-Elmer, Woodbridge, Canada). Cells were not added to outer perimeter wells, where 
only PBS was added to be used as background luminescence blanks. After 24h, cells were exposed 
to graded concentrations of the extracted samples (10x, 3x, 1x, 0.3x and 0.1x) or a DHT standard 
curve in quadruplicate wells for another 24h at 37 °C following the protocol by Wilson et al. (2002) 
for optimal response. Dosing solutions were prepared by pre-diluting either DHT standards or 
samples in supplemented media. Final dosing concentrations of DHT standards (1:2 serial dilution) 
ranging between 2.3-145.2 ng/L in 0.1% isooctane vehicle, as well as solvent control (SC) (0.1 
%v/v Isooctane) were included in each plate. After exposure, medium was removed, and 
androgenic activity was determined by adding SteadyLite (Perkin Elmer, USA) with luminescence 
measured by microplate luminescence reader (Polarstar Optima, BGM Labtech, Guelph, Canada). 
Samples from two or three collection days per sampling season were analyzed independently. 
Significant activities of samples were confirmed in an independent second experiment. Fold 
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change relative to the SC was calculated as described by Wilson et al. (2002), and androgen 
Equivalents (AEQs) were calculated from the DHT standard curve (four parameter logistic 
function). AEQs were expressed as ng DHT-equivalent/L of influent and effluent samples from 
the six WWTPs at 1x concentration during spring and summer of 2014. In a separate exposure, to 
determine anti-androgenic activities, the natural AR ligand DHT was added to the medium at a 
concentration that produced a sub-maximal response (36.3 ng/L; 125pM DHT), while the 
remaining test procedures were identical to those described above. The ability of chemicals to 
inhibit luminescence was then determined compared to the anti-androgen hydroxyflutamide (HF) 
added at the same time as DHT as described in Wilson et al. (2002).  
3.3.2.4 H295R cell assay 
Steroidogenesis disruption was measured using the H295R human adrenal cancer cell line H295R  
through the modulation of synthesis of E2 following the OECD Test No. 456 (2011) (Hecker et 
al. 2006, 2007, 2011), with modifications for wastewater extracts as described in chapter 2.  Cells 
were cultivated in supplemented medium containing DMEM-F12 Hams (Sigma), 2.5% of BD-
serum and 1% of ITS+ premium mix (both from BD Biosciences, Mississauga, Canada) under 
atmosphere at 37oC and 5% CO2 with final pH adjusted to 7.4, for a minimum of 4-5 passages to 
ensure sufficient basal E2 production, and for a maximum of 10 passages as described by Hecker 
et al. (2006). Once cells reached 80% confluency, they were seeded into 24-well tissue culture 
plates at a density of 300,000 cells/mL using 1000 µl/well (Corning Inc., NY, USA). After 24h, 
cells were exposed to graded concentrations of the extracted samples (10x, 3x, 1x, 0.3x and 0.1x) 
for another 48h as described by Hecker et al. (2006) for optimal response in triplicate wells at 37 
°C. Samples from two or three collection days per sampling season were analyzed independently. 
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Furthermore, forskolin (FOR) (10µM) and prochloraz (PRO) (3 µM), used as positive and negative 
controls for induction and inhibition of E2 production, respectively, as well as a SC (0.1 %v/v 
isooctane/DMSO) and blanks (medium only), were included in each plate. Following the exposure, 
medium was harvested and concentrations of E2 were measured by enzyme-linked immunosorbent 
assay (ELISA) (Cayman Chemicals, Ann Arbor, MI, USA) following the manufacturer’s protocol. 
Significant activities of samples were confirmed in an independent second experiment. CVs were 
≤20% in all cases.  
3.3.3 Chemical analysis 
3.3.3.1 Orbitrap chemical analysis - liquid chromatography mass spectrometry (LC-MS) 
Compounds were identified by reference to chemical standards via accurate mass and ms/ms 
comparison. Extracts were analyzed using a Q Exactive™ mass spectrometer (Thermo Fisher 
Scientific, Toronto, ON) interfaced to a Dionex™ UltiMate™ 3000 ultra-high-performance liquid 
chromatography (UHPLC) system (Thermo Fisher Scientific, Toronto, ON).  Separation of 
chemicals was achieved with a Betasil C18 column (5 µM; 2.1 mm × 100 mm; Thermo Fisher 
Scientific, Toronto, ON) with an injection volume of 5 µL.  Ultrapure water (A) and methanol (B) 
were used as mobile phases.  Initially, 10% B was increased to 50% in 5 min, then increased to 
100% at 20 min and held static for 6 min, followed by a decrease to initial conditions of 10% B 
and held for 3 min to allow for column re-equilibration.  The flow rate was 0.20 mL/min.  The 
column and sample chamber temperatures were maintained at 40°C and 10°C, respectively.  Data 
was obtained using full scan mode and selected ion monitoring (SIM).  Briefly, MS scans (100 - 
1000 m/z) were recorded at resolution R = 70000 (at m/z 200) with a maximum of 3×106 ions 
collected within 200 ms, based on the predictive automated gain control.  SIM scans (m/z = 
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227.1072, 271.1698, 269.1542, 295.1698) were recorded at a resolution R = 35000 (at m/z 200) 
with a maximum of 5×104 ions collected within 80 ms, based on the predictive automated gain 
control, with the precursor isolation width set at 2.0 m/z.  The general mass spectrometry settings 
applied for negative ion mode were as follows: spray voltage, 2.7 kV; capillary temperature, 
375°C; sheath gas, 46 L/h; auxiliary gas, 11 L/h; probe heater temperature, 375oC.  Similarly, the 
settings applied for positive ion mode were: spray voltage, 3.0 kV; capillary temperature, 400oC; 
sheath gas, 46 L/h; auxiliary gas, 15 L/h; probe heater temperature, 350oC. 
3.3.3.2 Spike recovery experiments 
Prior to chemical analysis, samples were diluted to a 100X concentration in acetonitrile (ACN) 
and 10 ng/mL of internal standards (Table S3.4) were added for recovery analysis for each sample 
injection. Extraction efficiencies were determined from a spike recovery experiment. Samples of 
influent and effluent were extracted following the same SPE method utilized for in vitro assays. 
Non-spiked extracts were first analyzed using the same standards. Pre-existing chemical 
concentrations in each type of sample were calculated to serve as background. Compound mixtures 
were then spiked in each sample in triplicates, with concentrations for each standard approximately 
ten times greater than pre-existing concentrations or maximum allowed concentrations. Recovery 
was calculated by comparing the detected concentration of each chemical to the expected 
concentration (Table S3.3). For SIM analysis, estrogenic hormone standards (E1, E2, EE2, and 
BPA) along with deuterated internal standards (E1, E2, and BPA) were injected at controlled 
concentrations every six samples. Peak areas of internal standards in samples were compared to 
peak areas of internal standards alone for recovery calculation. Concentrations of estrogenic 
hormones were calculated from the peak area ratio of each chemical in a sample and in standards 
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while making reference to the recovery of each individual sample. For full-scan analysis, a 
standard mixture containing 31 chemicals was injected at 500, 100, 50, 20, 10, 5, 1, 0.1, and 0.01 
ng/mL to construct calibration curves. Internal standards containing D3 naproxen, D3 caffeine, 
and D3 DEET at 10 ng/mL were present in each standard mixture for recovery analysis. The 50 
ng/mL standard was also injected after every six samples for concentration calculation. Chemical 
concentrations in each sample were calculated using the 50 ng/mL standard closest in time as the 
reference. 
3.3.4 Data analysis 
Dose-response relationships were calculated by fitting data to four-parameter logistic models using 
Microsoft Excel 2016. Androgenic and estrogenic potencies were expressed as the relative change 
to the SCs, as well as AEQs and EEQs in ng/L based on dilution of a sample as determined by the 
DHT and E2 standard curves tested simultaneously in each assay plate, respectively. 
Steroidogenesis disruption was determined by changes in E2 production expressed as relative 
changes compared to SC. 
Statistical analyses were performed using SPSS version 20.0 (SPSS, Chicago, IL, USA). Data 
were expressed as mean ± standard error of the mean (± 1SEM) and analyzed by one-sample 
Kolmogorov-Smirnov test for normality, and by Levene’s test for homogeneity of variance.  
Differences among samples (influent vs effluent, WWTPs, sampling day) for normally distributed 
data were analyzed by analysis of variance (ANOVA), followed by a 2-way Dunnett’s test or 
Tukey’s test. Non-parametric data were analyzed by Kruskal Wallis test followed by the Mann 
Whitney-U test. A probability of p ≤ 0.05 was considered statistically significant. 
 
87 
 
3.4 Results          
 3.4.1 Cytotoxicity 
Most of the extracted samples, particularly influent, at the highest concentrations (10x and 3x) 
caused high cell mortality in all bioassays (MVLN, MDA, and H295R), suggesting these extracts 
contained one or more acutely toxic compounds (Figures S3.2 to S3.7). Cytotoxic concentrations 
were excluded during further investigations of endocrine disrupting potentials, and the highest 
non-toxic dose, 1x, was used to compare results among WWTPs. 
3.4.2 Estrogenicity and anti-estrogenicity 
Most of the samples did not cause significant increases in estrogenic activity. However, samples 
of influents collected during spring from Montreal caused a 2.9-fold increase (0.9 EEQ ng/L) in 
estrogenicity, and samples of effluent collected from Regina during both spring and summer 
caused a 2.3- (0.9 EEQ ng/L) and 2.0-fold (0.7 EEQ ng/L) increase in estrogenicity, respectively 
(Figures 3.2A and 3.2B). No significant increase in estrogenicity was observed in any of the other 
samples. In contrast, all samples of both influent and effluent extracts from all six WWTPs showed 
significant anti-estrogenic activities during both seasons, ranging between 0.4- and 0.7-fold change 
(Figures 3.2C and 3.2D).   
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Figure 3.2 - Estrogenic (A and B) and anti-estrogenic (C and D) activity of extracts of influents 
and effluents (1x concentrated) collected from 6 WWTPs during spring (A and C) and summer (B 
and D) of 2014 determined using the MVLN in vitro assay. Estrogenicity is expressed as relative 
changes compared to the solvent control (SC). Anti-estrogenic activity is expressed as fold-change 
relative to the positive control (PC; 81.7 ng/L E2). Data are represented as the mean ± SEM (n=4, 
wells). Dashed line represents baseline (controls). The asterisk (*) denotes a significant difference 
from the SC/PC (p<0.05). Data for Regina and Saskatoon are from chapter 2. 
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3.4.3 Androgenicity and anti-androgenicity 
Most of all influent samples from the six WWTPs showed a significant increase in androgenicity 
when compared to the SCs, except for samples collected from Quebec City and Montreal during 
summer (Figures 3.3A and 3.3B). Samples of influents with the highest androgen activity were 
collected during spring from Regina, Kitchener and Quebec City with 10.2- (44.9 AEQ ng/L), 3.9- 
(13.4 AEQ ng/L) and 15.8-fold (86.3 AEQ ng/L) increase, respectively. During summer, influents 
from Saskatoon, Guelph, and Kitchener had the greatest androgenic activities with 11.9- (52.2 
AEQ ng/L), 4.5- (18.3 AEQ ng/L) and 5.4-fold (23.1 AEQ ng/L) increases relative to SCs. In 
contrast, only a few effluent samples showed significant androgen activities. Specifically, influent 
collected during spring from Quebec City and Montreal caused 3.1- (6.9 AEQ ng/L) and 2.3-fold 
(12.7 AEQ ng/L) increases, and samples collected during summer from Montreal caused an 8.9-
fold increase (2.2 AEQ ng/L) in androgenicity (Figures 3.3A and 3.3B). 
Significant anti-androgenic potentials relative to the controls were only observed in influent 
samples collected in spring from Saskatoon and Guelph, with 0.1- and 0.4-fold changes relative to 
the positive control, respectively, and collected from Kitchener during summer with a 0.7-fold 
change. Most of the effluent samples sampled during spring showed (anti)-androgenicity, with 0.6, 
0.8, 0.7 and 0.8-fold changes for Saskatoon, Regina, Guelph, and Kitchener, respectively. For 
samples collected during summer, only the effluent sample from Kitchener showed significant 
anti-androgenicity with a 0.7-fold change (Figures 3.3C and 3.3D). 
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Figure 3.3 - Androgenic (A and B) and anti-androgenic (C and D) activity of extracts of influents 
and effluents (1x concentrated) collected from 6 WWTPs during spring (A and C) and summer (B 
and D) of 2014 determined using the MDA-kb2 in vitro assay. Androgenicity is expressed as 
relative changes compared to the solvent control (SC). Anti-androgenic activity is expressed as 
fold-change relative to the positive control (PC; 36.3 ng/L DHT). Data are represented as the mean 
± SEM (n=4, wells). Dashed line represents baseline (controls). The asterisk (*) denotes a 
significant difference from the SC/PC (p<0.05). Data for Regina and Saskatoon are from chapter 
2.  
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3.4.4 Steroidogenesis disruption 
Some samples analyzed using the H295R assay affected the ability of extracts to modulate E2 
synthesis; however, no consistent patterns were observed (Figure 3.4A and 3.4B). Only samples 
of influents collected from Saskatoon during spring and summer, and Montreal during summer 
showed a significant increase in E2 production with a 2.3-, 1.5- and 1.4-fold change, respectively. 
Furthermore, samples of effluents collected from Regina in spring and Kitchener in summer 
caused a 1.4- and 1.9-fold increase in E2 production, respectively. In contrast, some samples 
showed a significant decrease in hormone production when compared to the SCs, such as influent 
samples collected from Guelph, Kitchener and Quebec City during spring, ranging between 0.5- 
and 0.7-fold changes; and samples of effluent from Saskatoon, Guelph and Kitchener during 
spring, as well as, Regina and Quebec City during summer ranging between 0.4- and 0.6-fold 
changes.  
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Figure 3.4 - Changes in 17β-estradiol production caused by extracts of influents and effluents (1x 
concentrated) from 6 WWTPs sampled during spring (A) and summer (B) of 2014 determined by 
H295R Steroidogenesis Assay. Data are relative changes compared to the solvent control (SC). 
Results are represented as the mean ± SEM (n=3, wells). The asterisk (*) denotes a significant 
difference from the SC (p<0.05). FOR forskolin [10 µM]. PRO prochloraz [3 µM]. *p<0.05. Data 
for Regina and Saskatoon are from chapter 2. 
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3.4.5 Chemical analysis  
A total of 19 chemicals were detected during this study across all samples of influent and effluent 
from the six WWTPs, including prescription and non-prescription drugs, insecticides, herbicides, 
and other emergent contaminants related to wastewater. Most of the chemicals were detected at 
greater concentrations in influents compared to effluents. However, in some cases, the opposite 
was observed. In particular, some of the effluent samples collected from Quebec City and Montreal 
showed higher concentrations of chemicals than influents (Table S3.2). Among these 
contaminants, the greatest concentrations observed were for ibuprofen and naproxen (anti-
inflammatory drugs), triclosan (antimicrobial disinfectant) and DEET (insecticide) at 41,618, 
11,446, and 1,427 ng/L (Kitchener, influent), and 7,814 (Regina, influent), respectively (Table 
S3.2).  While other chemicals were detected at lower concentrations, including carbamazepine 
(anticonvulsant) that ranged from 0.05 and 29.9 ng/L in the influents, and from 0.54 and 18.9 ng/L 
in effluent samples, as well as clofibrate (antihyperlipidemic) with concentrations from 27.9 and 
63.4 ng/L, and 30.9 and 109.4 ng/L in influent and effluent samples, respectively. Gemfibrozil 
(antihyperlipidemic) was only detected in Guelph and Regina influent samples at 23.1 and 268.2 
ng/L, respectively, and in Montreal and Quebec City effluent samples at 16.4 and 17.3 ng/L, 
respectively. Ibuprofen concentrations ranged from 202.7 to 41,618 ng/L in influents but were only 
detected in effluents of Quebec City and Montreal at concentrations between 194.1 and 1,637 ng/L.  
Naproxen was detected only in influents of Ontario and Quebec WWTPs (17.3-11,446 ng/L) and 
was only measured in effluents of Montreal and Quebec City at concentrations of 18.7 and 321.0 
ng/L during spring and summer, respectively. Finally, DEET and triclosan were detected in 
influents and effluents of all treatment plants. DEET was detected at concentrations between 3.15 
and 7,814 ng/L in the influents and between 6.98-3,168 ng/L in effluents, with significantly greater 
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concentrations during summer compared with spring. Triclosan was found at concentrations 
between 1.52 and 1,427 ng/L, and between 0.37 and 106.1 ng/L, in influent and effluents, 
respectively. Of the natural sex steroids, only progesterone (0.62-13.1 ng/L) and testosterone (93.4 
ng/L; Guelph) were found in influent samples.  In addition, progesterone and testosterone were 
also measured in effluent samples of Montreal during spring at concentrations of 7.47 ng/L and 
1.58 ng/L, respectively. Concentrations of other reproductive hormones, such as E2, EE2, E1, and 
E3 were below the detection limit in both influent and effluent samples (Table S3.2). Overall, there 
were no clear patterns in the occurrence and/or concentrations of detected chemicals as a function 
of geographic region, urban demographics (population) or treatment level.  
3.5 Discussion  
Significant endocrine potentials were observed across influents and effluents from all six WWTPs 
studied using in vitro bioassay-based analyses. However, there were significant differences in the 
types and magnitudes of responses, which were likely due to differences in population 
demographics, types of wastewater treated, and level of treatment systems utilized in the respective 
WWTPs. 
3.5.1 Estrogenicity and anti-estrogenicity 
Except for effluent samples collected from Regina during both seasons (see chapter 2) and 
influents from Montreal during spring, none of the samples analyzed showed significant 
estrogenicity. In particular, estrogenic potentials detected in influents that ranged between <0.3 to 
0.9 ng EEQ/L were much less than those detected by other studies conducted in China, the Czech 
Republic, Germany and Israel with EEQs ranging between 20 and 80 ng/L (Sui et al. 2010; Jálová 
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et al. 2013; Maletz et al. 2013; Shore and Shemesh 2016). Also, estrogenic potentials were in the 
lower range of those detected in influent from the Netherlands (1-120 ng/L), and Australia and 
New Zealand (<4-185 ng/L) (Leusch et al. 2006; Jálová et al. 2013).  In contrast, EEQs detected 
in effluent samples, which ranged from 0.5 to 1.4 ng/L, were similar to those reported by some of 
the above authors, which reported values ranging from <1.0 and 5.1 ng/L (Leusch et al. 2006; 
Jálová et al. 2013). Furthermore, the relative changes compared to the controls observed for 
effluents in this study, which ranged from <0.5 - to 3.5-fold, were comparable to those observed 
by Maletz et al. (2013) who reported 1.5- to 2.9- and 2.0- to 3.8-fold increases in estrogenic 
activities determined using the LYES and ER CALUX® assays, respectively.  
Effluent samples collected from the Regina WWTP showed higher estrogenicity than influents 
during spring and summer (see chapter 2) . Similarly, samples of effluent, but not influent, 
collected from the Guelph WWTP during spring showed a trend towards elevated estrogenicity. 
Studies such as Pessoa et al. (2014) and Kirk et al. (2002), reported that WWTPs utilizing lagoon-
based treatments, such as Regina, had the lowest efficiencies for the removal of estrogenic 
hormones, ranging between 54 to 80% and 7 to 10%, respectively, which is in accordance with the 
lack of removal of compounds with estrogenic properties observed in this study. The trend towards 
increased estrogenicity for the Guelph effluent samples in spring was somewhat unexpected given 
the advanced system this plant operates under, and which includes a tertiary treatment step with 
conventional and extended activated sludge. However, during the time of sample collection, the 
Guelph WWTP was undergoing a significant upgrade to a tertiary treatment plant and had a series 
of construction issues (Hicks et al. 2017c), which may explain the reduced efficiency at removing 
estrogenicity (Figure 3.2A).  
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It is hypothesized that the weak or lack of estrogenic potentials in most WWTP samples was due 
to high concentrations of other and diverse contaminants present in complex mixtures with anti-
estrogenic or general toxic potentials that were likely to have masked compounds binding 
agonistically to the estrogen receptor. Other studies made similar observations and suggested that 
chemicals with anti-estrogenic potencies, including pesticides such as linuron or atrazine that are 
commonly found in raw sewage and effluents, could be the cause of reduced or lack of estrogenic 
responses (Orton et al. 2009; Jálová et al. 2013). This is in accordance with the significant anti-
estrogenic potentials that were reported for all samples in our study. For the Regina and Guelph 
WWTPs, it can be assumed that true anti-estrogenic potentials may have even been greater 
considering the remaining significant estrogenicity in the same samples. Similarly, Jálová et al. 
(2013) reported anti-estrogenic potency in extracts from eight sites studied in the Czech Republic, 
including influents and effluents, with greatest anti-estrogenicities occurring in effluent samples. 
Furthermore, in two parallel in vivo studies conducted by Steeves et al. (in preparation) and Hanson 
et al. (in preparation a,b), the authors observed no estrogenic effects in laboratory or wild fish 
exposed to Regina and Saskatoon MWWEs; however, significant and marked anti-estrogenic 
responses, such as significant decrease in egg production, delayed maturity and increase in oocyte 
atresia in the ovaries in females were observed. Together with observations by Hill et al. (2010) 
who observed a trend for increased anti-estrogenic activity in fish exposed to effluents, this 
supports the hypothesis that anti-estrogenic potentials may be of greater relevance in many 
MWWEs than agonistic effects mediated through the ER.  In addition, a study conducted by Hicks 
et al. (2017a) that evaluated the endocrine disrupting effects of effluent samples from the Guelph 
and Kitchener WWTPs between 2007 and 2015 showed a significant reduction in the occurrence 
of intersex by 70-100%, which the authors attributed to the upgrades performed on the Kitchener 
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facility. This is in accordance with the lack of estrogenic responses observed during the in here-
applied in vitro assays for effluents collected from these plants.  
Furthermore, only chemicals with weak estrogenic properties, such as triclosan, were detected at 
very low concentrations that were much lesser (1.52-1,427 ng/L in influents and 0.37-106.1 ng/L 
in effluents) than those shown to cause effects (20,000 ng/L) (Ishibashi et al. 2004) while strong 
agonists including E1, E2, EE2, and E3 were not detected. This further supports the lack of or the 
weak estrogenic potentials observed during the in vitro tests. In contrast, a number of chemicals 
that were previously described to inhibit estrogenic responses were found both in influents and 
effluents, including atrazine (Orton et al. 2009), clofibrate (Fujimoto et al. 2012; Ezechiáš et al. 
2016), ibuprofen (Ezechiáš et al. 2016) and naproxen (Ezechiáš et al. 2016) (Table S3.5). Atrazine 
was only detected in effluent samples from Montreal at concentrations 2- to 21-million-fold less 
than those previously reported to inhibit estrogenic responses (Orton et al. 2009).  Therefore, this 
chemical was unlikely to be responsible for the anti-estrogenicity observed here. However, some 
other compounds, such as clofibrate (30.93-109.4 ng/L), ibuprofen (194.1-1,637 ng/L) and 
naproxen (18.73 and 321.0 ng/L; only detected in Montreal and Quebec City) occurred in some 
effluent samples at concentrations previously described to cause anti-estrogenicity; clofibrate at 
10 ng/L, ibuprofen at 700 ng/L and naproxen at 50 ng/L, using the in vitro yeast-based YES assay 
(Ezechiáš et al. 2016). In conclusion, the absence or presence of weak inducers and significant 
presence of inhibitors detected by the chemical analysis is in accordance with what was observed 
by the in vitro assays. 
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3.5.2 Androgenicity and anti-androgenicity 
Concentrations of androgens reported as AEQs observed in the present study (2.5-86.3 and <2.3-
12.7 ng AEQ/L in influents and effluents, respectively) were in the lower range of or less than 
those reported previously by other authors (<200-9,330 ng and 0-736 ng AEQ/L in influents and 
effluents, respectively) (Kirk et al. 2002; Leusch et al. 2006; Sousa et al. 2010; Shore and Shemesh 
2016). The relatively low androgenic potentials observed in this study may be explained by the 
relatively low population sizes served by most of the investigated WWTPs, which were below 
250,000 inhabitants for most of the treatment plants, with exception of Quebec City and Montreal. 
Kirk et al. (2002) hypothesized that androgens excreted by humans are responsible for most of the 
androgenic activity in municipal effluent with a high domestic input, which was reflected by the 
observation that the highest androgenic potentials were detected in WWTPs in the UK that were 
serving large populations (>1 million inhabitants). This is in accordance with the findings of our 
study that reported the greatest androgenic potentials in influents and effluents of the Quebec City 
and Montreal WWTPs serving populations of >500,000.  
For the majority of WWTPs, there was a significant decrease in androgen activity to baseline levels 
in effluents compared to influents. This is in agreement with earlier studies that suggested WWTPs 
are efficient at removing androgen-like compounds in general (Thomas et al. 2002; Svenson and 
Allard 2004; Hill et al. 2010;), as well as results from chapter 2. With the exception of Montreal, 
where greater AEQs were observed in effluents compared to influents, removal efficiencies of 
compounds with androgenic activities ranged from 64 and 81%, which is within the range of 
removal efficiencies of 7 to 99% previously reported by several other authors (Kirk et al. 2002, 
Leusch et al. 2005, Jálová et al. 2013). The highest removal efficiencies (90-97%) occurred in 
treatment facilities with secondary or greater treatment systems using activated sludge. However, 
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facilities with primary treatments, without activated sludge, had much lower removal efficiencies 
of approximately 7% (Kirk et al. 2002). A similar pattern was observed in the current study, where 
the lagoon-based Montreal WWTP showed no removal of androgenicity. In addition, despite the 
good-moderate removal efficiency (> 80%) observed by the Quebec City WWTP during spring, 
effluent samples from this WWTP, which does not include a nitrification treatment step, had 
significant remaining androgenic potencies during spring. The reduced removal efficiency of 
androgens from the Montreal WWTP may be also explained by the exposure to severe 
temperatures in the open lagoon system for extended periods of time, which may result in 
significantly decreased microbial activity during cold winters; and/or increased evaporation, and 
thus increasing concentration of contaminants, during hot summers (chapter 2; Pessoa et al. 2014).  
As Montreal treats combined storm- and waste-water flows, the greater androgenicity detected 
during summer compared to spring could potentially be due to higher dilution in the spring as a 
result of snowmelt events, which was similar to observations by Kirk et al (2002). Besides dilution 
and accumulation of contaminants due to the collection through stormwater and seasonal melting, 
in the case of heavy rain events, untreated sewage can bypass the WWTP and be discharged into 
the aquatic environment. In one such event in 2015, the Montreal WWTP discharged upwards of 
4.9 billion liters of untreated effluent into the Saint Lawrence River (Ross, 2016).  Interestingly, 
the Regina WWTP, which also used a lagoon as the secondary treatment step, did show good-
moderate removal efficiencies of approximately 80%. This could potentially be due to the seasonal 
UV-sterilization (April-November) performed by the Regina WWTP, a step not used at the 
Montreal facility. Previous studies have demonstrated that UV-sterilization has the ability to 
increase photodegradation of some natural and synthetic hormones, including androgens (Liu et 
al. 2003; Liu and Liu 2004; Gryglik et al. 2010).  
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In conclusion, the significant androgenic potentials that remain in Montreal and Quebec City 
effluents may pose a threat to receiving environments. Previous studies have observed negative 
impacts on reproduction by fish exposed to androgens, such as 17‐β‐trenbolone (≥ 27 ng/L), 
levonorgestrel (≥0.8 ng/L), and levonorgestrel or Gestodene (100 ng/L) (Ankley et al. 2003; 
Zeilinger et al. 2009; Runnalls et al. 2013).  While it is unclear how the potencies of the above 
androgens compare to the positive control used in this study, namely DHT, considering that DHT 
is among the most active androgens in mammals, the AEQs observed in effluents of the two 
Quebec WWTPs warrant further investigations into the potential environmental impacts in 
downstream organisms.  
Interestingly, anti-androgenicity was only observed in a few influent samples. This lack of anti-
androgenic responses was likely due to the very great androgenic potentials observed in most of 
these samples, and which is hypothesized to have masked the effects of contaminants with anti-
androgenic activity.  In contrast, significant anti-androgen potentials were detected in most of the 
effluent samples, particularly in spring, except for Quebec City and Montreal, indicating a limited 
capacity of the WWTPs to remove compounds with anti-androgenic properties. This is in 
agreement with Hill et al. (2010), who observed no androgenic activity in MWWE samples, but 
significant anti-androgenicity using the yeast-based YAS assay. The same pattern was not 
observed in samples collected during summer, where only Kitchener influent and effluent showed 
significant anti-androgenic activity. As also observed by Kirk et al. (2002) and results from chapter 
2, samples collected during spring showed generally higher endocrine activities than samples 
collected during summer. Kirk et al. (2002) attributed this to greater microbial activity due to 
higher temperatures during summer months as well as to increased rainfall causing greater dilution 
of contaminants in the combined storm- and waste-sewer system, all of which vary seasonally. 
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The hypothesis that colder temperatures were responsible for the observed increase in anti-
androgenic responses was unlikely the main reason for the observed greater potentials in this study 
as in a parallel study no elevated anti-androgenic potentials were observed for Regina and 
Saskatoon effluents during the much colder winter months when compared to summer (see chapter 
2).  Furthermore, none of the WWTPs investigated in this study, except for Montreal, treat 
combined storm- and wastewater flows, and thus, dilution was unlikely to have affected 
wastewater composition in a similar manner as described in Kirk et al. (2002).  The lack of 
androgen inhibition of effluents observed for the Quebec City and Montreal treatment plants was 
likely due to the high remaining androgenicity, suggesting that effects of anti-androgens were 
likely masked by androgens present in the same samples. In contrast, Saskatoon and Guelph 
influent samples showed low androgenic activity and significant antagonistic activity during 
spring, suggesting that androgenic effects could have been masked by the presence of potent anti-
androgens. This would be in agreement with observations by Weiss et al. (2009), who established 
that androgen receptor agonistic potency was masked by antagonist effects when testing sediment 
extracts.  
Overall, the data suggest that anti-androgenic potentials represented a greater concern in this study 
than androgenic potentials, which is in agreement with two parallel in vivo studies investigating 
effects of Regina and Saskatoon MWWEs on the endocrine system of fish (Steeves et al. (in 
preparation); Hanson et al. (in preparation a,b). These studies revealed significant 
demasculinization of male fish, which would be in accordance with the strong anti-androgenic 
potentials reported by the current study.  
Unlike estrogenic effects, androgenic and anti-androgenic effects have not been widely reported 
in wildlife to date; however, several studies have hypothesized that these types of disruptions may 
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be of environmental concern given that chemicals with (anti)-androgenic properties are commonly 
found in MWWEs (Johnson et al. 2007; Urbatzka et al. 2007; Jobling et al. 2009b; Hill et al. 2010). 
Although, chemicals with the ability to act as androgen agonists such progesterone, testosterone, 
and triclosan (Foran et al. 2000; Jenkins et al. 2003; Ishibashi et al. 2004; Dequattro et al. 2012; 
Zucchi et al. 2012; Sangster et al. 2016) were detected in the current study, none of these, with the 
exception of chemicals discussed below, were present at concentrations previously reported to 
cause androgenic effects, which is in agreement with the lack of androgenic potentials observed in 
effluents (Table S3.5). The one exception was effluent samples collected from the Montreal 
WWTP, and which contained 7.47 ng/L progesterone and 1.58 ng/L testosterone during spring, as 
well as 13.93-62.63 ng/L triclosan during both seasons, and which could potentially explain the 
androgenicity increase observed by the AR assay. In particular, progesterone concentrations were 
similar to previous studies showing androgenic effects at concentrations ranging from 2 to 10 ng/L 
(Jenkins et al. 2003; Dequattro et al. 2012; Zucchi et al. 2012; Sangster et al. 2016). However, 
concentrations of triclosan and testosterone were ˜200- and ˜400-fold lower than those previously 
reported to cause androgenicity in vitro (Foran et al. 2000; Ishibashi et al. 2004; Sangster et al. 
2016), and thus, it is uncertain to what extent these chemicals could have contributed to the 
observed effects. Furthermore, this study identified a number of chemicals in effluents and 
influents that have previously been reported to act as anti-androgens including carbamazepine 
(Fraz et al. 2018), clofibrate (Cook et al. 1999; Fernandes et al. 2011; Fujimoto et al. 2012; 
Ezechiáš et al. 2016), gemfibrozil (Liu et al. 1996; Mimeault et al. 2005), ibuprofen (Han et al. 
2010; Ezechiáš et al. 2016), naproxen (Ezechiáš et al. 2016) and DEET (Zenobio et al. 2014).  
However, of these compounds, only DEET occurred at concentrations that have previously been 
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observed to act as anti-androgens (600 ng/L; Table S3.5; Zenobio et al. 2014), while all other 
compounds were measured at concentrations below effective levels. 
3.5.3 Steroidogenesis disruption 
Overall, only a few samples influents or effluents from the six WWTPs investigated by this study 
showed a significant increase or decrease in E2 production. The effects of exposure to forskolin 
(positive control) and prochloraz (negative control) on the production of E2 (30-fold increase and 
a 0.5-fold decrease, respectively) met the performance criteria of ≥7.5-fold increase and ≥0.5-fold 
decrease, respectively, set forth in the OECD H295R guideline (OECD Test No. 456, 2011), 
demonstrating that the assay performed as expected. The magnitudes of effects were comparable 
to those reported by Maletz et al. (2013) after exposure of H295R cells to MWWEs in Germany, 
and which rarely exceeded 2-fold. Significant increases in E2 concentration in samples of influents 
from Saskatoon during spring and samples of effluents from Kitchener during summer indicated 
that these samples contained compounds with the ability to stimulate E2 production. In contrast, 
the majority of other samples, particularly effluents, that revealed altered sex steroid synthesis in 
H295R cells, inhibited hormone production. Thus, there was no clear pattern with regards to the 
presence of compounds that disrupt steroidogenesis either as a function of treatment level, 
population size or climate. It is hypothesized that this variation in responses observed in the current 
study was likely associated with the complex nature of the investigated wastewaters, where 
seasonal factors such as temperature, evaporation, photoperiod and daily flow changes were likely 
to have affected the different compounds in the complex mixtures in unique ways. Previous studies 
also observed unpredictable responses when chemicals individually known as steroidogenesis 
inducers or inhibitors were mixed, emphasizing that these chemicals do not always respond as 
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predicted when present in a complex mixture and that one chemical alone may not be responsible 
for the responses observed (Heindel et al. 1995; Olmstead and LeBlanc 2005; Hadrup et al. 2013b). 
Moreover, Gracia et al. (2008) reported high variability in the response of H295R cells to the 
exposure with MWWEs from different WWTPs in Hong Kong, SAR, China ranging from no 
effects in E2 production for most effluent samples to significant inhibition and induction of E2 
synthesis by one influent and effluent, respectively. The authors suggested the increased E2 
production in response to the effluent from the one WWTP (San Wai) was likely due to the 
outdated facility not being able to effectively remove EDCs with steroidogenesis disrupting 
properties. However, a similar pattern indicating that less advanced treatments systems, such as 
lagoon-based systems, have lesser efficiency to remove contaminants with steroidogenesis 
disrupting properties was not observed in this study. Consequently, it is uncertain what step of the 
wastewater treatment process contributed to the elimination of compounds with estrogen 
production promoting properties. 
Overall, few studies that investigated the potential impacts of MWWEs on E2 production are 
available to date, and the results of this study reflect the overall variation within and among studies 
in terms of the direction of responses and their magnitude (Gracia et al. 2008; Hadrup et al. 2013b; 
Maletz et al. 2013). Thus, it remains challenging to pinpoint the specific factors or chemicals that 
drive the steroidogenesis disrupting potentials of MWWEs. This is also in accordance with the 
results obtained with the receptor-mediated assays, which demonstrated that MWWEs contain 
complex mixtures of EDCs with continuous change in flow, chemical concentration, composition, 
and removal efficiency, resulting in varying effects on endocrine endpoints.  
Results obtained by chemical analysis identified few chemicals that have been previously reported 
to affect E2 production.  One such compound is ibuprofen, which has been shown to increase E2 
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production at concentrations ranging between 20,000 and 200,000 ng/L using the H295R assay 
(Han et al. 2010) (Table S3.5). In general, concentrations of this chemical in influents (<MDL-
8,813ng/L) and effluents (<MDL-1,637 ng/L) were less than effect concentrations in H295R cells.  
The exception was influent collected in summer from the Kitchener WWTP, with concentrations 
of 41,618 ng/L. However, this sample did not affect E2 production. Therefore, the observed 
increase in E2 production was unlikely to have been caused by the presence of ibuprofen, and it 
remains unclear what the specific chemicals or mixtures responsive for the measured effects were. 
Despite the variation in responses in E2 production, clear signs of disruption of steroidogenesis 
were observed, indicating that the steroidogenesis disruption assay represents an important 
component for EDC screening.  Specifically, the H295R Steroidogenesis Assay has been shown 
to be a reliable and relatively cost-effective screening method, providing important information 
regarding alteration of the endogenous synthesis pathways of sex steroids (Villeneuve et al. 2007; 
Ji et al. 2010; Hecker et al. 2011).  
3.6 Conclusion 
This study illustrated that WWTPs across the three provinces of Canada studied represent 
significant sources of compounds with endocrine active properties to surface waters, albeit the 
extent and type of the observed potentials varied greatly among the WWTPs as a function of 
treatment level, seasonality, and population size. Although most WWTPs investigated were highly 
efficient in removing compounds with androgenic properties, even most advanced WWTP systems 
were limited in their efficiency to remove compounds with anti-androgenic and anti-estrogenic 
potentials, regardless of the treatment level. Surprisingly, with exception of Regina, neither 
estrogenic potentials nor significant concentrations of compounds with estrogenic properties were 
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observed using a combination of bioassays-directed and chemical analyses, suggesting that 
estrogenicity does not seem to be a major concern in WWTPs in Central and Eastern Canada. 
Furthermore, the lagoon-based Montreal WWTP and the secondary treatment facility from Quebec 
City were the only ones that had significant remaining androgenic potentials in effluents. Concerns 
are particularly warranted in cases where the effluent flow is proportionally greater than that of the 
receiving water, as is the case of Wascana Creek, SK, and for which significant effects in resident 
fish population were observed, or where the population is greater than WWTPs’ capacity of 
treatment, as in the case of Montreal. In addition to treatment level and population demographics 
of the WWTPs investigated, seasonality also seemed to have affected the removal efficiency of 
certain compounds with endocrine potentials, in particular during spring. The highly complex 
mixtures present in influents and effluents of WWTPs, including agonists, antagonists, and 
cytotoxic components may explain the high variability in response patterns observed in the applied 
bioassays. To conclude, treatment level, seasonality, and population size seemed to play an 
important role regarding EDC removal, where treatment level and population size appeared to be 
the main factors driving the presence of chemicals with endocrine properties. Summary of results 
can be found in Table 3.1. Given the complex nature of the effluents analyzed, future studies 
should employ experiments that expand the endpoints utilized. Moreover, the significant 
remaining anti-estrogenic and anti-androgenic potentials regardless of treatment level warrant 
further examination of the effectiveness of current WWTP technologies to remove endocrine 
active compounds and assessment of the associated risks to receiving aquatic environments.            
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Table 3.1 – Summary of in vitro results describing the endpoints and outcomes of potential risks 
of MWWEs from all six WWTPs, detected by MVLN (anti-)estrogenicity, MDA (anti-
)androgenicity, and H295R (steroidogenesis disruption). YES, effluent from at least two WWTPs 
showed significant activity during both seasons. SOME, effluent from a minimum of one of the 
WWTPs showed significant activity at least during one season.  
 
 
 
 
 
 
Endpoint Outcome MWWEs
ER SOME Regina
Anti-ER YES All six WWTPs
AR SOME Quebec City and Montreal
Anti-AR SOME Monstly from SK and ON WWTPs during spring
Steroidogenesis disputors
SOME
Most of the WWTPs affected production of E2, 
with effluents causing decrease of E2 overall. 
However, no consistent pattern was observed
Does treament level affect EDC removal? SOME
Primary treament plants showed greater 
endocrine activity overal (Regina and Montreal)
Does population size affect EDC removal? SOME
Treament plants with population > 500,000 
people showed greater endocrine activity overal 
(Quebec and Montreal)
Does seasonality affect EDC removal? SOME Spring showed greater endocrine activity overal
Can in vitro assays be used as a cost-
effective tool for prioritizing potential 
endocrine disrupting impacts of MWWEs
YES
Results from parallel in vivo and chemical 
analysis  studies, were in agreement with in vitro 
findings
Are MWWEs a significante source of EDCs?
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CHAPTER 4: GENERAL DISCUSSION 
4.1 Introduction  
The occurrence of EDCs in aquatic environments has become a subject of increasing concern over 
the past decades due to their potential to adversely affect human and wildlife (Hughes et al. 2013; 
Gavrilescu et al. 2015). Large quantities of EDCs are released into surface waters through 
municipal wastewaters as a result of bodily excretion of natural hormones, unmetabolized 
pharmaceuticals, indiscriminate disposal of unwanted/expired pharmaceuticals and personal care 
products (PPCPs) as well as many other household products (Jobling et al. 1995; Daughton and 
Ternes 1999; Lahnsteiner et al. 2005). This is because traditional wastewater treatment 
technologies are designed to mainly remove organic nutrients, nitrate, and phosphorus; however, 
removal or breakdown of EDCs during the wastewater treatment process is either incomplete or 
inexistent, and thus, MWWEs are considered a major source of these compounds in the aquatic 
environment (Vieno et al. 2007; Lapworth et al. 2012; Luo et al. 2014b; Hai et al. 2016). Due to 
the multitude of mechanisms of actions and effects of EDCs, which can be attributed to various 
classes of chemicals this group of contaminants consists of, identification of these chemicals in 
complex mixtures such as MWWEs that are responsible for reproductive alterations in whole 
organisms can be challenging and requires the development of specific and integrative procedures 
for environmental risk assessments (Grund et al. 2011). Several studies have demonstrated that the 
combination of receptor and non-receptor-mediated in vitro assays and targeted chemical analysis 
represents a promising approach to address this challenge (Giesy et al. 2002; Grund et al. 2011; 
Maletz et al. 2013). Therefore, the main objective of the research conducted in this thesis was to 
identify and quantify EDCs with, (anti-)estrogenic and (anti-)androgenic and steroidogenesis 
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disruption potencies in MWWEs using a battery of in vitro assays and correlating the results to 
targeted chemical analysis, as well as to two parallel in vivo studies.  
The first study focused on evaluating MWWEs from two WWTPs in Saskatchewan, Canada, 
regarding their efficiency to remove compounds with endocrine disrupting properties, as well as 
to characterize the potential effects that extreme climatic conditions typical for the northern 
prairies may have on this process. From this study, we observed that in general both the Regina 
and the Saskatoon WWTPs ameliorated androgen potencies; however, the less advanced treatment 
plant of the city of Regina was less efficient at removing compounds that act as estrogens. 
Furthermore, both treatment plants were unable to completely remove ER and AR antagonists, 
which were still present at significant levels after treatment, thus remaining a major concern to 
receiving aquatic environments. Moreover, seasonality appeared to affect EDC removal, with 
spring showing greater endocrine activities in general when receptor and non-receptor mediated 
bioassays where compared. The second study was designed to investigate EDCs from six WWTPs 
across Canada with different treatment levels, population size, and climate. This study confirmed 
that in general androgenic activities significantly decreased after treatment by most WWTPs; 
however, less advanced treatment systems such as Montreal and Regina were less efficient at 
removing compounds with androgenic and estrogenic properties, respectively. This demonstrated 
that lagoon-based treatments plants, which are still common in many parts of Canada, are not as 
efficient at removing EDCs from wastewater compared to advanced secondary or tertiary systems. 
In addition, all six facilities showed significant remaining ER and AR antagonistic potentials 
regardless of treatment system, emphasizing that traditional WWTPs are limited regarding their 
ability to remove EDCs, particularly in regard to inhibitory compounds (Clara et al. 2005; Johnson 
et al. 2007; Benotti et al. 2009; Hecker and Hollert 2009). In addition, population size appeared to 
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have an impact on EDC removal efficiency, where WWTPs that served populations >500,000 
habitants were less efficient at removing EDCs, in particular of compounds with androgenic 
properties. Interestingly, annual variation in climatic conditions across the different provinces 
studied did not appear to significantly affect EDC removal efficiencies as originally hypothesized 
with colder months affecting treatment efficiencies due to reduced biological treatment efficiency. 
However, similarly to what was observed in the Saskatchewan study, spring showed the least 
removal of compounds with endocrine properties when comparing results from all three cell lines. 
4.2 Treatment level efficiencies at removing agonist and antagonist EDCs 
As discussed within the previous chapters of this thesis, in order to allow more objective ecological 
risk assessments of MWWEs, there is a need to identify the main factor or factors that contribute 
to the release of EDCs through effluents, including treatment level, seasonal changes in climate 
and population size. Several studies have evaluated the efficiency of different treatment techniques 
in removing endocrine potencies, particularly regarding estrogen removal (Villeneuve et al. 1997; 
Ternes et al. 1999; Wilson et al. 2002, 2004). However, treatment factors that drive elimination of 
compounds with other endocrine properties such as androgenic, anti-estrogenic and -androgenic 
activities, as well as steroidogenesis disruption have not been characterized very thoroughly to 
date. The results from this study confirmed that more advanced WWTPs appear to efficiently 
remove androgen agonists from raw sewage and that less advanced treatment facilities were unable 
to completely remove AR and ER agonists, as in the case of Montreal and Regina WWTPs, 
respectively. More importantly, most of the WWTPs were not efficient at removing compounds 
that antagonistically bind to the AR and ER, regardless of treatment level. This was potentially 
due to the strong presence of a wide variety of antagonists at significant concentrations, masking 
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agonists compounds. In other words, both agonistic and antagonistic of the ER and AR were 
present in influent samples, competing for the same receptors, and that treatment may have mainly 
removed agonistic acting compounds. Thus, inhibitory action at the AR and ER appear to be the 
greatest concerns associated with the MWWEs across Canada. This finding was also reflected by 
parallel studies investigating the effects of the same effluents or downstream environments on fish 
endocrine system (Steeves et al., in preparation; Hanson et al., in preparation a,b). The lack of 
significant estrogenicity in most of the influents and some estrogenic activity in the effluents could 
also be due to deconjugation and conjugation of natural and synthetic hormones. Particularly, the 
estrogenic activity in aquatic environments has been primarily correlated with the presence of free 
steroid estrogens due to incomplete removal by WWTPs. Most steroids are excreted in their 
conjugated, and thus inactive, form (Desbrow et al. 1998; Gomes et al. 2003). However, some of 
these steroids, particularly E1, E2, EE2, and E3, have been reported to be deconjugated by the 
metabolic actions of bacteria found in wastewater systems and lagoons, and as a result, these 
compounds can become reactivated (Baronti et al. 2000; Johnson et al. 2000; Gomes et al. 2009; 
Kumar et al. 2012). Thus, this may explain the lack of agonistic activities in influents, and the 
stronger agonistic potentials observed in effluents, particularly in the case of estrogenicity.  
4.3 Influence of seasonality and population size in the occurrence of EDCs  
Overall, limited information is available regarding seasonal variability of removal efficiency of 
EDCs from wastewater, particularly for compounds with androgen receptor and steroidogenesis 
disrupting properties.  This study is one of a few that investigated the seasonal variation in removal 
efficiencies of hormonally active substances from wastewater as a function of climatic conditions. 
Although a clear seasonality pattern was not observed for each in vitro assay individually, when 
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all three receptor and non-receptor mediated assays were compared, exposure to effluents collected 
during spring consistently resulted in the greatest effects, thus indicating least removal efficiency 
of EDCs. Several reasons have been hypothesized to explain these results. One possible reason for 
the elevated endocrine potencies measured during this season was the potential for reduced 
biological activity during the cold winter months prior to spring, especially for the lagoon-based 
Regina WWTP, likely decreasing biodegradation of compounds by microorganisms and/or light. 
However, the same pattern was not observed during early and late winter, which were also cold 
sampling periods.  Surprisingly, in some cases, and in particular for ER-mediated responses, there 
was even an increase in endocrine activity during summer. The latter could potentially have 
occurred due to high evaporation events resulting in an increase in concentration, especially 
affecting open lagoon-based systems, and which was also observed by other authors (Pessoa et al. 
2014). Therefore, the hypothesis that colder months would have the potential to adversely affect 
the removal of EDCs was not always supported by the results, and future research should include 
multiple seasons from all WWTPs analyzed to confirm the patterns observed in the present study. 
Furthermore, one of the difficulties of accurately quantifying removal efficiencies of EDCs by 
WWTPs is retention time, where depending on the length of time taken by the WWTP to process 
raw sewage, samples of effluent analyzed are often not directly representative of the initial influent. 
Some studies have been adopting the use of chemical markers, such as acetaminophen, 
carbamazepine, caffeine, DEET, and salicylic acid to trace the incoming raw sewage through the 
treatment process (Nakada et al. 2008; Tran et al. 2013, 2014). The quantification of chemical 
markers is performed by using isotopically labeled internal standards in the raw sewage, which 
allows for the detection of these chemicals during treatment processes, including in the final 
effluent (Tran et al. 2013). As these chemical markers are very stable and are not degraded during 
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treatment, they can be used to follow raw sewage through the whole process until it becomes 
treated effluent, reducing the possibility of misrepresentation of removal efficiencies. Although 
the results found here were similar among collection days and were in agreement with previous 
studies, future studies should include the use of chemical markers in order to avoid uncertainties 
related to such issue. In addition, another factor that appeared to be correlated with certain 
endocrine activities in MWWEs was population density.  The results from this study suggested 
that WWTPs that served greater populations (>500,000 habitants) also presented significantly 
greater endocrine activities, in particular, androgenicity. However, as only two WWTPs served 
greater populations then 500,000 in this study, including Montreal with a primary lagoon system 
and Quebec City with secondary treatment step, future studies should include more treatment 
facilities with advanced technologies, along with high population density in order to confirm the 
results observed here. 
4.4 Comparison of in vitro responses with in vivo studies 
In addition to their ability to characterize exposure to certain biologically active chemicals in 
complex mixtures, in vitro approaches are increasingly seen as a compelling and relevant 
alternative to the use of live animals for chemical screening and prioritization as they address 
several ethical and economic concerns associated with animal testing (Jeffcoate 1996; Meager 
2006; Hecker et al. 2011). However, there are a number of concerns regarding the direct 
predictivity of in vitro tests for in vivo effects, as in vitro tests often do not capture toxicokinetic 
processes such as metabolic elimination or activation of compounds, among others. Furthermore, 
in vitro tests use isolated cells from individual tissues that do not include interactions among tissues 
such as endocrine feedback loops that may occur under in vivo conditions. However, when in vitro 
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results obtained in chapter 2 were compared to those of two parallel in vivo studies that investigated 
the effects of Regina and Saskatoon effluents to the endocrine physiology of a native fish species 
(fathead minnow, Pimephales promelas), there was evidence of a direct correlation between 
responses observed with in vitro and in vivo systems.  The low or lack of estrogenic or androgenic 
potentials of effluents reported by the in vitro assays was in accordance with the fish studies that 
revealed no significant effects that could be linked to exposure with estrogens or androgens such 
as induction of vitellogenin and occurrence of testicular oocytes in males or expression of 
secondary male sex characteristics in females, respectively (Steeves et al., in preparation; Hanson 
et al., in preparation a,b). In contrast, fathead minnows exposed to both Regina and Saskatoon 
MWWEs showed general inhibition of reproductive functions such as delayed maturation, 
degeneration of gonadal tissues, reduction in the expression of secondary sex characteristics, and 
in the case of the Regina WWTP, significant reduction of fecundity, which correlated with the 
predominant antagonistic potentials detected by the ER and AR receptor assays. Furthermore, the 
fact that greater in vitro endocrine activities were observed during spring season may constitute a 
significant additional ecological concern, as this time coincides with the spawning season of many 
fishes. Overall, the results obtained during this study suggest that responses observed with the 
different in vitro assays applied here not only can be predictive of in vivo effects but also inform 
and prioritize environments at greater endocrine risks.  
4.5 Comparison of in vitro responses with the chemical analysis studies 
Previous studies have demonstrated that even the most comprehensive chemical analyses can only 
explain a limited fraction of the biologically effective endocrine disrupting potential of complex 
environmental mixtures such as MWWEs (Heindel et al. 1995; Olmstead and LeBlanc 2005). 
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Therefore, the combination of in vitro assays and targeted chemical analysis has been proposed as 
a preferred and more efficient approach to pinpoint potential causative agents and characterize the 
overall endocrine disrupting potential of complex mixtures (Giesy et al. 2002; Grund et al. 2011; 
Maletz et al. 2013). This study compared results from in vitro assays with chemical analysis, and 
in general, the results obtained by the targeted chemical analyses aligned with the endocrine 
activities observed in the in vitro assays. Specifically, the lack of agonistic potentials observed in 
the ER transactivation assay was in accordance with the failure of the chemical analytical analysis 
to detect female reproductive hormones including E2, EE2, E1 and E3 or other chemicals with the 
ability to act as estrogens, and which have been previously identified as the main causative agents 
for estrogenic activities of MWWEs. However, a number of chemicals that were previously 
described to have anti-estrogenic or -androgenic properties were found at biologically active 
concentrations. These compounds included clofibrate, ibuprofen, and naproxen, as well as 
chemicals with anti-androgenic properties, including DEET, which may potentially be responsible 
for some of the inhibitory effects observed in the in vitro bioassays. Although targeted chemical 
analysis allowed us to analyze multiple compounds in complex extracts, this analytical method has 
some limitations, as the detection of some compounds in complex mixtures can be difficult without 
extensive sample pre-treatment. Furthermore, the absence of other contaminants commonly found 
in wastewater, such as acetaminophen and diclofenac (pharmaceuticals) (Carballa et al. 2004; 
Focazio et al. 2008), could be due to extract samples containing compounds that were not included 
in our internal standards (Table S2.6), as they were not analyzed. To better understand what 
specific compounds may have been responsible for the biological activities observed in this study, 
and isolate active agents, future studies should include advanced analytical steps, such as sample 
clean-up; including the use of a more target-specific extraction cartridge and fractionation, where 
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each fraction could be more easily analyzed and targeted compounds could be more accurately 
quantified. However, for the scope of this project, further sample treatment was not performed. 
Nonetheless, this study obtained promising data to support that the combination of in vitro assays 
and chemical analysis are a useful tool for supplementing chemical analytical characterization for 
the evaluation of environmental samples for EDCs (Ankley et al. 1998; Matthiessen and Johnson 
2007). 
4.6 Limitations and future research 
There are several limitations within the studies conducted in this thesis that could be expanded on 
to provide further insights into the outcomes observed. Although results comparing both treatment 
level and seasonality showed some variability, this study demonstrated that in general, less 
advanced treatment facilities showed reduced removal efficiency of chemicals with endocrine 
active properties. While seasonality appeared to have affected removal of endocrine activities to 
some extent, with spring showing the greatest activities within all three bioassays and across 
treatment facilities, there are some remaining uncertainties regarding the hypothesis that colder 
temperatures may impact removal efficiencies by WWTPs as samples collected during early and 
late winter in Saskatchewan did not show comparable patterns. When it comes to removal 
efficiency, one of the limitations of evaluating endocrine removal is to track the effluent resulting 
from the processed influent as discussed above. Therefore, future studies should include some 
chemical markers, such as carbamazepine and caffeine to determine whether the effluent being 
discharged from the treatment plants is representative of the influent analyzed, particularly for 
WWTPs with long retention times (few to several months) where the effluent may not be 
representative of the same season as the influent.  
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Results also revealed greater androgenic activities in effluents of WWTPs serving greater 
populations (in exceedance of 500,000 inhabitants), and which has also been observed by Kirk et 
al. (2002). However, the sample size to derive these trends was small (only two WWTPs with 
population sizes >500,000). Therefore, future research should include more treatment plants with 
similar climate and level of treatment to better characterize the direct effect population size may 
have on treatment efficiency.  
Results from the in vitro and the two parallel in vivo studies demonstrated that neither estrogen nor 
androgen receptor agonists appeared to be a significant concern in the majority of MWWEs 
investigated. Instead, ER and AR antagonists were the primary drivers of endocrine potentials in 
MWWEs, and which was confirmed by two parallel fish endocrine physiology studies (Steeves et 
al., in preparation; Hanson et al., in preparation a,b). Therefore, the combination of in vivo and in 
vitro studies provided comprehensive insights into the factors affecting whole organisms living in 
downstream environments of WWTPs, particularly in small water bodies such as Wascana Creek 
that provide little dilution of effluents. However, given the general inhibitory responses observed 
in fish exposed to Regina and Saskatoon MMWEs or collected from Wascana Creek, there is the 
possibility that chemicals other than those with anti-androgenic or -estrogenic potentials could 
have contributed to the observed effects. Therefore, to gain a more comprehensive understanding 
of the different drivers of the toxicities observed, future studies should employ experiments that 
expand the endpoints utilized by analyzing effects on additional steroidogenic processes including 
androgen or corticosteroid production, as well as general toxicity markers such as oxidative stress, 
genotoxicity, neurotoxicity and metabolic toxicity, among others. The results observed throughout 
this research were supported by in vivo findings obtained during two parallel studies (Steeves et 
al., in preparation; Hanson et al., in preparation a,b). However, in vitro assays have some 
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limitations with regard to predicting effect in whole organisms, including lack of interaction 
among tissues, such as endocrine feedback loops, as well as lack of toxicokinetic processes 
responses, such as metabolic elimination or activation of compounds that may be observed under 
in vivo conditions. Therefore, future studies should include development and optimization of in 
vitro assays to include these outstanding aspects (e.g. toxicokinetic modeling or metabolic steps). 
Furthermore, due to the limitations described here, to date there is still need to include in vivo 
components to correlate with in vitro studies to assess the true risks associated with the exposure 
to contaminants contained in effluents. Hence, future research should continue to use in vivo tests, 
and perhaps include the use of organisms, such as mammals, birds and fish that may show different 
sensitivity to the endocrine disruptors found within this study to confirm the results observed here. 
Additionally, the significant remaining ER and AR antagonistic potentials found across all 
WWTPs investigated, regardless of their treatment level, require further investigations to 
determine how effective even more advanced quaternary WWTP treatment technologies (e.g. 
membrane reactors, ozonation) are at removing chemicals with such properties to better understand 
associated risks to receiving water bodies. 
Targeted chemical analysis results aligned with what was observed in the in vitro studies revealing 
the presence of compounds that can potentially act as ER and AR antagonists, while low or no 
presence of hormones or chemicals that can act as agonists at the ER and AR occurred. As the 
significant anti-estrogenic and anti-androgenic activities observed in most of the effluent samples 
were unlikely caused by only one or two of the individual chemicals detected by the targeted 
chemical analysis, there is also need to characterize the potential combinatory effects of the 
plethora of compounds present in the investigated MWWEs. Therefore, given the complex nature 
of the effluents analyzed and to better understand the specific components of MWWEs driving 
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toxicity, future studies should also include sample fractionation, such as fractionating sample 
extracts by e.g. polarity followed by in vitro bioassays, in order to be able to better pinpoint the 
types of chemicals and combinations of chemicals potentially responsible for the observed effects.  
Finally, as this study showed variable effects with many different layers of information, including 
different endocrine endpoints, varying treatment levels across WWTPs, seasonality, and different 
population sizes, the statistical approach utilized by this study that only applied a one-way 
ANOVA with pairwise comparisons (SCs and treatment groups) has its limitations. Thus, future 
studies should submit the data generated by my study to more sophisticated statistical analysis, 
such as mixed regression models and/or multiple-way ANOVAs considering temperature, 
population size, etc. as co-factors. Such an analysis may help identifying key (confounding) factors 
that affect the efficiency of WWTPs to remove EDCs from raw sewage, and thus, affect the release 
of endocrine active compounds into Canadian surface waters. 
4.7 Conclusion 
This research successfully demonstrated that MWWEs are significant sources of EDCs to surface 
waters across Canada. Moreover, estrogenicity and androgenicity did not appear to be a main 
concern for the majority of effluents investigated; however, highly significant anti-estrogenic and 
anti-androgenic potentials remained in treated effluents of most of WWTPs regardless of 
treatments system, which was reflected by effects observed in fish living in downstream 
environments. In contrast to many other studies that focused on estrogenicity as the main endocrine 
property of concern (Kümmerer 2001; Carballa et al. 2004; Clara et al. 2005; Díaz-Cruz et al. 
2009; Zorita et al. 2009), this study demonstrated that other inhibitory effects appeared to be of 
greater concern across Canada, which could be due to the interaction of the diverse chemicals in 
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mixtures potentially resulting in synergistic or antagonistic effects (Matthiessen and Johnson 
2007), and thus, should be given more attention. Considering these inhibitory endocrine potentials 
remain in wastewater after treatment, there is a significant concern regarding the potential impacts 
of effluents from WWTPs due to incomplete removal of endocrine active compounds on 
downstream receiving environments. This is particularly true in cases of primary and outdated 
lagoon-based treatment systems, as well as in situations in which effluent flow is proportionally 
greater than the flow of the receiving water (e.g. Regina), which is the case of many urban 
municipalities in semi-arid regions such as southern Saskatchewan (Waiser et al. 2011a), or in 
situations in which the population is greater than WWTPs’ capacity of treatment, as in the case of 
Montreal.  
Although seasonality seemed to play an important role regarding endocrine activity, treatment 
level and population size appeared to be the more significant aspects influencing EDC removal. 
However, given the complex nature of effluents, sources, and climate, future research warrants a 
more integrative approach including a greater diversity of endpoints, including more complete 
characterization of effects along the steroidogenic pathway (e.g. androgen or corticosteroid 
production), and other general toxicity endpoints such as oxidative stress, genotoxicity, etc.  In 
addition, future studies should be conducted at the Regina facility, which has recently undergone 
a significant upgrade, to assess whether endocrine removal has improved, and potentially confirm 
whether more advanced treatment level can efficiently remove endocrine activity. Moreover, it is 
recommended to apply advanced effect-directed analysis steps, such as sample fractionation to 
better-enabling pinpoint specific chemicals responsible for the observed effects.  
Overall, this study successfully demonstrated that in vitro assays are a cost-effective tool to predict 
EDCs in complex mixtures, and results from in vitro, in vivo and targeted chemicals analysis were 
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found to be generally in agreement. To conclude, all three in vitro assays could be used as a first 
screening tool for the identification of EDCs in an environment in question, especially when 
attempting to analyze complex mixtures. This would not only help with the identification and 
quantification of EDCs in MWWEs but also allow regulators to prioritize specific treatment plants 
when reviewing future upgrades, with the potential of less investment in time, cost and use of live 
animals.  
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APPENDIX: SUPPLEMENTAL FIGURES AND TABLES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental figures and tables are included in this chapter. The figure or table is presented x.y, 
where x indicates chapter number; y indicates figure or table number.  
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Figure A2.1 - Example of dose-response expressed as relative changes compared to the solvent 
control (SC) of extracts of influents and effluents at 0.1x, 0.3x, 1.0, 3.0x and 10x concentrations 
from Regina during spring determined by MDA-kb2 in vitro Assay. Results are represented as the 
mean ± SEM (n=4). Dashed line represents baseline (controls). 
 
 
 
 
Figure A2.2 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from Regina and Saskatoon 
determined by MVLN in vitro Assay during four seasons. Results are represented as the mean ± 
SEM (n=4). Dashed line represents baseline (controls).  
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Figure A2.3 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from Regina and Saskatoon 
determined by MDA-kb2 in vitro Assay during four seasons. Results are represented as the mean 
± SEM (n=4). Dashed line represents baseline (controls).  
 
 
 
 
Figure A2.4 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from Regina and Saskatoon 
determined by H295R Steroidogenesis Assay during four seasons. Results are represented as the 
mean ± SEM (n=4). Dashed line represents baseline (controls).  
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Figure A3.1 - Example of dose-response expressed as relative changes compared to the solvent 
control (SC) of extracts of influents and effluents at 0.1x, 0.3x, 1.0, 3.0x and 10x concentrations 
from Regina during spring determined by MDA-kb2 in vitro Assay. Results are represented as the 
mean ± SEM (n=4). Dashed line represents baseline (controls). 
 
  
 
 
 
 
Figure A3.2 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from six WWTPs determined by 
MVLN in vitro Assay during spring of 2014. Results are represented as the mean ± SEM (n=4). 
Dashed line represents baseline (controls).  
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Figure A3.3 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from six WWTPs determined by 
MVLN in vitro Assay during summer of 2014. Results are represented as the mean ± SEM (n=4). 
Dashed line represents baseline (controls).  
 
 
 
 
 
 
Figure A3.4 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from six WWTPs determined by 
MDA-kb2 in vitro Assay during spring of 2014. Results are represented as the mean ± SEM (n=4). 
Dashed line represents baseline (controls).  
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Figure A3.5 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from six WWTPs determined by 
MDA-kb2 in vitro Assay during summer of 2014. Results are represented as the mean ± SEM 
(n=4). Dashed line represents baseline (controls).  
 
 
 
 
 
 
Figure A3.6 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from six WWTPs determined by 
H295R in vitro Assay during spring of 2014. Results are represented as the mean ± SEM (n=4). 
Dashed line represents baseline (controls).  
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Figure A3.7 – Cytotoxicity assay expressed as relative changes compared to the solvent control 
(SC) of extracts of influents and effluents (10x concentrated) from six WWTPs determined by 
H295R in vitro Assay during summer of 2014. Results are represented as the mean ± SEM (n=4). 
Dashed line represents baseline (controls).  
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Endpoint High concern Low concern
Treatment plant Regina Saskatoon 
Population Served 215,106 246,376
Treatment type
Primary – Lagoon 
system with 
phosphorous removal 
Tertiary – with 
Biological nutrient 
removal (BNR), 
Conventional activated 
sludge
Primary treatment
Bar screen, grit removal 
and Primary clarifier
Bar screen, grit 
removal,and  primary  
clarifier
Secondary 
treatment
Aeration, biological or 
bacterial removal of 
solids and other 
pollutants within 
lagoons
Biological nutrient 
removal (BNR), 
aeration and secondary 
clarifier.
Advanced 
treatment
Chemical phosphorus 
removal
Chemical phosphorus 
removal and nitrogen
Disinfection Seasonal UV 
sterilization (April-
November)
UV sterilization
Nitrification No Yes
Ammonia (mg/L) 1.2-41.2 4.5-42.6
Solids Retention 
Time
>30 d <12 hours
Flow Capacity 
(m3/day) - Dry 
season
70,000 90,000
Flow Capacity 
(m3/day) - 
Rainfal/snow melt 
season
- 285,000
Flow (m3/day) - 
Maximum capacity
- 300,000
Geological 
Locations
Southern Saskatchewan Central Saskatchewan
Upstream 
Watershed
Urban, Agricultural Agricultural
Receiving Water
Wascana Creek
South Saskatchewan 
River
Dilution Very low > 1% High ~ 94 - 99%
Overflow            Bypasses Wascana 
Creek following special 
analysis
Treated
Caracteristics - 
Hospital Effluents?
Residential, 
commercial and 
hospitals
Yes - Residential, 
commercial and 
hospitals
Future upgrades Build a new WWTP 
within 4 years to attend 
increased population 
and implemetation of 
nutrient removal 
process
None are planned
Table A2.1: Characteristics of Regina and Saskatoon WWTPs. Information obtained through a 
collaboration between WWTPs’ personnel and the AIME project. Concentrations below than 
Method of detection limit (<MDL). (-) Data not available.   
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Table A2.2 – Summary of analytical results detected by Orbitrap Liquid Chromatography-Mass 
Spectrometry (LC-MS) expressed as ng/L in samples of influents and effluents from Regina and 
Saskatoon WWTPs during spring and summer of 2014 for 19 emergent contaminants.  
 
 
Endpoint Formula Uses Season
Influent Effluent Influent Effluent
Atrazine C8H14ClN5 Herbicide spring <MDL <MDL 0.1 0.1
summer 1.1 0.1 0.5 0.2
Caffeine C8H10N4O2 Stimulant spring 135.9 9.7 62.6 <MDL
summer 626.7 3.3 459.5 178.1
Carbamazepine C15H12N2O Anticonvulsant spring 7.8 7.6 1.7 0.7
summer 14.7 0.9 17.6 8.8
Clofibrate C12H15ClO3 Antihyperlipidemic spring 52.7 37.8 35.9 39.8
summer 48.1 <MDL 43.5 30.9
DEET C12H17NO Insecticide spring 671.1 395.5 152.1 10.3
summer 7814.5 25.5 6702.1 3168.8
Diazepam C16H13ClN2O Benzodiazepine spring 0.8 0.2 0.0 <MDL
summer <MDL <MDL 0.1 0.1
EE2 C20H24O2 Ovulation inhibitor spring <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL
Estradiol C18H24O2 Reproductive hormone spring <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL
Estrone C18H22O2 Reproductive hormone spring <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL
Gemfibrozil C15H22O3 Antihyperlipidemic spring <MDL <MDL <MDL <MDL
summer 268.2 <MDL <MDL <MDL
Ibuprofen C13H18O2 Anti-inflammatory spring <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL
Naproxen C14H14O3 Anti-inflammatory spring <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL
Pentachlorophenol C6HCl5O Pesticide spring <MDL <MDL <MDL <MDL
summer 1.1 <MDL <MDL <MDL
Progesterone C21H30O2 Reproductive hormone spring 2.3 <MDL <MDL <MDL
summer 2.3 <MDL 1.8 <MDL
Testosterone C19H28O2 Reproductive hormone spring <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL
Triclocarban C13H9Cl3N2O Antimicrobial disinfectant spring <MDL <MDL <MDL <MDL
summer 0.3 <MDL <MDL <MDL
Triclosan C12H7Cl3O2 Antimicrobial disinfectant spring 87.0 29.0 6.1 0.2
summer 85.3 0.4 140.7 8.7
Trimethoprim C14H18N4O3 Antibiotic spring <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL
D3-Caffeine - Stimulant spring 56.9 78.1 93.3 98.2
summer 116.0 78.6 59.7 76.0
Regina Saskatoon
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Table A2.3: Collection dates mean temperature (°C) of water and day. 
 
 
 
 
 
 
 
 
 
 
 
°C Effluent °C Day °C Effluent °C Day °C Effluent °C Day °C Effluent °C Day
Day 1 2.0 -2.5 22.0 21.9 5.0 -8.2 5.0 -10.9
Day 2 4.0 -12.5 22.0 22.3 4.0 -9.3 2.0 -19.6
Day 3 2.0 -14.7 22.0 20.4 4.0 -11.2 2.0 -21.5
Day 4 22.0 21.2
Mean 2.7 -9.9 22.0 21.5 4.3 -9.6 3.0 -17.3
°C Effluent °C Day °C Effluent °C Day °C Effluent °C Day °C Effluent °C Day
Day 1 9.4 -13.9 17.50 21.7 14.30 -11.5 9.1 -8.0
Day 2 11.8 -11.0 17.60 20.0 13.00 -13.9 9.5 -16.0
Day 3 10.20 -22.2 9.4 -14.2
Mean 10.6 -12.5 17.6 20.9 12.5 -15.9 9.3 -12.7
Day of Collection
Day of Collection
Regina
Saskatoon
Spring Summer Early Winter Late Winter
Spring Summer Early Winter Late Winter
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Table A2.4: Occurrence of Carbamazepine, Clofibrate, DEET, and Triclosan in Influent and 
Effluents from WWTPs. 
 
 
 
Chemical Influent Effluent Location Authors
Removal 
Efficiency
Carbamazepine 325-1,850 940-1,510 Austria Clara et al. (2005)
33–426 Canada
Metcalfe et al. (2003); Miao et 
al. (2003 and 2005); Gagne et 
al. (2006); Arlos et al. (2015)
60-108 China Sui et at. (2010)
10-20% 
(Primary), 
Negative 
(Secondary 
Treatment)
1075–6,300 Germany
Heberer (2002b); Hummel et 
al. (2006); Ternes et al. (2003)
8%
291 Italy Zuccato et al. (2004)
15-270 81–86 Japan
Okuda et al. (2008); Nakada et 
al. (2006, 2007 and 2008)
120-310
Mediterranean 
coast
Gómez et al. (2007)
73–729 South Korea
Kim et al. (2007); Choi et al. 
(2008); Behera et al. (2011)
<MDL-950 Spain Gros et al. (2006)
290–960 Taiwan
Chen et al. (2008); Lin et al. 
(2005)
152–4,596 UK
Kasprzyk-Hordern et al. (2009); 
Zhang and Zhou (2007); Zhou 
et al. (2009)
33–270 USA
Guo and Krasner (2009); 
Spongberg and Witter (2008); 
Vanderford and Snyder (2006); 
Glassmeyer et al. (2005); 
Skadsen et al. (2004)
Range <MDL-1,850 33-6,300 8-20%
Concentration ng/L
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Chemical Influent Effluent Location Authors
Removal 
Efficiency
Clofibrate 37 Canada Brun et al. (2006)
China Sui et at. (2010)
<20% 
(Primary),  
<60% 
(Secondary 
Treatment)
Germany Ternes (1998); Heberer (2002b) 0-51%
<MDL-110 Spain Gros et al. (2006)
360 60-990 Switzerland
Tauxe-Wuersch et al. (2005); 
Tixier et al. (2003)
Range <MDL-360 37-990 0-60%
DEET 10-10,000 140 Australia
Costanzo et al. (2007); French 
et al. (2015)
600-1,200 China
Qian et al. (2010); Sui et at. 
(2010)
Negative 
(Primary),  
65-85% 
(Secondary 
Treatment)
3,000 1,500 Germany Knepper et al. (2004)
88-2,238 Singapore Tran et al. (2013) 20%-55%
180-2,100 USA Glassmeyer et al. (2005)
Range 10-10,000 140-2,238 20-85%
Triclosan 23-434 Australia Ying and Kookana (2007)
10-4,010 10-960 Canada
Lishman et al. (2006); Waiser et 
al. (2011); Arlos et al. (2015)
>95%
1,200 10-600 Germany Bester (2003 and 2005)
2,700-11,900 260-270 Japan Nakada et al. (2008 and 2010)
380 160 Sweden Bendz et al. (2005) 
42-213 Switzerland Singer et al. (2002)
340-3,100 UK
Kanda et al. (2003); Sabaliunas 
et al. (2003); Thompson et al. 
(2005)
>95%
2,700-26,800 30-2,700 USA
McAvoy et al. (2002); Fair et al. 
(2009)
>95%
Range 0-26,800 10-3,100 >95%
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Mean SD Mean SD
Atrazine 0.0 0.0 0.0 0.0
Caffeine 44.3 10.5 9.8 17.0
Carbamazepine 270.8 116.7 285.7 68.0
DEET 369.4 110.0 0.0 0.0
EE2 0.0 0.0 18.6 5.5
Progesterone 17.5 16.3 70.0 5.7
Testosterone 74.5 8.4 34.4 4.7
Triclosan 48.6 14.8 70.2 3.3
 Influents (%) Effluents (%)
Chemicals
Table A2.5: Extraction recovery (%) of spiked water samples from influent and effluent. Each 
sample was spiked in triplicate, average results are shown (n=3). 
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Table A2.6 - Chemical standard used for Orbitrap analysis and sample spikes 
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Endpoint
Treatment plant Saskatoon Guelph Quebec City Regina Kitchener Montreal
Population Served 246,376 131,794 531,000 215,106 233,222 1,700,000
Treatment type
Tertiary – with 
Biological nutrient 
removal (BNR), 
Conventional activated 
sludge
Tertiary (Conventional 
and extended aeration 
activated sludge)
Secondary -Enhanced 
CPT, UV disinfection
Primary – Lagoon 
system with 
phosphorous removal 
Secondary 
(Conventional 
activated sludge)
Primary - Lagoon with 
phosphorous removal
Primary treatment
Bar screen, grit 
removal,and  primary  
clarifier
Bar screen, grit 
removal, primary 
clarifier, sedimentation
Bar screen, grit removal 
and primary clarifier
Bar screen, grit removal 
and Primary clarifier
Bar screen, grit 
removal, primary 
clarifier
Bar screen, grit 
removal, coagulant and 
polymer injection, 
sedimentation
Secondary 
treatment
Biological nutrient 
removal (BNR), 
aeration and secondary 
clarifier.
Aeration, secondary 
clarifier
Aeration, biofiltration 
and secondary clarifier
Aeration, biological or 
bacterial removal of 
solids and other 
pollutants within 
lagoons
Fine aeration bubbles 
and secondary clarifier
None
Advanced 
treatment
Chemical phosphorus 
removal and nitrogen
Rotating Bacterial 
Contactors, Sand filters
Enhanced Chemical 
phosphorus treatment
Chemical phosphorus 
removal
Chemical phosphorus 
removal
None
Disinfection
UV sterilization
Sodium hypochlorite 
(chlorination); Sodium 
Bisulphite (de-
chlorination)
Seasonal UV sterilization 
(May-October )
Seasonal UV 
sterilization (April-
November)
(Chlorination when UV 
system is not working 
properly)
None
Nitrification Yes Yes No No Yes No
Ammonia (mg/L) 4.5-42.6 0.1-1.5 5.0-25.0 1.2-41.2 13.4-29.1
Approx. 0.05 (non 
ionised)
Solids Retention 
Time
<12 hours >10 d - >30 d TP1 <2 - TP2 5.4 d -
Flow Capacity 
(m3/day) - Dry 
season
90,000 45,942 388,000 70,000 65,858 2,500,000
Flow Capacity 
(m3/day) - 
Rainfal/snow melt 
season
285,000 - - - - 7,600,000
Flow (m3/day) - 
Maximum capacity
300,000 - 1,200,000 - - -
Geological 
Locations
Central Saskatchewan Southern Ontario
Appalachain province 
(type A8) Paleozoique 
(cambrian to inferior 
ordovician), Mudrock, 
conglomerate, 
sandstone & limestone
Southern Saskatchewan Southern Ontario
St. Lawrence Platform, 
Paleozoic (Sup. 
ordovician - mid), Black 
river Trenton group, 
Limestone, shale, 
dolomite and 
sandstone. 
Upstream 
Watershed
Agricultural Urban Suburban Urban, Agricultural Urban Heavily Urbanized
Receiving Water South Saskatchewan 
River
Speed River (a trib of 
the Grand River)
St. Lawrence River Wascana Creek Grand River St. Lawrence River
Dilution High ~ 94 - 99% Lower <20% High ~ 94 - 99% Very low > 1% Low 1-10% -
Overflow            
Treated Treated
Retention basins with a 
total capacity of 142 
000m3, overflow is 
mixed with rainwater 
and sent to the 
treatment plant. Excess 
is released, mixed, into 
local waters
Bypasses Wascana 
Creek following special 
analysis
Treated
Not treated  discharged 
into the St. Lawrence 
River
Caracteristics - 
Hospital Effluents?
Yes - Residential, 
commercial and 
hospitals
-
Yes - 4 mean of 2,141 
m3/day
Residential, 
commercial and 
hospitals
- Yes - 25 hospitals
Future upgrades
None are planned
Membrane Bioreactors, 
TP removal
None are planned
Build a new WWTP 
within 4 years to attend 
increased population 
and implemetation of 
nutrient removal 
process
Nitrification, filtration
Add a terminal  
disinfection process 
using ozone (capacity 
of 40 m3/seconds) 
High concernLow concern
Table A3.1: Characteristics of all six WWTPs in Canada. Information obtained through a 
collaboration between WWTPs’ personnel and the AIME project. Concentrations below than 
Method of detection limit (<MDL). Data not available (-).  
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Mean SD Mean SD
Atrazine 0.0 0.0 0.0 0.0
Caffeine 44.3 10.5 9.8 17.0
Carbamazepine 270.8 116.7 285.7 68.0
DEET 369.4 110.0 0.0 0.0
EE2 0.0 0.0 18.6 5.5
Progesterone 17.5 16.3 70.0 5.7
Testosterone 74.5 8.4 34.4 4.7
Triclosan 48.6 14.8 70.2 3.3
 Influents (%) Effluents (%)
Chemicals
Table A3.2 – Summary of analytical results detected by Orbitrap LC-MS expressed as ng/L in 
samples of influents and effluents from six WWTPs across Canada during spring and summer of 
2014 for 19 emergent contaminants. Concentrations below the method detection limit (<MDL). 
Samples not available for chemicals analysis (N/A).  
 
 
Table A3.3: Extraction recovery (%) of spiked water samples from influent and effluent. Each 
sample was spiked in triplicate, average results are shown (n=3). 
 
 
 
 
 
 
Endpoint Formula Uses Season
Influent Effluent Influent Effluent Influent Effluent Influent Effluent Influent Effluent Influent Effluent
Atrazine C8H14ClN5 Herbicide spring 0.09 0.06 <MDL <MDL 6.06 0.33 1.93 0.61 <MDL 0.23 0.73 10.11
summer 0.52 0.16 1.06 0.08 0.08 0.21 22.09 N/A <MDL <MDL <MDL 1.05
Caffeine C8H10N4O2 Stimulant spring 62.56 <MDL 135.85 9.74 215.38 6.29 751.39 <MDL 3.57 288.33 20.93 660.90
summer 459.50 178.06 626.70 3.27 252.41 2.49 1,033.42 N/A 354.19 660.70 <MDL 368.64
Carbamazepine C15H12N2O Anticonvulsant spring 1.66 0.65 7.84 7.62 5.07 18.90 2.25 1.24 0.05 15.86 1.22 5.33
summer 17.61 8.79 14.70 0.91 5.82 16.55 29.90 N/A 0.47 2.93 <MDL 0.54
Clofibrate C12H15ClO3 Antihyperlipidemic spring 35.90 39.82 52.73 37.80 <MDL 109.35 63.68 <MDL <MDL 90.77 27.89 <MDL
summer 43.49 30.93 48.14 <MDL 31.20 78.96 <MDL N/A <MDL <MDL <MDL <MDL
DEET C12H17NO Insecticide spring 152.12 10.29 671.07 395.45 179.27 74.38 70.28 7.68 3.15 168.15 56.21 6.98
summer 6,702.12 3,168.79 7,814.49 25.54 1,603.63 61.14 3,161.11 N/A 28.25 113.70 <MDL 34.41
Diazepam C16H13ClN2O Benzodiazepine spring 0.03 <MDL 0.82 0.22 <MDL <MDL <MDL <MDL <MDL 0.48 <MDL 0.08
summer 0.06 0.11 <MDL <MDL 0.04 <MDL <MDL N/A <MDL <MDL <MDL <MDL
EE2 C20H24O2 Ovulation inhibitor spring <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL <MDL <MDL <MDL N/A <MDL <MDL <MDL <MDL
Estradiol C18H24O2 Reproductive hormone spring <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL <MDL <MDL <MDL N/A <MDL <MDL <MDL <MDL
Estrone C18H22O2 Reproductive hormone spring <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL
summer <MDL <MDL <MDL <MDL <MDL <MDL <MDL N/A <MDL <MDL <MDL <MDL
Gemfibrozil C15H22O3 Antihyperlipidemic spring <MDL <MDL <MDL <MDL 23.13 <MDL <MDL <MDL <MDL <MDL <MDL 16.40
summer <MDL <MDL 268.22 <MDL <MDL <MDL <MDL N/A <MDL 17.31 <MDL <MDL
Ibuprofen C13H18O2 Anti-inflammatory spring <MDL <MDL <MDL <MDL 8,813.05 <MDL <MDL <MDL 202.72 <MDL <MDL 687.90
summer <MDL <MDL <MDL <MDL <MDL <MDL 41,618.64 N/A 543.31 1,637.31 374.47 194.13
Naproxen C14H14O3 Anti-inflammatory spring <MDL <MDL <MDL <MDL 895.16 <MDL <MDL <MDL <MDL <MDL <MDL 18.73
summer <MDL <MDL <MDL <MDL <MDL <MDL 11,446.64 N/A 72.20 320.99 17.32 <MDL
Pentachlorophenol C6HCl5O Pesticide spring <MDL <MDL <MDL <MDL 4.59 <MDL <MDL <MDL <MDL <MDL <MDL 0.36
summer <MDL <MDL 1.08 <MDL <MDL <MDL 1.45 N/A 0.08 1.12 <MDL 1.26
Progesterone C21H30O2 Reproductive hormone spring <MDL <MDL 2.31 <MDL 13.05 <MDL 1.58 <MDL <MDL <MDL 0.87 7.47
summer 1.78 <MDL 2.31 <MDL 0.62 <MDL 9.32 N/A <MDL <MDL <MDL <MDL
Testosterone C19H28O2 Reproductive hormone spring <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL 1.58
summer <MDL <MDL <MDL <MDL <MDL <MDL 93.44 N/A <MDL <MDL <MDL <MDL
Triclocarban C13H9Cl3N2O Antimicrobial disinfectant spring <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL 1.08
summer <MDL <MDL 0.26 <MDL <MDL <MDL <MDL N/A <MDL <MDL 0.91 <MDL
Triclosan C12H7Cl3O2 Antimicrobial disinfectant spring 6.06 0.23 87.03 28.95 60.51 3.79 24.11 1.76 7.13 53.36 7.24 62.63
summer 140.74 8.74 85.33 0.37 34.07 2.27 1,427.69 N/A 15.68 106.08 1.52 13.93
Trimethoprim C14H18N4O3 Antibiotic spring <MDL <MDL <MDL <MDL 2.26 <MDL <MDL <MDL <MDL <MDL <MDL 0.75
summer <MDL <MDL <MDL <MDL <MDL <MDL 1.31 N/A 0.39 0.71 <MDL 0.90
D3-Caffeine - Stimulant spring 93.30 98.20 56.90 78.10 79.60 94.50 65.10 20.50 42.60 38.30 59.70 82.70
summer 59.70 76.00 116.00 78.60 66.10 89.30 92.80 N/A 74.00 38.30 86.10 59.20
MontrealReginaSaskatoon Guelph Kitchener Quebec
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Table A3.4 - Chemical standard used for Orbitrap analysis and sample spikes 
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Table A3.5: Occurrence of Carbamazepine, Clofibrate, DEET, Gemfibrozil, Ibuprofen, Naproxen, 
Progesterone, Testosterone, and Triclosan in Influent and Effluents from WWTPs. 
 
 
Chemical Influent Effluent Location Authors
Carbamazepine 325-1,850 940-1,510 Austria Clara et al. (2005)
33–426 Canada
Metcalfe et al. (2003); Miao et 
al. (2003 and 2005); Gagne et 
al. (2006); Arlos et al. (2015)
60-108 China Sui et at. (2010)
1075–6,300 Germany
Heberer (2002b); Hummel et 
al. (2006); Ternes et al. (2003)
291 Italy Zuccato et al. (2004)
15-270 81–86 Japan
Okuda et al. (2008); Nakada et 
al. (2006, 2007 and 2008)
120-310
Mediterranean 
coast
Gómez et al. (2007)
73–729 South Korea
Kim et al. (2007); Choi et al. 
(2008); Behera et al. (2011)
<MDL-950 Spain Gros et al. (2006)
290–960 Taiwan
Chen et al. (2008); Lin et al. 
(2005)
152–4,596 UK
Kasprzyk-Hordern et al. (2009); 
Zhang and Zhou (2007); Zhou 
et al. (2009)
33–270 USA
Guo and Krasner (2009); 
Spongberg and Witter (2008); 
Vanderford and Snyder (2006); 
Glassmeyer et al. (2005); 
Skadsen et al. (2004)
Range <MDL-1,850 33-6,300
Range    
(Current study)
0.05-29.90 0.54-18.90 
Concentration ng/L
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Chemical Influent Effluent Location Authors
Clofibrate 37 Canada Brun et al. (2006)
China Sui et at. (2010)
Germany Ternes (1998); Heberer (2002b)
<MDL-110 Spain Gros et al. (2006)
360 60-990 Switzerland
Tauxe-Wuersch et al. (2005); 
Tixier et al. (2003)
Range <MDL-360 37-990
Range    
(Current study)
27.89-63.38 30.93-109.35
Chemical Influent Effluent Location Authors
DEET 10-10,000 140 Australia
Costanzo et al. (2007); French 
et al. (2015)
600-1,200 China
Qian et al. (2010); Sui et at. 
(2010)
3,000 1,500 Germany Knepper et al. (2004)
88-2,238 Singapore Tran et al. (2013)
180-2,100 USA Glassmeyer et al. (2005)
Range 10-10,000 140-2,238
Range    
(Current study)
3.15-7,814 6.98-3,168 
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Chemical Influent Effluent Location Authors
Gemfibrozil 2,000-3,800 >MDL-2,800 Australia Ying et al. (2009)
59-3,380 Canada
Metcalfe et al. (2003b); Gagne 
et al. (2006); Waiser et al. 
(2011b)
4,760 Europe Andreozzi et al., 2003
60-1,350 France Quinn et al. (2008)
0.71 Greece Quinn et al. (2008)
810-4,760 Italy Quinn et al. (2008)
1,000-6,800 Spain Bueno et al. (2012)
Range 2,000-3,800 0.71-6,800
Range    
(Current study)
23.13 and 
268.22 
16.40 and 
17.31 
Chemical Influent Effluent Location Authors
Ibuprofen 384-4,000 Canada
Metcalfe et al. (2003); Lishman 
et al. (2006); Zorita et al. (2009)
3,350 Germany
Ternes et al. (1998); Stumpf et 
al. (1996)
Japan Nakada et al. (2006)
14,000 5,000 Spain Bueno et al. (2012)
1,300 Switzerland Tixier et al. (2003)
Range 3,350-14,000 384-5,000
Range    
(Current study)
202.72-
41,618 
194.13-1,637 
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Chemical Influent Effluent Location Authors
Naproxen 600 Brazil Daughton and Ternes (1999)
7,600 Canada Waiser et al. (2011b)
520 Germany Daughton and Ternes (1999)
11,000 Italy Verlicchi et al. (2012)  
1,500 Spain Bueno et al. (2012)
3,700 2,500 Sweden Bendz et al. (2005)
2,600 Switzerland Tixier et al. (2003)
Range 600-11,000 520-7,600
Range    
(Current study)
17.32-11,446 
18-73 and 
320.99 
Chemical Influent Effluent Location Authors
Progesterone 1.5-16.9 Europe Vulliet et al. (2007)
0.2-100 Belgium Pauwels et al. (2008)
408 South Africa Manickum and John (2013) 
72.9-74.2 <MDL USA Esperanza et al., (2007) 
Range 72.9-74.2 <MDL-408
Range    
(Current study)
0.62-13.05 7.47
(I) Guelph 
influent 
samples from 
summer and 
spring, (E) only 
in Montreal  
during spring
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Chemical Influent Effluent Location Authors
Testosterone 24-180 <1 Canada Lee et al. (2004)  
343 11 South Africa Manickum and John (2013) 
89.5 <MDL USA Esperanza et al., (2007) 
Range 24-343 <MDL-11
Range    
(Current study)
93.44 1.58
Chemical Influent Effluent Location Authors
Triclosan 23-434 Australia Ying and Kookana (2007)
10-4,010 10-960 Canada
Lishman et al. (2006); Waiser et 
al. (2011); Arlos et al. (2015)
1,200 10-600 Germany Bester (2003 and 2005)
2,700-11,900 260-270 Japan Nakada et al. (2008 and 2010)
380 160 Sweden Bendz et al. (2005) 
42-213 Switzerland Singer et al. (2002)
340-3,100 UK
Kanda et al. (2003); Sabaliunas 
et al. (2003); Thompson et al. 
(2005)
2,700-26,800 30-2,700 USA
McAvoy et al. (2002); Fair et al. 
(2009)
Range 0-26,800 10-3,100
Range    
(Current study)
1.52-1,427 0.37-106.08 
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°C Effluent °C Day °C Effluent °C Day
Day 1 9.4 -13.9 17.50 21.7
Day 2 11.8 -11.0 17.60 20.0
Mean 10.6 -12.5 17.6 20.9
°C Effluent °C Day °C Effluent °C Day
Day 1 2.0 -2.5 22.0 21.9
Day 2 4.0 -12.5 22.0 22.3
Day 3 2.0 -14.7 22.0 20.4
Day 4 22.0 21.2
Mean 2.7 -9.9 22.0 21.5
°C Effluent °C Day °C Effluent °C Day
Day 1 Not available 9.7 Not available 19.5
Day 2 Not available 19.4
Day 3
Day 4
Mean 9.7 19.5
°C Effluent °C Day °C Effluent °C Day
Day 1 Not available 4.7 Not available 15.0
Day 2 Not available 13.4
Day 3
Day 4
Mean 4.7 14.2
°C Effluent °C Day °C Effluent °C Day
Day 1 9.4 -10.8 19.2 12.9
Day 2 19.7 16.7
Day 3 18.2 15.7
Mean 9.4 -10.8 19.0 15.1
°C Effluent °C Day °C Effluent °C Day
Day 1 7.3 -6.3 20.6 7.8
Day 2 20.6 12.6
Mean 7.3 -6.3 20.6 10.2
Kitchener
Spring Summer 
Saskatoon
Regina
Day of Collection
Spring Summer 
Day of Collection
Gueph
Day of Collection
Spring Summer 
Montreal
Day of Collection
Spring Summer 
Day of Collection
Spring Summer 
Quebec
Day of Collection
Spring Summer 
Table A3.6: Collection dates mean temperature (°C) of water and day from six WWTPs. 
 
 
 
 
 
 
 
 
 
 
 
